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Research Abstract  
In the post-genomic era a major paradigm shift occurred in biological research. The ability to 
catalogue all known genes and corresponding nucleotide sequences and to correlate this information 
with disease state, cellular function and phenotype, promised to change scientific approaches. As the 
wealth of genomic data increased, however, it became clear that far more information, in the form of 
the gene products (proteins), was required to put these new data into context. To achieve this, 
proteomics; the systematic analysis of the protein complement to the genome, became key. The 
protein sequence database information derived from gene sequencing heralded mass spectrometry-
based proteomics emergence as an indispensable tool in biological studies. No other analytical tool 
offers the ability to determine the identity, quantity, modification status and cellular stability of 
hundreds to thousands of proteins in relatively short time periods. Continued technological and 
bioinformatics developments have increased the ability of mass spectrometry to catalogue proteomes 
and we are now at a point where close to comprehensive coverages are possible for simple 
organisms.   
An ever increasingly aged western society has seen a steady increase in the prevalence of age-
related diseases. Neurodegenerative diseases, are, like many other age-related diseases associated 
with protein misfolding. The cellular responses to protein misfolding and how they relate to disease 
clinical symptoms are not fully understood. It is, however, commonly accepted that protein misfolding 
is a key component in disease aetiology. Proteome alterations as a result of protein misfolding, 
therefore, represent an important avenue of research to better understand this debilitating category of 
diseases. 
This work describes the use of label-free quantitative proteomics to expand upon currently known 
cellular responses to two misfolding diseases, Alzheimer’s disease and α1-antitrypsin deficiency. 
Initially a GeLC-MS
E
 workflow was developed and successfully utilised to identify proteins that were 
potentially implicated in Aβ42 toxicity and age-related vulnerability to Aβ42 in D. melanogaster. It is 
hoped that follow-up studies will provide more information on how these proteins are functionally 
implicated in the link between ageing and Alzheimer’s disease.  
 [xvi] 
 
Following this, a recently developed proteomic technology, that uses ion mobility to increase system 
peak capacity on the fly, HDMS
E
, was employed to conduct time-course analysis of cellular responses 
to wild-type ageing and chronic Aβ toxicity in D. melanogaster. Using this more comprehensive 
approach, quantitative protein profiles across two lifespans were recorded. The data successfully 
identified large number of proteins that were significantly altered in abundance in relation to age and 
Aβ42 misfolding. The data represent a unique resource for follow-up reductionist and functional 
studies on the link between ageing and Alzheimer’s disease. 
Finally, a subcellular GeLCMS
E 
approach was successful at characterising ER enriched stress 
responses to the misfolding of two α1-antitrypsin variants in relation to the wild-type, well folded and 
fully secreted variant. The present study expands on current pathways implicated in ER stress which 
have been largely characterised by reductionist studies. Interestingly co-fractionating bioenergetic 
components were quantified with large fold changes measured between variants. Follow-up live cell 
confocal imaging correlated these changes with mitochondrial elongation as a result of protein 
misfolding. This represents a novel finding not previously documented for α1-antitrypsin deficiency.  
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Chapter 1. Introduction 
[1] 
 
1 Introduction 
 
1.1 The Development of Mass Spectrometry as an Analytical Technique 
Mass spectrometry is an analytical technique that is sensitive, specific and applicable to a multitude of 
workflows. For this reason, since its introduction by J.J. Thomson et al in 1912, mass spectrometry 
has been adopted as the preferred technique for the measurement of a wide range of analytes [1]. 
Proteins, metabolites, small molecule drugs and lipids to name a few are now routinely detected, 
characterised and quantified in academic and industrial settings by mass spectrometry. 
In its simplest terms mass spectrometry is an analytical technique that allows the accurate 
measurement of an ionised molecule’s mass-to-charge (m/z) ratio. Since its initial development in 
1912 mass spectrometry has seen rapid advancement due to the versatility of the technique. J.J. 
Thomson’s first experiments in 1897 identified that previously unquantified elements within cathode 
rays were deflected by a magnetic field to varying extents, which was later identified to be 
proportional to the particles m/z. Using the deflection properties of protons and electrons Thomson 
was able to ascertain that an electrons’ mass is 1000 times less than a hydrogen atom.  In one of his 
more famous experiments he was able to identify that neon consisted of more than one isotope, using 
the first purpose built mass spectrometer that he and Francis William Aston had built in the previous 
year. The identification of isotopes, which had been previously unknown, was based upon the 
observation of two distinct deflection patterns on photographic plates (Neon-20 & Neon-22). 
Early applications of mass spectrometry focused on the analysis of small molecules with instruments 
that were either built by individual researchers or custom built by physicists interested in isotope 
determination and the study of ion formation. Early instrumentation employed magnetic-sector mass 
analysers. During World War II mass spectrometry was adopted for weapons-grade plutonium 
preparation. This led to the first ever commercialisation of such instrumentation. After WWII, time-of-
flight (ToF) mass analysers, quadrupole mass analysers and gas chromatography (GC) for prior 
compound separation were developed.  These developments made mass spectrometry applicable to 
areas such as organic chemistry and petroleum analysis which had been previously too challenging to 
analyse [2]–[5]. 
Chapter 1. Introduction 
[2] 
 
During the initial years of MS analysis ionisation of compounds for mass analysis was achieved either 
through electron ionisation (EI) or chemical ionisation (CI) [6], [7]. Although EI and CI are still used to 
good effect in small organic compound analysis, both ionisation methods have major limitations. The 
use of high energy electrons to produce molecular ions during EI often results in the complete 
fragmentation of the compound of interest. Subsequent identification of compounds after EI is often 
achieved by fragment ions giving a fragmentation pattern characteristic of the compound in question. 
CI is a lower energy technique that better preserves the original molecule intact and almost 
exclusively produces singly charged ions. The major drawback of the two ionisation methods is the 
inability to generate gas phase ions for larger biological structures such as large peptides and 
proteins that are both non-volatile and thermally labile.     
The introduction of early desorption/ionization techniques were the first steps towards the analysis of 
large biomolecular complexes. Indeed fast atom bombardment (FAB), secondary ion mass 
spectrometry (SIMS) and plasma desorption were all significant steps towards the routine analysis of 
bimolecular complexes [8]–[10]. In particular FAB, which entails the bombardment of a glycerol-
analyte solution with a high energy beam of non-reactive elements provided the first practical 
ionisation method for the study of biopolymers. The requirement of high concentrations of analytes 
due to inefficient ionisation and the inability to study large protein/DNA structures meant that mass 
spectrometry’s applicability to biological sciences was still limited.  
Electrospray ionisation (ESI) and matrix assisted desorption ionisation (MALDI) heralded mass 
spectrometry’s establishment as a technique for the study of bimolecular molecules [11]–[13]. The 
impact was such that in 2002 John Fenn (electrospray ionisation) and Koichi Tanaka (soft laser 
desorption) received the Nobel prize in Chemistry for their work on the “development of methods for 
the identification and structure analysis of biological macromolecules”. ESI in particular is still the 
main ionisation techniques chosen to help answer a variety of biological questions by mass 
spectrometry. These include protein identity, quantity, the presence of post translation modifications, 
subunit connectivity, topology and dynamics.       
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1.2 Electrospray Ionisation (ESI) 
ESI, developed by Fenn et al, uses the generation of a fine liquid aerosol by electrostatic charging to 
generate gas phase ions, Figure 1.1. In electrospray, liquid is passed through a capillary held at a 
high voltage whilst a potential difference exists between the capillary and a counter electrode. The 
application of a high voltage (1-4 kV) causes charge to accumulate at the tip of the capillary. As 
charge accumulates the electrostatic Coulombic attraction to the counter electrode increases. As 
attractive forces increase beyond the point of the solvent surface tension, a spray forms in the shape 
of a pointed cone, termed the Taylor cone. This shape is formed due to droplets of cylindrical shape 
being able to hold more charge than when spherical. The droplets (µm in diameter) that constitute the 
Taylor cone evaporate whilst in flight, thereby reducing in size, resulting in a subsequent increase in 
charge per droplet volume. Similar to the action at the capillary, as charge density increases the 
applied electric field causes deformation of the droplets, eventual formation of a second Taylor cone 
and the ejection of smaller droplets. Each secondary droplet is around 1/10 the size of the ejecting 
droplet, making the ESI process efficient at producing a fine dispersion of liquid prior to large amounts 
of evaporation. It is from this population of highly charged small droplets that the majority of ions 
detected by mass spectrometry originate from.    
 
Figure 1.1 Diagram of the electrospray ionisation process 
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A number of possible ionisation mechanisms exist for ESI but the two predominant models are the ion 
evaporation model (IEM) and the charge residue model (CRM) [14], [15]. Ion evaporation is proposed 
for smaller analyte molecules and predicts that when droplet radii reach a certain limit, analyte 
molecules are desorbed from the surface, taking charge with them as they enter the gas phase. 
Alternatively, in the CRM, molecules, are ionised in a more passive fashion. In the CRM, which is 
thought to be more applicable to macromolecules, droplets undergo the evaporation-ejection process 
leading to the eventual situation where droplets contain an average of one or less analyte per droplet. 
Following eventual evaporation of all solvent, droplet surface charge is retained on the now gas phase 
analyte ion.     
More recently a third mechanism has been proposed that involves both the IEM and CRM. This new 
mechanism states that IEM can occur before CRM and that the mode of ionisation is dependent on 
electric field strength at ion emission [16]. Ions with low requirements for electric field strength are 
emitted from the droplet via the IEM until depleted. Ions with higher requirements for field strength 
(larger analytes) are retained within the droplet and become gaseous ions via the CRM.    
One of the beneficial characteristics of ESI is the production of multiply charged ions. If several 
ionisable sites are present then a number of these will be charged at any one time. During peptide 
and protein analysis this is observed as a charge state distribution. This is of particular advantage 
when analysing large molecules such as proteins, as it reduces the analyte m/z to a mass range that 
is optimal for data acquisition by commercial mass spectrometers. 
 
1.3 Nanoelectrospray Ionisation (nESI) 
ESI efficiency is largely governed by the size of the primary droplets. ESI flow rates of 1 ml – 10 µl 
min
-1
 mean that high temperature and pneumatic nebulization are required for adequate aerosol 
formation and efficient desolvation.  Lower flow rates are employed during nESI, as developed by 
Wilm and Mann, ( < 500 nl min
-1
) and efficiently produces smaller droplets than ESI without the need 
for heat or sheath gas [17], [18]. nESI is performed with glass capillaries that have orifices with 
diameters in the range of 1-10 µm. For applications that require direct infusion the use a conductive 
material, e.g. gold, coated on the capillaries ensures adequate sample charging. For high-throughput 
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workflows, where MS analysis is coupled to chromatographic systems, charge can be applied at the 
nano-junction between column and capillary.  
An obvious benefit of nESI, is the small sample amounts required for analysis. This has led to its 
widespread adoption in workflows where analysis is often sample limited, such as discovery 
proteomics, biomarker screening and metabolomics. Another benefit of nESI in such workflows is its 
increased tolerance for background ions such as salts. This is especially pertinent for quantitative 
proteomics where label-free quantification is sensitive to the matrix effects. The increased tolerance 
afforded by nESI originates from the production of smaller, but more highly charged droplets than 
those produced during ESI. Less droplet desolvation and fewer off-spring generations are therefore 
required during nESI prior to ion generation. As desolvation increases droplet concentration, reduced 
desolvation levels equates to reduced salt concentrations prior to ion formation. 
 
1.4 Mass Analysers 
Post ion production, ions are separated in relation to their m/z ratio where m/z analysis is based upon 
ion behaviour within an electric and/or magnetic field. Numerous mass analysers have been 
developed for the measurement of ion m/z ratios. The mass analyser chosen for use depends on both 
the application in question and the budgetary requirements of the laboratory. Broadly speaking there 
are two classes of mass analysers, analysers that perform quasi-simultaneous transmission/detection 
of ions, (time-of-flight (TOF), Orbitrap) and analysers that scan across an m/z region over a set period 
of time (quadrupoles, magnetic sectors). 
 
1.4.1 Quadrupoles 
Transmission quadrupoles or quadrupole mass filters are perhaps the most simple in design of 
common mass analysers currently in use. Quadrupoles, as the name suggests, consist of four 
hyperbolic rods arranged symmetrically, Figure 1.2. Opposing rods are connected electrically and a 
radio frequency (RF) voltage is applied between each pair of rods. A direct current is superimposed 
on the RF voltage. At any given RF voltage only ions of a particular m/z ratio range will have a stable  
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Figure 1.2 Representation of stable ion path through a quadrupole mass analyser 
trajectory and successfully reach the detector. Unstable ions will collide with the rods and not be 
detected. Based on a required transmission window (m/z range), the required RF and DC voltage 
components can be calculated using the reduced Mathieu equation, Equation 1.1-1.3, where qx and 
ax are used to calculate the amplitudes of both components. Here z is the ion charge, e is the total 
charge of an electron, r0 is half the distance between opposing rods, m is the ion mass and ω is the 
angular frequency of an ion. The stable path of a particular ion is defined by the magnitude of the RF 
voltage V and by the ratio U/V where U is the direct current magnitude.   
Equation 1.1 
𝑎𝑥 =  −𝑎𝑦 =
4𝑧𝑒𝑈
𝑚𝑖𝑟0
2𝜔2
 
Equation 1.2 
𝑞𝑥 =  −𝑞𝑦 =  
2𝑧𝑒𝑉
𝑚2𝑟2𝜔2
 
Equation 1.3 
𝜏 =
𝜔𝑡
2
 
 
In order to obtain a full mass spectrum, quadrupoles can be set to scan across a chosen m/z range, 
Figure 1.3. The number of steps used during the scan is proportional to spectrum mass resolution 
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and inversely proportional to duty cycle. For this reason, although the maximum resolving power of a 
typical quadrupole is ~ 3,000, they are most often operated in unit mass resolution, representing the 
ideal trade-off between required resolution and duty cycle. Alternatively quadrupoles can be used in 
RF mode only, where they act as high-mass filters to transfer ions between regions of mass 
spectrometers.        
 
Figure 1.3 Ion stability graph as a function of DC and RF voltage. Triangles indicate stable regions for ions of different 
masses. Solid line indicates the quadrupole mass scan that would successively transmit the three different ions   
  
1.4.2 Time of Flight (ToF) 
The first published design of a linear ToF mass spectrometer was presented in 1952 by William E. 
Stephens [19]. All ToF mass analysers operate on the principle of measuring the time required for an 
ion to travel from an ion source to a detector. For this reason, unlike quadrupole mass analysers that 
operate with a continuous flow of ions, TOF mass analysers require pulses of ions to measure m/z.  
During ToF mass acquisitions, packets of ions are accelerated by a potential difference V, within an 
acceleration region. Ion packets are either generated by an intermittent ionisation process, such as 
MALDI, or if coupled to a continuous ionisation source by the transient application of potential 
energies.  The application of a constant potential results in all ions acquiring the same amount of 
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kinetic energy. Ions leaving the acceleration region enter a field free region, commonly referred to as 
the flight tube, which is maintained at a high vacuum (E
-7 
Torr). By measuring the time taken for each 
ion to reach the detector, which is positioned at the end of the field free region, the m/z of an ion can 
be calculated using Equation 1.4-1.8 
As mentioned all ions receive the same kinetic energy in the acceleration region which is given by: 
Equation 1.4 
𝑞𝑉 = 𝑧𝑒𝑉 = 𝐸 =
1
2𝑚𝑣2
 
Where m = ion mass, q = total ion charge, V= push voltage, z= ion charge, e= electron charge, E= 
total energy and v= ion velocity. Further to this the time taken t for an ion to traverse the field free 
region is given by:  
Equation 1.5 
𝑡 =
𝑠
𝑣
 
Where s = distance and v = ion velocity. Upon substitution of v with Equation 1.4 gives:  
Equation 1.6 
𝑡 =
𝑠
√
2𝑒𝑧𝑉
𝑚𝑖
 
Finally rearrangement of Eq. reveals the relationship between time taken for an ion to reach the 
detector and its m/z 
Equation 1.7 
𝑡 =
𝑠
√2𝑒𝑉
 √
𝑚𝑖
𝑧
 
With the knowledge that  
𝑠
√2𝑒𝑉
 is a constant, it is clear that t and m/z are directly proportional. 
Calibration of a ToF mass analyser with chemicals that yield ions of known m/z ratios can be used to 
calculate the constant within Equation 1.7. 
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Linear ToF analysers offer a high level of sensitivity as transmission efficiency is close to 90 % with 
low levels of losses caused by collisions with residual gases. Due to the quasi-simultaneous detection 
of ions, ToF analyser also offer much faster acquisition speeds than quadrupole analysers. A 
spectrum can be obtained across a large m/z region in a µsec time period. Another benefit of ToF 
analysers is the high mass detection limits afforded, which, given an infinitely long flight tube is 
theoretically limitless. Practically ToF analysers offer the highest mass range of all commercially 
available mass analysers. Indeed in 2013 a ToF analyser was used by Snijder and co-workers during 
the native MS analysis of a 18 MDa virus, highlighting the ability of ToF instrumentation to detect very 
large ions [20]. The main limitation of linear ToF analysers is the low mass resolution that is 
obtainable. Resolution is limited due to a number of factors. Theoretically all ions prior to acceleration 
have zero kinetic energy and are focused into the same region with little spread. This, however, is not 
true in practice with size of the ion volume, length of ion formation pulse (for pulsed ionisation 
methods) and initial kinetic energy variations all contributing to reduced mass resolution, Figure 1.4. 
The most obvious method for increasing the resolving power of a ToF analyser is to increase the 
length of the flight tube, but this however can become impractical for use in laboratories. Expanding 
upon Equation 1.7 shows the direct relationship between flight tube length and mass resolution.  
Equation 1.8 
𝑚
𝑧
= (
2𝑒𝑈
𝑆2
) 𝑡2 
and integrating 
Equation 1.9 
1
𝑧
 𝑑𝑚 = (
2𝑒𝑈
𝑆2
) 2𝑡 𝑑𝑡  
Gives 
Equation 1.10 
𝑚
𝑑𝑚
=
𝑡
2𝑑𝑡
 
Equation 1.11     
Finally  
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𝑅 =
𝑚
𝛥𝑚
=
𝑡
2𝛥𝑡
~
𝑆
2𝛥𝑥
  
 
Where m is mass, t is flight time, Δm and Δt are the peak width at ½ levels on the mass and time 
scales respectively. Δx denotes the ion packet thickness as it approaches the detector. 
The use of delayed pulse extraction, where a time lag between ionisation and extraction is introduced, 
overcomes differences in initial ion kinetic energies [22]. Ions in the source are allowed to expand into 
a field-free region for a period up to several microseconds before an extraction pulse is applied. The 
result of this delayed pulse is that ions with more initial kinetic energy are further from the source of 
acceleration when the pulse is applied and therefore receive less energy than ions which were closer 
to the source. 
 
Figure 1.4 Time, space and kinetic energy distributions of ions during time of flight that cause of reduction in data mass 
resolution. Adapted from [21] 
Even with delayed pulse extraction the kinetic energy dispersion of ions limits the resolution of linear 
ToF analysers. The use of an electrostatic reflector, more commonly known as a reflectron is an 
effective way to reduce the effects of kinetic energy dispersion, thereby improving mass resolution 
[23]. In its most simple form a reflectron consists of a retarding electric field located opposite the ion 
source and at the end of the field-free region, Figure 1.5. The electric field is composed of a series of 
electrodes (or rings) at an increasing potential. Ions entering the field are slowed by the field until they 
reach zero kinetic energy at which point they are accelerated out of the field in the opposite direction 
they entered. Ions with more kinetic energy will travel further through the reflectron than lower energy 
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ions. This path length differential corrects for time-of-flight differences due to kinetic energy dispersion 
and dramatically improves mass resolution. Using this approach current reflector ToF analysers can 
achieve a mass resolution > 25,000 full width half mass (FWHM). If more than one  
 
 
Figure 1.5 Schematic of a reflectron time of flight mass analyser. Shown are two ions of the same m/z but with different 
kinetic energies. Here the blue ion has more kinetic energy than the red ion.  
reflectron is employed higher still mass resolution can be achieved but at the cost of reduced ion 
transmission.  
 
1.5 Detectors 
As ions leave the mass analyser, they must be detected, most commonly as an electrical signal. 
There are various methods of detection including photographic plates, photon multipliers and array 
detectors but the preferred method is electron multiplication.  
An electron multiplier uses the property that when energetic particles collide with a metal or 
semiconductor, secondary particles (positive ions, negatives ions, electrons and neutrals) are emitted. 
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The type of particle emitted from the electron multiplier conversion dynode is dependent on the 
particle that originally collided. In an electron multiplier this property is enhanced by holding the 
conversion dynode at a high potential, opposite the charge of the particle to be detected. This 
accelerates the ions leaving the mass analyser. High velocity impacting ions cause higher numbers of 
subsequent emissions thereby increases the sensitivity of detection. By placing an electrode, or 
primary dynode at a more positive potential opposite the conversion dynode, emitted electrons are 
accelerated towards the dynode. Upon impact, further emissions occur, thereby amplifying the 
number of emitted electrons. This process is repeated a number of successive times, with dynodes 
arranged in a series, until the current is measured. This process can result in an amplification of 
signal up to 7 orders of magnitude. 
In modern mass spectrometers, the detector most commonly used is a microchannel plate detector 
(MCP). A MCP consists of an array of parallelised electron multiplier channels. Electron multiplication 
is achieved by coating each channel with a semiconducting material and the curvature of each 
channel is designed to prevent positive ions accelerating toward the input side. Amplification achieved 
by a MCP detector is around 10
3
-10
4
 and for this reason two are often used in conjugation. A benefit 
of MCP detectors is that due to the large number of channels, many different ions can be detected 
simultaneously, where a single ion that reaches the detector will only affect a small number of 
channels. The large detection area of the plate also removes the requirement for additional ion 
focusing prior to detection. A major limitation of MCP detectors is that a finite number of ions can be 
detected before detection saturation is reached and further ion collisions are not detected.  Saturation 
is a result of the intrinsic time period taken for each channel to recover from an ion detection event 
before further ions can be detected. This dynamic range limitation can prevent low abundance ions 
being detected if they are co-ionised with a much higher abundance ions, a common occurrence 
during the analysis of complex biological samples.      
Previously time-to-digital converters (TDC) were used to digitise a ToF signal recorded by MCP 
detection. A TDC acquisition requires a trigger (or discriminator), where once a signal threshold is 
met, data recognition will begin. As the threshold is met, the signal in question is registered by a 
counter which records flight time. A brief dead time then follows before the counter and discriminator 
are ready to record the next ion that arrives with above the required intensity. A TDC approach limits 
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dynamic range due to its ability to only record the initial incoming ion signal. TDCs mark the arrival of 
an ion but do not record how many ions were the result of this mark. When multiple ions of a given 
m/z are present during a ToF push or transient TDC detection underrepresents the true number of 
ions that are present. Improvements in ion optics and ion sources means that current mass 
spectrometry sensitivity is high enough that TDC systems do not offer a large enough dynamic range 
for quantification. The use of analogue-to-digital converters (ADC) is now commonplace the systems 
offer a much higher linear signal dynamic range. An ADC does not determine the exact arrival time of 
ions, it only records detector output at a fixed interval. During each cycle of detection signal is 
converted to digital data with data from successive cycles being combined. As an ADC is an analog 
device it is able to combine signal from several near simultaneous ion arrivals thereby providing data 
representative of ion counts per ToF push.              
 
1.6 Tandem Mass Spectrometry (MS/MS) 
Tandem mass spectrometry is the coupling of two mass analysis stages. Between the first and 
second mass analysis there is either a dissociation process or chemical reaction that causes a 
change in the mass or charge of an ion, Figure 1.6A. The data obtained can be used to determine 
more chemical or structural information on the ion in question than is possible from MS analysis 
alone. Tandem mass spectrometry can be achieved in two ways, either in space or in time, with the 
former being the most common approach. MS/MS in space involves the coupling of two distinct mass 
analysers together, whilst MS/MS in time is achieved by sequentially performing mass analysis steps 
in an ion storage device. In order to perform tandem in time, an analyser that is capable of trapping 
ions is therefore required. Proteomics  makes use of a number of different tandem mass spectrometry 
configurations to study proteins and peptides including the Q-TOF (a hybrid instrument where a 
quadrupole is coupled to a ToF analyser), the triple quadrupole, QQQ, (three quadrupoles placed in 
sequence) and the ion trap. A widely used ion trap-based instrument is the Orbitrap, a modified ion 
trap where an ion’s radial trajectory around a center electrode is directly related to its m/z [24]. 
Deconvolution of data is performed by Fourier transform. An Orbitrap instrument is an unusual mass 
analyser as although all mass analysis steps can be performed in the Orbitrap itself, ion dissociation 
is performed in a second ion trap placed prior to the Orbitrap mass analyser. 
Chapter 1. Introduction 
[14] 
 
 
 
Figure 1.6 Tandem mass spectrometry. A) Schematic of precursor ion isolation and dissociation  B) Four common MS/MS 
modes of acquisition 
Depending on instrument configuration, there are four main MS/MS experiments that can be 
performed with each experiment providing distinct information on the given ion, Figure 1.6B. During a 
product ion scan, a specific precursor ion is isolated for dissociation. Following this, an m/z scan is 
performed to collect information on the product ions produced. This experiment is commonly 
performed in proteomic studies used to characterise tryptic peptides present in a sample. A precursor 
ion scan consists of choosing a product ion of interest and determining the precursor ion/s whose 
dissociation results in that ion’s formation. This is achieved by using the first mass analysers to scan 
across the precursor m/z range whilst the second mass analyser is focused on the product ion m/z. 
The third experiment that can be performed is the neutral loss scan. The aim of a neutral loss scan is 
to identify all precursor ion dissociations that result in a characteristic neutral loss. To do this, both 
mass analysers are operated in scanning mode, the second analyser, however, is offset by the 
neutral loss being searched for. By operating in this manner, detection of an ion occurs if the 
precursor and product ions have a mass difference equal to that of the neutral loss. A fourth, but not 
final mode of operation possible is selected reaction monitoring (SRM), an experiment most often 
used for ion quantification due to the high specificity and sensitivity of the method [25]. In a SRM 
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experiment the first analyser isolates a precursor ion. Following dissociation of the ion, the second 
mass analyser isolates a single product ion. Sensitivity is increased in this mode as both analysers 
are focused on a particular m/z range; increased times spent on the chosen detection range 
increases sensitivity. 
 
1.7 Collision Induced Dissociation (CID) 
As mentioned, a tandem mass spectrometry experiment involves either a dissociation process or 
chemical reaction between the two mass analysis steps. The most widely used of the dissociation 
techniques is collision induced dissociation (CID). CID is a fragmentation process whereby ions are 
accelerated through a chamber that contains an inert gas (He, N2 or Ar) maintained at a higher 
pressure than the surrounding vacuum. The gaseous ions collide with inert gas molecules, in a very 
fast process (10
-14
 – 10
-16
 s) where a fraction of the ion translational energy is converted into internal 
energy. The faster the ion is accelerated, the more energetic the collisions that occur are. The ion, 
now in an excited state undergoes unimolecular decomposition. Ion disassociation is slow in 
comparison to the collisions and allows the randomisation of ion internal energy. Subsequent 
fragmentation only occurs at bonds that are lower in energy than the redistributed internal energy. 
This ‘ergodic’ fragmentation pathway is particularly beneficial for the analysis of peptides as it yields 
predictable fragment ions. A product ion nomenclature, initially proposed by Roepstorff and 
Fohlman[26] but later modified by Biemann,[27] has been adopted for peptide analysis because of the 
uniform fragmentation pathways that are observed, Figure 1.7.  
 
Figure 1.7 Fragmentation ion nomenclature for peptides 
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In CID molecules fragment at the weakest bonds of the ion being analysed. For peptides this is the 
amide bond, yielding what are referred to as b-and y-ions. b-product ions are formed when, during 
fragmentation, charge is retained on the N-terminus fragment, whilst y-ions are formed by retention of 
charge on the C-terminus fragment. Both sets of ions are numbered from the most terminal fragment 
ion. The site of fragmentation for a protonated peptide is best described by the mobile proton theory 
which states that immediately following ionisation positive charge will be retained on the most basic 
amino acid residues. Following ion activation, however, proton[s] can be transferred from the less-
basic of the initially occupied sites and cause subsequent charge-site initiated fragmentation. It is, 
therefore, the position of the mobile proton that influences the site of peptide bond dissociation.    
A major caveat of CID is that due to the most labile bonds being fragmented, its applicability to the 
analysis of post translation modifications (PTMs) is limited. PTMs, such as phosphorylation, have 
labile bonds and are therefore lost upon CID. Subsequently it is possible to identify phosphorylated 
peptides using CID, however if two or more possible sites of phosphorylation are present it is not 
possible to locate the exact site of modification. For the analysis of PTMs, electron capture 
dissociation (ECD) and electron transfer dissociation (ETD) are better suited.  
 
1.8 Electron Capture Dissociation (ECD) & Electron Transfer Dissociation (ETD)     
Electron capture dissociation (ECD) and electron transfer dissociation (ETD) are analogous 
dissociation techniques that transfer electrons to positive ions to create radical cations following 
charge state reduction.[28], [29] The radical cations formed then undergo fragmentation. The 
difference between the two fragmentation techniques is the method of electron transfer, with ECD 
using low energy electrons whilst ETD utilises radical anions such as anthracene or fluoranthene.  
During dissociation by ECD, electron capture by a multiply charged ion occurs with charge state 
reduction to form an odd electron cation. This increases the ion’s internal energy leading to 
fragmentation. The process of activation is very short (< 10
-14
s) and is thought to occur faster than 
bond vibration, meaning fragmentation is directed by radical ion chemistry. ETD fragmentation follows 
a similar pathway, with the main difference being the method of electron transfer. As such both ECD 
and ETD are non-ergodic processes. 
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The use of a strong electric field during ECD makes it incompatible with the majority of mass analyser 
and must be combined with a Fourier transform ion cyclotron resonance mass analyser (FTICR). For 
the ECD process to be efficient, precursor ions must be maintained in a dense population of near-
thermal electrons. The RF fields used in ion traps and quadrupole time –of-flight instruments do not 
maintain the thermal energy for periods long enough to induce sufficient fragmention. ETD was 
developed to circumvent this problem. Reagents such as fluoranthene can be delivered to the source 
whilst a high voltage generates the required anions. 
ECD and ETD fragmentation offer complementary information to CID. Dissociation occurs about the 
amine bond, producing primarily c and z-type ions, Figure 1.7. It has previously been shown that 
employing both CID and ETD in a proteomics workflow can provide better peptide sequence coverage 
than the two fragmentation methods provide separately [30], [31].  Where ECD and ETD offer the 
most benefits however, are in the analysis of post translation modifications and larger 
peptides/proteins, with, ETD in particular being heavily adopted in these areas [30]–[34]. With the 
ETD fragmentation being driven by radical ion chemistry, labile bonds such as PTMs, which are lost 
during CID, are maintained, allowing the determination of site specific modifications. For larger 
peptides and proteins, ETD has been demonstrated to provide better sequence coverage than CID 
[35]. ETD’s efficiency is seen to increase with increasing ion charge, a correlation that is explained by 
Coulombic effects. Larger peptides and proteins contain multiple basic sites for protonation and tend 
to be highly charged post ESI which is beneficial for fragmentation efficiency. Indeed the 
fragmentation of large biomolecules by ETD has been demonstrated to provide better sequence 
coverage than CID. ETD has yet to be universally adopted for discovery-based proteomic studies 
mainly due to the lower efficiency fragmentation provided by ETD in comparison to CID when 
analysing short peptides (~10 residues) typically produced by a tryptic digestion.  
 
1.9 The Emergence of Mass Spectrometry-Based Proteomics 
After the development of rapid DNA sequencing methods in the 1970’s, advances in whole genome 
sequencing technology have facilitated the determination of the entire genetic makeup of complex 
eukaryotic organisms including humans [36]. Proteomics is now benefiting from archived and 
annotated sequence information that allows results to be queried and correlated to distinct biological 
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pathways. The term proteome was coined in 1975 and refers to the protein complement to the 
genome [37]. Proteomics is, therefore, the experimental analysis of the proteome; the complete 
protein content of a defined set of cells.  The complexity of the proteome and its dynamic nature limits 
the ability of current mass spectrometric instrumentation to conduct proteomic analyses without 
experimental bias. Proteomic analyses, therefore, tend to fall under a number of categories 
depending on the desired target of the experimental design. Protein translation, turnover and post 
translational modifications are all areas proteomics is able to characterise to better understand how 
complex biological processes function through a systems level approach.  
Mass spectrometry is now the technique of choice for proteomic investigations due to its sensitivity 
(low fmol-amole), versatility and its high throughput nature. Early work in proteomics focused on the 
identification and quantification of a select number of proteins, however with rapid advancement in 
both mass spectrometry instrumentation and chromatographic systems this number has increased by 
orders of magnitude.  Whereas immunoassay techniques such a western blots and enzyme-linked 
immune sorbent assays are able to quantify small numbers of target proteins with reasonable 
sensitivity within a single experiment, mass spectrometry is now able to identify and quantify up to 
4000 proteins in a single hour analysis Fig 1. 8 [38]. The antibody free nature of mass spectrometry-
based analysis provides a major benefit in relation to the alternate immunoassay-based techniques. 
This allows a far more unbiased approach to cell biology studies to be carried out. Indeed a study 
reported by Edwards and colleagues compiled a selection of research papers before and after the 
complete human genome was sequenced [39]. The findings of the study were two-fold; firstly the 
majority of researchers are focused on a very small percentage of proteins, which is directly related to 
the availability of effective antibodies and secondly that increased accessibility to human genome 
data and the proteomic techniques has done little to change this trend. An additional benefit to mass 
spectrometry is that, if performed correctly, added specificity can be provided. The large number of 
variables that a mass spectrometry-based proteomic experiment records, including peptide(s) 
retention time, peptide(s) mass and peptide fragment(s) mass in order to identify a protein offers a 
specificity not possible by antibody based techniques [40].    
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Figure 1.8 The one hour yeast proteome. Performance metrics from the analysis of a yeast tryptic digest using a 70 min LC 
gradient analysed on an Orbitrap Fusion. A) Protein identifications B) Protein identification reproducibility C) Box plot of 
protein sequence coverage D) Dynamic range of proteins identified. This research was originally published in MCP. A. S. 
Hebert et al, The one hour yeast proteome, MCP, 2013, 13(1), 339-47. © the American Society for Biochemistry and 
Molecular Biology[38]  
 
1.10 Proteomic Workflows 
Mass spectrometry-based proteomics is a wide-reaching subject matter and the aims of the 
experiment in question guide the workflow chosen. Despite this the majority of proteomic experiments 
follow a very similar protocol with an ever increasing number of variations on this model possible, 
Figure 1.9. The generic workflow consists of protein extraction from the system being characterised. 
Following protein extraction into a suitable buffer, protein level separation can be used to decrease 
sample complexity. Protein samples are then proteolytically cleaved into peptides. Enzymes such as 
trypsin are preferred due to the specific nature of cleavage and the generation of peptides that upon 
ionisation have an m/z in the range suited to mass spectrometric analysis. MS instrumentation is 
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commonly coupled to reverse phase- high pressure liquid chromatography (RP-HPLC) systems for 
peptide level separation prior to analysis. If further separation is required, orthogonal peptide 
separation techniques (e.g. strong cation exchange) can be employed prior to RP separation. Mass 
spectrometry analysis can be acquired in a non-targeted (discovery proteomics) or targeted manner 
(quantitative validation) and the choice depends on both experimental aims and instrumentation 
available. Data acquired are then searched against a protein database. At this stage there are a 
number of different software programs available for this task. Database searching for peptide 
identification is possible due to the predictable nature of peptide fragmentation and the specificity of 
enzymatic cleavage. Protein identification is then inferred from the presence of characteristic peptides 
predicted from in-silco digestion. 
  
1.11 The Need for Prior Separation 
The proteome is a far more dynamic and complex entity than the genome. Whilst the human genome 
contains ~20,000 protein coding genes, splice variants, single-nucleotide polymorphisms (SNPs) and 
PTMs means the number of protein variants (isoforms and proteoforms)  translated from the genome 
is far higher. This complexity has challenged proteomics and driven mass spectrometry 
instrumentation developments. A typical sample obtained from cell lysis for proteomic analysis 
contains thousands of distinct proteins. Enzymatic digestion before analysis increases complexity by 
at least an order of magnitude. It is for this reason that MS instrumentation is coupled with 
chromatographic equipment, primarily reverse phase liquid chromatography. Separation of peptides 
based on their physicochemical properties reduces sample complexity prior to MS analysis but does 
not ensure the detection of all peptides present in a sample. In a research paper presented by 
Michalski and colleagues it was shown that during the analysis of a HeLa cell lysate, an estimated 
100,000 peptide like species were observed by LC-MS [41]. Peptides targeted for MS/MS were 
however only 16 % of the total number of peptide-like ions, therefore dramatically limiting the  
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Figure 1.9 Generalised proteomics workflow. At each stage common techniques/software programs are indicated    
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number of peptides successfully sequenced. Instrumentation scan speed and sensitivity has since 
improved, increasing the number of peptides accessible by MS, however proteomics is still limited by 
sample dynamic range. Modern MS instrumentation has a detection dynamic range of up to four 
orders of magnitude. This can be increased by a further order if targeted analysis is undertaken. 
Protein abundances span at least seven orders of magnitude increasing to 10 in the case of human 
plasma. It is this discrepancy that limits mass spectrometry proteome coverage to the identification 
more abundant proteins, Figure 1.10. In a recent review of the challenge that the proteome dynamic 
range presents discovery proteomics, Zubarev examines the proteome abundance distribution in 
respect to mass spectrometer dynamic range. He subsequently concludes that efforts should be 
focused on developing methods as an alternative to extensive fractionation to enable rapid deep 
proteomics [42]. 
 
 
Figure 1.10 Density plot of protein numbers in reference abundance (copy number per cell) for a typical eukaryotic cell 
lines or tissue sample. Image adapted from R.  A. Zubarev, 2013. [42]    
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1.12 Peptide Level Chromatographic Separation 
 
1.12.1 High Pressure Liquid Chromatography (HPLC) 
High pressure liquid chromatography is the most commonly employed on-line fractionation method 
coupled to MS. Reverse phase separation is used to separate peptides based on their hydrophobicity 
and is well suited to MS as the solvents are directly compatible with ESI. For proteomics research, 
separations are performed on nano columns with an internal diameter (ID) ≤ 100 µm, designed to 
provide separations for sample amounts of < 1 µg. Due to sample complexity in proteomics the peak 
capacities (Pc) provided by a typical HPLC column are not sufficient to adequately separate all 
peptides[43]. Solutions to increase column resolution typically include increasing the length of the 
column and/or decreasing the particle size[44], [45]. Both solutions increase column stationary phase 
surface area but at the expense of increased back pressure. Typically HPLC systems can operate up 
to ~ 6000 psi which limits the degree to which one can alter the two parameters and therefore limits 
maximum peak capacity.  
 
1.12.2 Ultra High Pressure/ Ultra Performance Liquid Chromatography (UHP/UPLC) 
Ultra performance liquid chromatography (UPLC) was made commercially available by Waters Ltd in 
2004. The first ACQUITY UPLC systems were initially capable of operating at back pressures of up to 
10,000 psi which opened up the possibility of utilising significantly decreased particle sizes. With the 
introduction of the M-class ACQUITY range the back pressure limit has been increased further to 
15,000 psi. It can be seen from the van Deemter plot, based upon the empirical formula, Equation 
1.12,  that describes the relationship between flow rate and column efficiency, Figure 1.11, that there 
are additional benefits of sub 2 µm particles beyond increased peak capacity[46].  Here A is the Eddy-
diffusion parameter, B is the diffusion coefficient, C is the resistance to mass transfer coefficient and u 
is the linear velocity of the solvent. At larger particle sizes it can be seen that there is a limited optimal 
mobile phase flow rate to achieve maximal peak resolution. Beyond this flow rate resolution rapidly 
deteriorates and this characteristic is more extreme for the larger particles. Sub 2 µm particle-based 
columns do not have this problem and significantly higher flow rates can be tolerated without a large 
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reduction in peak resolution. This allows the development of high throughput methods where good 
peak separation can be achieved with short run times. This attribute is of particular benefit in targeted 
validation of discovery proteomic findings where a large number of analytical runs are typically 
required.  
Equation 1.12 
𝑅𝑒𝑠𝑜𝑙𝑣𝑖𝑛𝑔 𝑝𝑜𝑤𝑒𝑟 = 𝐴 + 
𝐵
𝑢
+ (𝐶𝑠 + 𝐶𝑚) 𝑥 𝑢 
 
Figure 1.11 Van Deemter curves for four common particle sizes. Adapted from L. Novakova, 2006 
 
1.12.3 Multidimensional liquid chromatography (MD LC) 
Multidimensional liquid chromatography is the combination of two or more forms of LC to offer a 
higher degree of chromatographic peak capacity in order to increase peptide identification rates[47]. 
The LC methods coupled together have, to some degree, orthogonal peptide selectivity where the 
second LC dimension is almost exclusively low pH RP. A variety of first dimensions can be used 
including RP, strong cation exchange (SCX), isoelectric focusing (IEF) and hydrophilic interaction 
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liquid chromatography (HILIC)[48]–[51]. The most commonly employed first dimension is SCX, which 
separates peptides based on charge and RP.  As the majority of tryptic peptides have a charge of 2+ 
and 3+ there is limited scope in SCX to utilise the entire separation space. It has been previously 
shown during an SCX separation that the majority of peptides from a tryptic digestion elute in two 
main clusters. RP-RP separation has emerged as an effective alternative to SCX-RP[52]. In RP-RP 
the first dimension is carried out using a mobile phase with a pH ~ 10 as opposed to pH ~ 3. Tryptic 
peptides typically contain ionisable basic and acidic residues and peptide isoelectric constant (pI) is 
determined by the distribution of these residues. By dramatically changing the mobile phase pH 
between the first to second dimension of separation, peptide charge and therefore retention behaviour 
will be altered, providing the required degree of orthogonality. The use of RP-RP in the context of 
label-free quantitation was recently demonstrated by Patel and colleagues [53]. It was shown that RP-
RP separation can increase protein identifications almost two-fold with only a minor increase in 
technical variation of quantitative results.  
 
1.13 Protein Level Separation 
Protein level separation, prior to proteolytic digestion is an alternative method for providing orthogonal 
separation to RP-LC. Protein level separation is most commonly carried out by SDS-PAGE where 
proteins are separated based on protein molecular weight in the presence of high concentrations of 
SDS. Sample lanes are then cut into a defined number of slices (anywhere from 4 - >20). Proteins 
contained within each slice are digested within the gel. Resultant peptides can be extracted from the 
gel with the use of acid and an organic solvent such as acetonitrile. SDS-PAGE separation provides a 
cheap and effective method for reducing sample complexity and is ideal for situations where sample 
amount is not limited. A major benefit of SDS-PAGE separation is the ability to use high 
concentrations of SDS during cell lysis/tissue homogenisation. The use of high SDS concentrations 
ensures the solubilisation of hydrophobic proteins, such as membrane spanning proteins, which can 
be under-represented when using in-solution digestion protocols. Where sample amount is limited, 
low recovery of peptides post in-gel digestion can pose problems with peptide recovery rates from gel 
slices being dependent on peptide physiochemical properties including size and hydrophobicity 
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1.14 Mass Spectrometry Analysis in Proteomic Workflows 
As previously mentioned, mass spectrometry is now able to detect and quantify thousands of proteins 
in a single sample. There are a number of different mass spectrometry techniques that can be 
employed for the detection and quantification of a protein/s and indeed the ability to determine relative 
and absolute amount of proteins expressed by a cellular system at particular time points (TP) is an 
integral part of proteomics. Mass spectrometry is not, however, an inherently quantitative technique 
due to the ionisation efficiency of biomolecules being highly dependent on their amino acid sequence. 
Techniques for the quantification of proteins in a complex sample have developed rapidly over the 
past decade. There are now a large number of different quantification methods that can be employed 
for the analysis of a sample. The technique of choice depends on a number of factors including 
sample type and amount, time, instrument availability and cost. Broadly speaking the methods of 
quantification can be divided into two main categories label-based and label-free, Figure 1.12. Within 
these categories there are a number of common protocols each with benefits and limitations.  
The earliest form of mass spectrometry-based quantitative proteomics was based on two-dimensional 
gel electrophoresis (2-DE). 2-DE is a gel-based separation technique, first proposed by P. O’Farrell in 
1975,[54] where proteins are first separated based on their pI by isoelectric focusing. Following this, 
proteins are separated by their molecular weight at a 90 degree axis. Gels are then stained for protein 
quantification. Resultant spots correspond to a protein/protein group which can be characterised, after 
in-gel digestion, by MS analysis. Although this technique provides good protein resolving power it 
does have a number of limitations including the poor separation of hydrophobic, acidic and highly 
alkaline proteins [55], [56]. 
Over the past decade label-based quantitative techniques have become the chosen method for 
quantifying large numbers of proteins in a complex biological sample. Mann and co-workers’ 
development of stable isotope labelling by amino acids in cell culture (SILAC) in 2002 was perhaps 
the biggest factor in popularising label-based quantification [57]. SILAC allows the direct comparison 
of biological samples within the same analytical run by the in vivo incorporation of ‘heavy’ amino acids 
into one of the biological samples being analysed. The method was first developed in cell culture 
experiments where one of the two cell cultures for comparison is grown in a culture media containing 
13
C labelled lysine and/or 
13
C labelled arginine. Samples can be combined post lysis and prior to 
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Figure 1.12 Overview of the four common quantitative workflows. Coloured boxes represent two experiment conditions. 
Horizontal lines that connect two boxes indicate when samples are combined. Empty boxes indicate that the samples are 
treated separately at each stage   
digestion, minimising measurement uncertainties that can be introduced through pipetting errors and 
digestion efficiency differences. SILAC has been expanded to include a range of model organisms 
including mice, zebrafish and more recently Drosophil.[57]–[59]. The main limitations of SILAC 
protocols were previously the inability to study more than two biological conditions in an experimental 
workflow and that it was not applicable to human tissue samples. A protocol where SILAC labelled 
cells were used as a spike-in standard was developed to address these problems.[60] The concept 
was expanded to ‘Super-SILAC’ where a spike in standard is produced from a mixture of cell lines 
that differ in origin, stage and subtype [61]. This has been shown to be of particular benefit for cancer 
studies where tumour tissues show complex cell type diversity [62].  
Other common label-based methods used for discovery proteomics are based upon isobaric labelling 
where quantitation is achieved at the MS/MS level through the detection of reporter ions. Two of the 
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most common methods are isobaric tags for relative and absolute quantification (iTRAQ) and tandem 
mass tags (TMT)[63], [64]. Both methods use the reactivity of primary amines to label lysine residues 
and/or the N-terminus of tryptic peptides with specific tags. In iTRAQ the tagging molecule contains 
three regions. The first region is the peptide reactive group which reacts with primary amines to form 
a covalent bond. The third group is a reporter ion which upon CID is fragmented. The reporter group 
can be changed in mass to vary the m/z at which it is detected. The second region is called the 
balancer group as this region’s mass is altered in respect to the mass of the reporter group to ensure 
the combined tag mass remains consistent. Samples to be tested are labelled with a specific reporter, 
post-protein extraction and digestion. Post-labelling samples are pooled into a combined sample and 
analysed by LC-MS/MS. Relative quantities for each detected peptide can be attributed to each 
condition by comparing the intensities of the reporter ions detected in MS/MS scans. 
Similar to SILAC, isobaric labelling methods allow the analysis of different samples within the same 
analytical run, leading to increased analytical precision. Indeed iTRAQ has been shown to offer higher 
precision quantitation than SILAC in some cases.[65] A major caveat with isobaric labelling methods 
is that one of the prerequisites for accurate quantitation is the isolation of single precursor peptides. 
The co-isolation of precursors can cause the measured peptide ratio to become skewed towards 
unity. This can be commonplace for complex samples and methods subsequently often under report 
fold changes, thereby increasing the false negative rate of quantitative results.   
The use of isotopically labelled peptides as internal standards for protein quantification is still a gold 
standard method. The principles of isotope dilution mass spectrometry (IDMS) for relative and 
absolute quantification are well established [66], [67]. By using multiple isotopically labelled analogues 
of specific proteolytic peptides per target protein, quantitation precisions <10% can be easily achieved 
[68]. IDMS lends itself well to absolute quantification as exact amounts of the labelled standards can 
be spiked in for reference. Absolute quantification refers to the determination of protein 
concentrations, often in reference to total protein amounts, volumes or protein copy numbers per cell. 
IDMS however, is almost exclusively used for the validation of discovery proteomic results due to the 
cost of peptide internal standards and the fact that only a limited number of proteins can be quantified 
per analytical run.  
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A recently developed label-based method, QconCAT, aims to simplify the absolute quantification of 
large numbers of proteins through the synthesis of artificial proteins that are concatamers of surrogate 
peptides for the protein/s to be quantified.[69] The labelled protein or QconCat, which has been 
expressed, purified and quantified, are spiked into samples prior to digestion to act as an internal 
standard in a similar manner to IDMS. Endoproteolytic digestion of the sample releases surrogate 
peptides from the QconCat at a 1:1 ratio which can then be used for absolute quantification. The 
protocol represents a theoretically simplified method for quantifying large numbers of proteins in 
comparison to traditional IDMS methods. In addition, having the labelled peptides spiked as a 
pseudo-protein should help reduce the potential for the modification or degradation of standards 
during the digestion protocol. In practise, however, a number of challenging steps must be addressed 
for this protocol to work effectively including efficient expression and complete digestion.  
Early label-free quantitation methods were primarily based on peptide or spectral counting methods 
where the number of fragment spectra assigned to a given protein is used as a proxy for protein 
abundance [70], [71]. The method is based on the observation that the more abundant a protein is the 
more MS/MS spectra are collected for peptids derived from the protein in question, Figure 1.13. This 
approach is often referred to as a semi-quantitative technique as it allows differential protein 
expression to be detected but the measurement of exact fold changes or absolute amounts are not 
robust [72]. The spectral counting method, although easy to implement, has never been fully adopted 
as a routine quantitative method. Spectral counting assumes a linear response for every protein 
however it is known that spectrum counts are peptide specific as changes in retention time, peak 
width and fragmentation efficiency can vary. Despite this a number of methods have been devised for 
calculating absolute protein expression levels from spectral counting values. emPAI, one of the higher 
profile methods takes into account the number of possible tryptic peptides that could be detected for 
each protein [73]. The method, however, still produces a large amount of error and even with more 
advanced computational methods, absolute amounts can still only be determined with an order of 
magnitude error.  
An alternative label-free quantitative method that has seen a recent surge in popularity is based upon 
using precursor (or fragment) ion abundance to calculate protein concentration [74]–[76]. Relative 
peptide abundances can be determined by either calculating the area under the curve (AUC) or the 
Chapter 1. Introduction 
[30] 
 
apex of peptide chromatographic peak, Figure 1.13. The method is based around the observed 
property of ESI efficiency being directly proportional to analyte concentration.  Peptide intensity, 
therefore, correlates extremely well with its abundance. The relative levels of a protein, therefore, can 
be easily compared from sample to sample by the summation of peptide ion intensities derived from 
their parent protein. The improvement of instrument and chromatographic resolving power has 
continued to improve label-free quantitation through the reduction of potentially co-eluting and isobaric 
peptides which can interfere with quantitation. It was however the development of nESI that had the 
biggest contribution to ion-based label-free quantitation. As previously mentioned, nESI has a much 
larger tolerance for ion suppression effects which is of particular importance when samples to be 
compared are analysed in separate LC-MS/MS runs. The use of nESI allows the comparison of 
samples whose background may differ slightly in constituents due to the minimisation of potential 
matrix effects on peptide ionisation efficiencies.  
 
 
Figure 1.13 Overview of two label-free quantification approaches; Ion intensity-based and spectral counting 
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The use of ion-based, label-free relative quantitation is now commonplace. This is well demonstrated 
by the adoption of label-free quantitative functionality within the MaxQuant software developed by the 
Mann lab, software which was initially developed to perform SILAC data analysis [77]. Recent 
approaches have developed label-free techniques to allow the estimation of absolute protein amounts 
with good success. The approach developed by Selbach and co-workers, intensity-based absolute-
quantification method (iBAQ), uses the sum of extracted ion intensities of all identified peptides per 
protein and normalises this value to the number of peptides theoretically produced by enzymatic 
digestion [78]. These values can be converted to copy numbers per cell if the number of cells used in 
an experiment is known. This value is easily quantifiable when analysing cell lines but is far more 
challenging when working with tissues. Mann and colleagues have utilised the depth of proteome 
coverage possible with current mass spectrometry technologies, to estimate absolute values without 
the need for cell counting [79]. Using their method total sample protein content can be assumed to be 
represented by the sum of all peptide ion intensities detected from a sample. The ratio of MS signal 
for a particular protein with respect to total signal intensity is therefore considered a proxy for its 
absolute amount per total protein amount. Copy numbers per cell can be derived from these ratios by 
dividing the values by protein molecular weight, multiplying by the Avogadro constant and the average 
protein content of a single cell. This technique, referred to as total protein approach (TPA) can be 
theoretically applied to sample where total protein can be determined by an assay such as the 
Bradford. The same group more recently has taken their approach forward and are now able to 
calculate absolute amounts based on MS data and without the need for any other sample assay 
information. In what they term the ‘Proteomic Ruler’, they demonstrate that the MS signal attributable 
to histones can be used to accurately determine cell numbers based on the proportionality of total 
histone concentration to DNA amount [80]. 
An alternative methodology for determining absolute protein amounts (in addition to relative 
quantification) was first published by Geromanos and co-workers and is commonly referred to as Hi3 
quantification [81]. Hi3 utilises the unexpected discovery that the MS signal response from the three 
highest ionising peptides derived from each protein correlates (R
2 
> 0.95) to the original protein 
concentration. Results using this method typically have a technical CV of <10-15%. To convert 
intensities into absolute values an internal standard, usually a single protein digest, can be spiked into 
the sample of interest at a known amount, an approach analogous to the IDMS/AQUA approach. The 
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use of an internal standard has the additional benefit of controlling for run to run loading amount and 
instrument sensitivity variability.  
Although label-free approaches still do not provide the precision and accuracy of some label-based 
techniques, data quality is now at a point that biological questions can be answered without the need 
of expensive labelling reagents. Label-free quantitation is applicable to any biological sample that can 
be analysed by mass spectrometry and the numbers of conditions that can be directly compared are 
theoretically limitless. An additional benefit of the label-free approach is that it can be applied to any 
dataset post analysis and can even be used to compare datasets that were produced by different 
labs. A caveat of this is that label-free quantitation relies upon sample preparation being identical for 
each sample being analysed. Normalisation techniques or the use of relative changes can address 
this issue to a certain extent. In a recent seminal paper that presented the first mass spectrometry 
derived draft of the human proteome, label-free quantitation was used to estimate absolute protein 
abundances for 27 human tissues and body fluids.[82] The data used were derived from a number of 
different research labs with some obtained from public data repositories. The authors found that data  
were easily comparable without the need for extensive normalisation. Interestingly in the same 
publication, a comparison of Hi3 and iBAQ showed little difference in measurement error apart from 
Hi3 showing slightly higher error when the number of detected peptides per protein is low (<5), a 
characteristic that has been observed previously for Hi3 [83], [84].  
Quantitation methodology is not the only technical consideration prior to beginning a quantitative 
proteomics experiment. One of the benefits of MS is the large number of acquisition modes that are 
available with each one having their own benefits and drawbacks. Depending on the aims of an 
experiment a particular mode may an obvious choice. One example is that the validation of previous 
quantitative results would typically require a targeted mode where reducing data dimensionality will 
reduce measurement errors. Discovery proteomic experiments, by their very nature, use an 
untargeted approach to quantify proteomes in an unbiased approach. Within this category, however, 
there are two distinct sub categories that define the acquisition approach taken. 
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1.15 Data Dependent Acquisition (DDA) 
Data dependent acquisition (DDA) is the traditional “bottom up” approach for analysing a complex 
protein mixture. A DDA experiment consists of a series of precursor selections, isolations and 
fragmentations. A cycle typically consists of a survey MS scan to determine the m/z and relevant 
intensities of precursors currently eluting from the chromatographic column. Precursor ions are 
isolated serially for fragmentation, for either a set time period or until an ion current threshold is 
reached, Figure 1.14. The order in which they are isolated is almost exclusively based on intensity, 
with the most common approach being to target peptides for MS/MS from the most abundant to the 
least. Depending on instrumentation speed, the maximum number of peptides that can be targeted 
following a survey is currently ~ 30 and this number can be set by the user. Once the maximum 
peptide number is reached, or all detectable peptide ions have been sequenced, the cycle starts 
again with another survey scan. 
 
 
Figure 1.14 Data dependent methodology. MS scan identifies 5 most abundant precursor ions. Precursors are sequentially 
quadrupole isolated and fragmented in order of intensity   
The intensity based selection of DDA is one of the contributing factors to MS’ bias towards the 
identification of abundant proteins, as these will inherently produce more abundant tryptic peptides. A 
further problem is its contribution to the stochastic nature of peptide identifications. Technical 
replicates, although identifying a large number of common peptides will also identify peptides that are 
not observed in one of the replicates, despite the analysis of a sample of identical constituents.[85] In 
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addition to ESI fluctuations, this is thought to occur due to run to run variability in LC and MS time 
alignment. If the start of the DDA series is different from run to run, in reference to LC sample 
injection, peptides may or may not be at their chromatographic apex when a survey scan is 
undertaken. This will influence the selection of peptides for fragmentation and result in the loss/gain of 
peptides that are near the threshold for selection.  
 
1.16 Data Independent Acquisition (DIA) 
An alternative acquisition mode that is beginning to see more widespread adoption is data 
independent acquisition (DIA) [86]. DIA encompasses a number of different strategies that pertain to 
remove the need for precursor selection for identification. The motivation behind the removal of 
precursor selection, during MS/MS analysis, is to achieve a more unbiased analytical approach. One 
such approach developed in the Aebersold lab is “SWATH MS” which takes its name from the 
sequential isolation windows (or SWATHs) that are acquired during an acquisition [87], [88]. During a 
SWATH analysis, precursor isolation windows, each 26 Da wide and overlapping by 1 Da, are used to 
scan across a pre-determined mass range (nominally 400-1200 m/z). MS/MS data is acquired for all 
precursors within the isolation window. Identification of peptides is achieved by matching MS/MS data 
with a spectral library that is usually produced by prior in depth DDA analysis of a sample 
representative of those being analysed.  Protein quantification is achieved at the MS/MS level through 
the combination of fragment ion chromatograms that are derived from the same protein. Each cycle of 
SWATHs across the mass range takes 3.2 sec, which based on a chromatographic peak of ~30 s (if 
using HPLC) provides 9 points across a peak and is adequate for quantitation. The method has been 
shown to provide a quantitative CV of < 10 % for technical replicates which compares well with more 
targeted approaches. 
The reliance of SWATH on spectral libraries for identification,[89] which are in the main created with 
the use of a DDA approach, means that SWATH is more of a ‘semi-DIA’ method. The concept of MS
E
, 
which completely removes the need for DDA derived data, was introduced by J.C. Silva and 
colleagues [83], [90]. During an MS
E
, acquisition MS and MS/MS data are recorded concurrently by 
altering the energy within the collision cell, Figure 1.15. No pre-selection of precursors is made and 
the quadrupole is used only to transfer ions within the expected m/z range that tryptic peptides are 
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predicted to fall within, usually 300-2000 m/z. Post data acquisition, fragment ions are assigned to 
their respective precursor ions based primarily on chromatographic time correlation. This process is 
refined during the database search to include information of the physiochemical properties of detected 
peptides when undergoing collision induced dissociation. The assignment follows an iterative 
depletion process where single proteins are identified sequentially and the associated peptides and 
fragments are removed from the dataset that is being mined. The result is a protein-centric search 
which provides high protein coverage. The concept of MS
E 
builds on the work of Clemmer and co-
workers who, on their in-house built instrument collected MS and MS/MS data across the entire mass 
range [91]. This early incarnation of MS
E
 was named ‘parallel fragmentation approach’ for obvious 
reasons.  
 
Figure 1.15 MS
E 
approach to data independent acquisition. As peptides elute the quadrupole is set to transmit all peptides 
ions. Energy within the collision cell is continuously alternated between low energy and a high energy ramp across the 
entire chromatographic run, allowing simultaneous acquisition of MS and MS/MS data   
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Interestingly Clemmer and co-workers were not the only group, at this point in time, working on the 
idea of multiplexed peptide MS/MS measurements, with the ultimate aim of higher-throughout peptide 
identification rates. Work published by the group of R. D. Smith successful demonstrated that the use 
of a high resolution instrument, in this case tandem FTICR MS, allowed the simultaneous 
fragmentation of polypeptides and their successful identification [92]. Some years later Yates and 
colleagues presented data showing the benefits of the data independent acquisition approach, using 
a method, somewhat analogous, to the now popular SWATH method [93]. By sequentially isolating 
and fragmenting across precursor windows of 10 Da, within an ion trap mass analyser, it was shown 
that signal-to-noise was consistently increased by three-to fivefold in comparison to a traditional DDA 
methodology. This concept was further developed, through the incorporation of high resolution 
instrumentation, namely an orbitrap mass analyser, by the group of D.R. Goodlett [94]. In their 
method, precursor acquisition independent from ion current (PAcIFIC), by scanning across very small 
isolation windows (typically 2.5 Da), whilst collecting MS/MS data for all ions, it was shown that 
hundreds of proteins could be detected across 8 orders of magnitude, a range that was not 
achievable by traditional DDA.   
With no pre-selection of precursors, MS
E
 aims to collect MS and MS/MS data for all peptides across 
the whole mass range as they elute from the chromatographic column. For all peptides where 
sufficient quality data is acquired a successful identification should be made, opening up the potential 
for peptide identification rates that surpass that of DDA runs. Whereas DDA methods are limited by 
scan speeds, MS
E
 and other such DIA methods are theoretically limited only by system peak capacity. 
Another major benefit is a close to 100% duty cycle that increases the number of points across a peak 
that can be used for quantitation. Quantitation by MS
E
 is on MS level data where, per scan, the 
instrument spends half its time acquiring. If a 1 sec scan speed is considered, typical for an MS
E
 
experiment, then 0.5 sec will be spent acquiring MS data and the remaining 0.5 sec spent acquiring 
MS/MS data. Including the inter scan delay of ~0.2 sec, MS
E
 records 25 data points across a 30 sec 
chromatographic peak. With the high duty cycle that MS
E
 provides comes its applicability to UPLC 
chromatography where due to the high level of resolving power peptides can elute with a peak width 
at half height (PWHH) of < 10 sec. To achieve sufficient data points for high quality quantitation (15-
20 ideally) across such high resolution peaks a very high duty cycle is required. Indeed MS
E
 coupled 
to UPLC has been demonstrated to provide good technical reproducibility, typically < 15 %[81]. 
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Although the theory behind MS
E 
does offer the potential for improved peptide identification rates in 
comparison to DDA, initial proteome coverages achieved were not as high as those achieved on high 
resolution instruments. MS
E
 is only available on Q-ToF instruments developed by Waters Ltd, whilst 
the majority of high proteome coverage datasets were achieved with the use of Orbitrap technology, 
so differences between instrument sensitivity and resolution cannot be discounted as contributing 
factors. The development of the Synapt G2, followed more recently by the Synapt G2-S, introduced 
ion mobility based peptide separation with QToF mass spectrometry and went some way towards 
realising the potential of MS
E
[94], [95].  
High resolution mass spectrometry allows the separation of potentially isobaric co-eluting peptides by 
small mass differences, however the development of ion mobility coupled to mass spectrometry  has 
provided an alternative ‘on the fly’ method for increasing proteome coverage. Until the development of 
the commercially available Synapt instruments, ion mobility mass spectrometry (IMMS) was only 
available to a small number of labs with custom made instruments [96]–[98]. Ion mobility separates 
gas phase ions prior to the mass analyser, based upon their mass, charge and shape (rotationally 
averaged, or collision cross section), Figure 1.15. Synapt instruments use traveling wave ion mobility 
separation (TWIMS) to achieve this separation. In TWIMS ions are accelerated through the mobility 
chamber by a series of stacked ring ions guides. The mobility chamber is kept at low pressure, 
relative to the high vacuum region of a mass spectrometer, by the introduction of nitrogen gas. Pulsed 
ions accelerated through the mobility cell undergo collisions with nitrogen gas molecules with the 
number of collisions experienced by a molecule being proportional to its size. The result is that 
smaller molecules traverse the mobility cell quicker than large molecules. TWIMS has until recently 
been primarily used to probe the conformations of proteins and protein complexes due to the earliest 
Synapt platform, Synapt HDMS, not being suitable for peptide analysis due to saturation effects [99]. 
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Figure 1.15  Principle of ion mobility separation. Two protein ions of the same m/z are separated based upon 
their collision cross section. Here, the more extended protein (yellow) traverses the mobility cell more slowly as it 
experiences more collisions with the buffer gas than the more compact protein (red)   
 
The Synapt G2 saw the use of an ADC detector in place of the previous TDC to reduce the problem 
of saturation effects, although the effects are still present for highly abundant ions [100]. The 
introduction of ion mobility adds an extra dimension of separation which is orthogonal to RP and 
occurs on a timescale that fits between LC and MS, Figure 1.16. HDMS
E
, as it is referred to, uses 
both chromatographic retention time and gas phase mobility to align precursors with their respective 
fragments. The additional mode of separation during HDMS
E
 provides protein and peptide 
identification rates up to 60 % higher than achieved using MS
E
 on the same instrument. An additional 
benefit of HDMS
E 
acquisitions are increased quantitation precision for low abundance peptides and 
increased peptide detection dynamic range. This along with the saturation effects which are apparent 
on the Synapt HDMS are partly a result of the compression of ions in space during ion mobility 
separation. This process is analogous to the enhanced sensitivity provided by chromatographic 
separation. A further reason for increased quantitative precision and dynamic range during HDMS
E
 is 
a reduction in co-detected species, including both isobaric peptides and contaminants, through their 
cross sectional based deconvolution.  
Chapter 1. Introduction 
[39] 
 
 
Figure 1.136 Complementarity of ion mobility as an orthogonal separation method to liquid chromatography mass 
spectrometry.  
Even with the addition of IMS, HDMS
E
 is still not able to provide the identification rates and the 
proteome coverages at a level similar to those of DDA-based workflows. Tenzer and colleagues were 
able to demonstrate that a major limiting factor of both the MS
E
 and HDMS
E
 approach was inefficient 
precursor ion fragmentation  [101]. During MS
E
 a collision energy ramp is conducted during the 
elevated energy scan where in HDMS
E
 mode a fixed collision energy is used during each individual 
IMS cycle and across the entire m/z range. This is in contrast to DDA-based methods where collision 
energies can be determined based on precursor m/z, an approach that is not possible in DIA-based 
methods. Tenzer and co-workers were instead able to use ion mobility profiles to improve 
fragmentation efficiency. In UDMS
E
 the collision energy is ramped with reference to the ion mobility 
profile during each IM cycle. Peptides that traverse the cell quickly and are therefore more likely to be 
small and/or highly charged are subjected to lower collision energy whilst peptides that arrive later in 
the IM cycle are fragmented with higher collision energy. Using the optimised collision energy profiles, 
fragmentation efficiency was significantly improved (105% increase) in comparison to both MS
E
 and 
HDMS
E
. Proteome coverage for a HeLa cell lysate was increased by 47 % in comparison to HDMS
E
 
and importantly it was shown that UDMS
E
 had a larger peptide identification rate than is theoretically 
possible on current generation Orbitrap instruments in DDA-mode.  
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1.17 Database Searching 
The emergence of gene sequencing technology has facilitated the complete nucleotide sequencing of 
commonly used cell lines and organisms. Genome wide sequences for each organism can 
subsequently be translated to form a predicted protein sequence database. The availability of 
predicted protein sequence databases has been a significant factor in the rapid popularisation of 
mass spectrometry for proteomic analyses.  
The interpretation of mass spectrometry proteomic data relies upon the use of enzymes with 
predictable cleavage sites and the well characterised fragmentation of peptides by CID/ETD. Along 
with the sample origin, which is used for the selection of the correct protein sequence database, these 
factors allow the prediction of all possible peptide and peptide fragment masses that could be 
produced from a theoretical mass spectrometry experiment. Peaks extracted from the raw mass 
spectrometry data are then searched against the in-silco data in order to identify peptides from the 
sample in question. The use of an enzyme with well-defined cleavage sites means that the 
identification of proteins can be inferred by the direct identification of peptides.  
Due to the vast nature of possibilities that are produced from such in-silco predictions the possibility of 
false discoveries is a well-documented problem in the proteomics field. There are a number of 
statistical algorithms that have been developed to allow the proportion of incorrect identifications to be 
controlled  [102]–[104]. The most common approach is to measure the false discovery rate by using a 
target decoy database search strategy [105]. This approach creates a composite database by 
concatenating the target protein sequence database with a decoy database. The decoy is created by 
either reversing or randomising the protein sequences from the target. By doing this the overall 
residue composition of the target database is retained but the two databases contain practically no 
common peptide sequences. Two assumptions are made in this approach which was validated by J.E 
Elias and S.P Gygi in an early methods paper documenting the approach [106]. The first assumption 
is that sequences within the target and decoy database do not overlap as if they did this would cause 
an erroneously high FDR estimation. Elias and Gygi found that for peptides over 7 residues there 
were only 0.02% common sequences between the two databases. The second is that false positives 
are equally likely in both the target and decoy. This was again validated by using an in-silco approach 
to show that distribution of considered peptides for two common database search programs was 
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equal for both database types. Interestingly, the agreement between the target and decoy only holds 
true when the search space is large enough. Although it is commonly accepted that the use of very 
small databases will incorrectly measure the FDR for this reason, the effect of using high mass 
accuracy searches on the FDR has only been assessed by a small number of groups. This is of 
particular importance now that the vast majority of proteomic experiments are performed with 
instruments that offer mass accuracies < 5ppm. This high mass accuracy is often used to reduce 
database search space which has been shown to have deleterious effects on FDR determination 
[107].   
Database searches of mass spectrometry data are performed by dedicated search engines of which 
there are many [108]–[112]. Although each search engine essentially follows the same basic premise 
there are important differences which are mostly how the different software packages determine the 
confidence of peptide identification. Four common search engines are Sequest developed by the 
Yates lab, Mascot, developed by Matrix Science, Andromeda, developed by the Mann lab and 
ProteinLynx Global Server (PLGS), developed by Waters Ltd. Other popular search engines include 
OMSSA, X!Tandem and CRUX.   
Sequest, first presented in 1994, is one of the original search engines used to automatically identify 
MS/MS spectra based on a protein sequence database [113]. Briefly for each MS/MS spectra 
precursor mass is used to generate a list of in-silco peptides that have a mass close to the observed 
mass. For each peptide theoretical fragment spectra are compared with the raw data and the 
candidate peptide with the closest matching spectrum is reported as the best identification.    
Mascot was one of the earlier search engines and follows a similar approach to Sequest. Mascot has 
been adopted by many as it is designed to process a wide range of mass spectrometry data derived 
from various different instruments [109]. Mascot uses a probabilistic scoring algorithm for protein 
identification that is based upon the molecular weight search (MOWSE) algorithm. The algorithm 
calculates the probability that an observed match between experimental data and the protein 
sequence database is by chance. The best match is therefore the match with the lowest probability. 
Whether the best match is significant depends on the size and database and Mascot provides a 
significance threshold which is based upon a p value < 0.05. Mascot is a search engine only and is 
not designed to process raw data into the MS and MS/MS peak lists required as input for the search. 
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Proprietary software is available for all main instruments to generate the mascot generic format (mgf) 
from raw data.   
MaxQuant is a more recently developed search engine that has been designed to process high 
resolution data, produced primarily from Orbitrap mass analysers. In its early form, MaxQuant 
performed feature detection and SILAC quantification but relied upon Mascot to determine peptide 
candidates for MS/MS spectra [114]. MaxQuant now has its own dedicated search engine, 
Andromeda [110]. MaxQuant uses the high resolution provided by FT-based mass analysers to 
identify mass features at the MS level. The centroid mass of each peak is then determined by fitting a 
Gaussian peak shape to the three most central data points. The peak is then represented in 3D by 
including the retention time elution profile. Mass accuracy is improved by using SILAC charge state 
pairs, assigned prior peptide identification, to recalibrate the data post acquisition. Mass accuracies in 
the ppb region are possible with this approach. Andromeda uses a probabilistic scoring function which 
has been shown to perform as well as Mascot and is suitable for scoring post-translational 
modifications such as phosphorylation.  
ProteinLynx Global Server software has been developed specifically to processes MS
E
 data along 
with DDA data [90], [108]. The program subsequently has novel processing steps that are not 
required for DDA derived data. As mentioned because of the method of acquisition during MS
E 
fragment ions must be assigned to their parent precursors post acquisition, which is currently only 
possible with PLGS. Prior to fragment assignment two algorithms are used to process raw data. 
Apex3D subtracts noise before integrating ion current signal across the entire chromatographic 
profile. The ion outputs from this stage are converted into exact mass and retention time (EMRTs) by 
the Pep3D algorithm which de-isotopes and charge state reduces all common peptides. It is at this 
point that fragments are initially assigned to their precursor counterparts based upon their elution and 
mobility (HDMS
E
) profiles. This process is not highly discriminatory and will associate fragment ions 
with a number of precursors. The Ion Accounting algorithm performs the database search in a protein 
centric manner. Three stages of searches are performed starting with the identification of the most 
confident peptides and the removal of their EMRTs and associated fragments. This stage or “Pass1” 
continues until the protein FDR, as calculated by a decoy database, is reached. The second stage, 
Pass2, searches the remaining data for peptides derived from proteins identified from the previous 
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stage. Here peptides with missed cleavages, modifications and those derived from in-source 
fragmentation can be identified. Again the EMRTs of identified peptides are removed from the search 
space. The final search allows fragment ion intensity to be higher than its precursor, an attribute 
indicative of the in-source fragmentation of a highly labile peptide.          
 
1.18 Spectral Libraries 
A spectral library consists of a database of well characterised fragmentation patterns for the various 
compounds that are to be analysed, which in the case of proteomics are almost exclusively tryptic 
peptides. The identification of an unknown compound or peptide is made by successfully matching an 
unknown spectrum to a spectrum contained within the library. In small molecule analysis libraries are 
compiled by collecting fragmentation patterns from the analysis of known compounds [115], [116] 
whereas in proteomics such libraries can be produced from the results of extensive DDA analysis of a 
proteomic sample followed by database searching [117]. Spectral libraries are widely used in the 
analysis of small molecules where fragmentation is much harder to predict. Due to the predictable 
nature of peptide fragmentation, which facilitates database searching methods, the use of spectral 
libraries is far less popular. Spectral libraries do have their benefits in comparison to more traditional 
database searches and the development of DIA approaches, in particular SWATH, has seen their use 
in recent times increase [89]. Additionally the work of Thalassinos and colleagues has demonstrated 
its applicability to MS
E
 and HSMS
E
 data [118]. By developing identification metrics based on 
precursor, product ion exact mass, peptide fragmentation efficiency, peptide retention time and 
mobility they were able to show that the use of a well validated spectral library can be successfully 
used to process DIA data.  
Although traditional searching methods are well suited to the identification of new sections of 
proteomes that may have not been previous observed, spectral library searching is more efficient at 
providing in-depth coverage of proteome sections previous characterised. Due to the reduced search 
space the use of spectral libraries also offers faster searching speeds, a benefit that is becoming 
more important as the data volume produced by latest generation instruments increases. As DIA and 
targeted data validation becomes more widespread it would be expected that the use of spectral 
libraries will increase dramatically. 
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1.19 Protein Aggregation and Disease 
Proper folding of proteins is essential for correct cellular function. Nascent polypeptide chain folding is 
dependent on both the intrinsic properties governed by the amino acid sequence and influences from 
the cellular environment. Without correct tertiary structures proteins are unable to perform their 
respective functions and as such the cell has a large number of quality control mechanisms that act to 
promote proper protein folding and identify misfolding [119], [120]. The difficulty of maintaining 
proteostasis cannot be understated, with thousands of different proteins, over a large concentration 
dynamic range, to be persevered in various environmental and metabolic conditions. Additionally the 
folding mechanisms of proteins mean that their native structures tend to be marginally stable at 
physiological conditions [121]. Under certain circumstances protein misfolding can overload the 
quality control mechanisms and cause misfolded protein load to increase. Alongside the high total 
protein concentration within cells (~300 g/l) such an increase leads to a high propensity for misfolded 
proteins to aggregate within or in the area surrounding cells.  
The aetiology of diseases such as Alzheimer’s disease (AD) and systemic amyloidosis have long 
been linked with the aggregation of proteins [122], [123]. More recently a far larger range of diseases 
have been identified as being caused by or have been correlated with protein misfolding and 
aggregation.[124] Such diseases are commonly associated with mutations that destabilise the native 
structure of the protein or prevent a protein ever reaching its native fold. It is however interesting to 
note that around 30% of proteins in higher eukaryotes have intrinsically disordered regions giving rise 
to a metastable nature increasing their propensity to aggregate [125]. The archetypal example is α-
synuclein which is neuropathologically linked with Parkinson’s disease (PD) where it forms well 
characterised Lewy bodies within nerve cells [126]. Indeed AD and PD are stereotypical misfolding 
diseases in that they both affect the central nervous system. In both diseases the biggest risk factor, 
disregarding any of the more severe mutations, is age. An ageing population has led to a dramatic 
increase in misfolding disease prevalence in western countries [127]. It is probable that this risk factor 
is linked to the decline in quality control mechanisms, such as chaperoning systems, upon 
senescence. It has been demonstrated by transcriptional profiling of Caenorhabditis elegans that a 
wide range of heat shock proteins display age-related mRNA level decline [128].                   
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Pathological symptoms as a result of protein misfolding generally fit into two broad categories. A loss 
of function can be caused by a reduction in native protein availability due to only a percentage of 
synthesised protein adopting the correct fold. Gain of function symptoms conversely are thought to be 
caused by the toxic properties of oligomers and extended aggregates that arise from the exposure of 
hydrophobic regions upon misfolding. An alternative mechanism that leads to gain of function 
symptoms doesn’t directly implicate the toxicity of oligomers and aggregates. Instead the overloading 
of available degradation and molecular chaperoning systems leads to a collapse of proteostasis 
creating a self-propagating cycle leading to eventual cell death. A key step towards developing 
treatments for misfolding diseases is to dissect the mechanisms by which pathological symptoms are 
induced. This is most accessible through the use of cell or animal models and indeed a number of 
important developments for various misfolding diseases have been enabled by such models.  
 
1.20 Aims and Objectives 
Although the aetiology of misfolding diseases are on the whole understood, the downstream events 
that result in clinical symptoms are far more complex. A major question in many misfolding diseases is 
how misfolded aggregates or oligomers induce damage to surrounding cells. Although the classic 
reductionist approach has its place in the study of misfolding diseases, the advancement and 
availability of mass spectrometry-based proteomics offers a more comprehensive and unbiased 
approach to characterising cellular responses to misfolding events.  
The major objectives of my research were:  
1. To develop a label-free quantitative proteomics workflow to identify differentially regulated 
proteins that are implicated in age-related vulnerability to Aβ42 toxicity in an adult-onset D. 
melanogaster model for Alzheimer’s Disease  
2. Use a data independent acquisition approach to conduct label-free quantitative proteomic 
time-course analysis of chronic Aβ toxicity in an adult onset Drosophila model for AD and 
compare with wild-type ageing. Use these data to identify candidate proteins and cellular 
responses that better explain the link between ageing and Alzheimer’s disease  
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3. Develop a subcellular label-free quantitative proteomic workflow to characterise endoplasmic 
reticulum (ER) enriched protein responses to the expression of two misfolding variants of α1-
antitrypsin in comparison to the well folded, wild-type variant, in a Chinese hamster ovary cell 
line.   
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2.0 Abstract 
 
Alzheimer’s disease (AD) accounts for 60-80% of all senile dementia cases and is one of the fastest 
growing chronic diseases in developed countries.  Although the aetiology of the disease has been 
linked to increased levels of Aβ peptide concentration within the brain and the subsequent formation 
of toxic protein aggregates, the biggest risk factor for developing the disease is increasing age. 
Previously the use of an inducible D. melanogaster, for the first time, successfully demonstrated age-
related vulnerability to the neuronal expression of an aggregating variant of Aβ42 peptide. Using a 
data independent, mass spectrometric approach, quantitative proteomic analysis of D. melanogaster 
brain tissue at two different ages, with and without Aβ42 induction, was undertaken to identify proteins 
implicated in age-related vulnerability to peptide aggregation. Using our experimental design, 
differentially expressed proteins were successfully linked to Aβ toxicity, increasing age and a 
combination of the two variables. Results indicate a mixed response of chaperones to both Aβ and 
age which had all previously been identified as modulators of peptide toxicity and longevity. Our data 
provides further evidence towards the possible implication of altered chaperone activity in  age-related 
susceptibility to Alzheimer’s disease. Interestingly protein-protein interaction analysis identified 
enrichment in proteins involved in small GTPase mediated signal transduction to be regulated across 
conditions. Here, complex and varied expression levels were measured indicating mixed responses to 
age and Aβ42 aggregation. Our unbiased approach has provided a novel insight into cellular 
responses to both ageing and Aβ peptide toxicity. These data provide avenues for follow up functional 
studies, potentially with the same model organism, to better understand the link between ageing and 
Alzheimer’s disease.     
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2. 1 Introduction 
 
Alzheimer’s disease is the most common form of senile dementia, accounting for between 60-80% of 
all cases and represents one of the fastest growing chronic and fatal diseases in developed countries 
[1]. The cause and progression of the disease is not well understood but the widespread presence of 
extracellular amyloid plaques in the brain tissue of AD patients, supports that the aetiology of the 
disease is an increase of amyloid beta (Aß) peptide concentration within the brain [2], [3]. These Aβ 
peptides vary in length (between 38-43 amino acids long) and are therefore referred to in reference to 
their length, i.e. Aβ42. The peptide species are known to be derived from the amyloid precursor 
protein (APP) following it sequential cleavage by the proteolytic enzymes α-, β- and γ-secretase, 
Figure 2.1, however their normal biological function is unknown. Indeed neurodegenerative diseases 
are almost exclusively linked with the formation of toxic protein aggregates, often within neurons. 
Increased Aß concentration is linked by a large body of evidence, to Aβ oligomerisation, leading to 
aggregation and the formation of extended aggregate structures, amyloid plaques, in the extracellular 
regions that surround neurons.[4]  
The ‘amyloid cascade’ hypothesis is further supported by the mutations that have been identified as a 
cause of the familial form of Alzheimer’s disease (FAD). Mutations to the amyloid precursor protein, 
from which Aß peptides are enzymatically derived, and to the presenilins PS1 and PS2, which are 
both involved in the enzymatic cleavage process, are directly implicated in the familial form of AD [5], 
[6]. Such mutations lead to an increase in Aß production, the propensity for Aß42 to aggregate, or  
levels of Aß42 relative to Aß40. A large body of research into AD has focused primarily on the role of 
amyloid aggregates, using genetic models based upon FAD. These models range from C. elegans 
through to M. musculus and display AD-related phenotypes including shortened lifespan, cognitive 
impairment and/or neuronal dysfunction and the accumulation of Aß in an age-dependent manner [7]–
[9]. FAD only accounts for <1% of all AD cases and whilst genetic wide association studies (GWAS) 
have successfully identified mutations associated with the development of sporadic AD, age is still the 
biggest risk factor [10]–[12]. Age as a risk factor is common among many neurodegenerative 
diseases with increasing age also seen to increase the propensity for developing Parkinson’s disease 
[13]. The link between age and neurodegenerative diseases, however, is not well understood 
mechanistically. Elucidating the mechanisms that link AD and age so closely should aid in the  
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Figure 2.1 The processing of the amyloid precursor protein and it’s relation to Alzheimer’s Disease. APP is cleaved by β-
secretase and subsequently by γ-secretase to form the Aβ peptide, of which, an increase in concentration is thought to 
start the amyloidogenic pathway. Mutations to APP and the transmembrane proteins presenilin 1 & 2 (PS1 & 2) are known 
to cause familial Alzheimer’s disease through an increase in Aβ peptide concentration. In sporadic AD, however, these 
mutations are not present and the disease occurs at a much later age. The disease is also thought to be as a result of 
increased Aβ peptide concentration, although the cause for this is unknown. A number of genes are known to contribute 
to increased susceptibility to sporadic AD (pink box), however the biggest risk factor is increased age. 
 
development of improved treatments and therapies that up until now have been unsuccessful [14].  
Such research is particularly pertinent as a result of rapidly ageing populations in both developed and 
developing countries, which is driving the increased prevalence of AD. Currently it is estimated that 
>40 million people are living with dementia and this figure is predicted to rise to 135.5 million, with a 
large proportion of these cases being from poorer developing countries [12].  
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Recently, with the use of an inducible adult-onset Drosophila AD model, Figure 2.2,  an age related 
vulnerability to the expression of the FAD -associated Arctic Aß42 (Arc-Aß42) isoform, specifically in 
neuronal cells was reported, Figure 2.3 [15]. Normalised expression of Arc-Aß42 was induced in flies 
of three different ages for equivalent time periods. After controlling for the duration of exposure to the 
toxic peptide and for normal ageing, it was shown through both negative geotaxis assays (climbing 
assay) and lifespan measurements, that older flies were significantly more susceptible to peptide 
toxicity. The underlying mechanisms behind the observed vulnerability were beyond the scope of the 
initial paper and have subsequently been pursued using an unbiased mass spectrometry-based 
proteomics approach.   
 
Figure 2.2 Representation of the GeneSwitch-UAS expression system used in adult onset Alzheimer Drosophila models.[7] 
Transgenic flies contain the transcriptional activator GeneSwitch which is under control of the nervous system specific elav 
promoter, termed elavGS (in grey). An Arctic Aβ42 transgene is fused to a GAL-4 binding upstream activation sequence , 
UAS-Aβ (red and blue). During treatment with the hormonal rug  mifepristone RU486 (+RU, Green), the GeneSwitch 
protein become transcriptionally active, binds to UAS and induces the expression of Aβ42 within the nervous system. 
Without RU486 treatment, the gene switch protein is still expressed but is transcriptionally silent.  
 
Mass spectrometry (MS)-based proteomics, in particular the identification of differentially expressed 
proteins, through both relative and absolute quantification has been an important technique to help 
elucidate the constituent pathways that may contribute to AD progression. The majority of this 
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research has focused on the identification of enriched or depleted proteins in the post-mortem brains 
of AD patients, leading to a better understanding of the late-stages of the disease. Such proteomic 
studies have helped confirm the roles of inflammation and oxidative stress, amongst others, in the 
mechanism of neuronal and synaptic dysfunction. Information attainable from post-mortem samples is 
however, limited to the final stages of the disease, a point at which, it is thought, possible therapeutic 
routes will be small in number. The use of animal AD models alongside quantitative proteomics 
facilitates the collection of data that can better explain the earlier stages of the disease progression, 
where the identification of druggable targets has a better chance to prove effective. One such 
unbiased proteomics approach which utilized a triple transgenic AD mouse model was able to directly 
implicate mitochondrial dysfunction with Aβ and tau expression. Follow up experiments then 
effectively validated the synergistic effects of Aβ and tau protein in mitochondrial death, which is a 
well characterized AD pathogenic pathway [16].   
The mainstay of quantitative proteomics has been the use of label-based methods, notably stable 
isotope labelling by amino acids in cell culture (SILAC) and isobaric labelling methods such as 
tandem mass tag (TMT) or isobaric tag for relative and absolute quantification (iTRAQ) [17]–[19]. 
Although these methods offer high precision, in part due to the minimization of errors during sample 
preparation and mass spectrometric analysis, they also have their limitations. SILAC is now routine 
for in vitro screens however its use in model organisms is not always straightforward. Until recently 
near complete incorporation of heavy amino acids in Drosophila was not possible.  Since its 
emergence as a viable technique in Drosophila,  little research has been published with the use of 
such a method [20].  Recent developments that have provided robust liquid chromatography mass  
spectrometry platforms, alongside increased linear dynamic range and high duty cycle have meant 
that label-free quantitative proteomics has seen a surge in popularity, as it has become a viable 
alternative for quantitative studies [21], [22]. Label free proteomics now can routinely produce 
technical reproducibility <10% coefficient of variance and with the addition of improved normalization 
techniques has been reported to be as low as 1% [23], [24]. The benefits of label free-based methods 
include low cost, the ability to directly compare an unlimited number of samples and improved 
proteome coverage in comparison to label-based method where the multiplexing of analysis increases 
sample complexity. 
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As the popularity of label-free has increased, a multitude of approaches both in terms of acquisition 
methods and data analysis have been developed, aimed at improved precision and accuracy of 
quantitation [25], [26]. Data independent acquisition (DIA) strategies have emerged as an alternate 
approach to the classical mass spectrometry-based proteomic approach of data dependent 
acquisition (DDA), where precursors are selected for fragmentation based upon intensity (see 
Chapter 1.16) [27]. 
 
Figure 2.3 Age-related vulnerability to Aβ42 in D. melanogaster. A)  Standardised Aβ42 expression, induced in flies of 
different ages. RU486 concentration was varied to account for differences in feeding and protein translation. B)  Survival 
curves with Aβ42 induction carried out at three different ages. Induction in flies 5-19 days old demonstrates a statistically 
significant increase in lifespan compared to flies with Aβ42 induction at 20-34 days or 30-44 days. 
The suitability of MS
E
 for quantitative proteomic studies has been well demonstrated by a number of 
applications. A well designed evaluation by Levin et. al, demonstrated a linear dynamic range of 2.5-3 
orders in samples of varying complexity, with R
2
 values >0.99 consistently reported [28]. The 
technique has been used with success to study a number of different biological systems including AD. 
M.D. Hoos and colleagues were able to identify a range of differentially expressed proteins extracted 
from the brains of 42 week old CVN-AD mice; a transgenic mouse line that presents age-related 
accumulation of Aβ under low nitric oxide conditions [29].               
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In order to probe the underlying biological system perturbations that may help explain the age-related 
vulnerability to Aβ toxicity previously reported, we employed a LC-MS
E
 platform with prior gel-based 
fractionation, to probe in an unbiased manner the underlying pathways that might contribute towards 
the age-related vulnerability to Aβ toxicity observed in Drosophila. Our experimental design facilities 
the identification of proteins that are differentially expressed upon Aß42 expression, with age or 
display both an Aβ and age-related response. Proteins identified as differentially expressed from 
binary comparisons were found to carry out varied cellular functions, as assigned by gene ontology 
terms. Protein-protein interaction network analysis highlighted an enrichment of differentially 
expressed small GTPase proteins in older flies. Expression profiling found these proteins to display 
both age and Aβ expression responses, however the direction of expression change across this set of 
proteins was varied. 
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2.2 Materials and Methods 
 
2.2.1 Fly stocks and Husbandry 
Fly stocks were maintained at 25°C on a 12:12-h light and dark cycle. Humidity was kept constant and 
flies were fed on a sugar-yeast (SY) medium which consisted of 15 g l
-1
 agar, 50 g l
-1
 sugar, 100 g l
-1
 
autolysed yeast, 100 g l
-1
 nipagin and 3ml l
-1
 propionic acid. Where neuronal expression of arctic 
Aβ42 is indicated, food was prepared as stated and spiked with mifepristone (RU486) at a final 
concentration of 200 µM.  
The use of the elav GeneSwitch (elavGS)-UAS system [GAL4-dependant upstream activator 
sequence] allowed the adult-onset neuronal-specific expression of Arctic Aβ42 peptide upon 
treatment with the progesterone steroid, mifepristone (RU486, Sigma).[30] UAS and elavGS-lines had 
been backcrossed into the w
1118
 genetic background six times prior to male flies expressing UAS-
constructs being crossed to female flies expressing elavGS to ensure a homogenous wild-type 
background genome. 
 
2.2.2 Aβ42 Expression and Dissections 
Fly crosses were staggered so that Aβ42 expression was induced in both 5 day and 20 day old 
Drosophila simultaneously. Expression was induced for 7 days for both conditions. Drosophila brain 
tissue was dissected 14 days post initial induction. For each biological repeat dissections were 
conducted at the same time each day, to limit experimental variability caused by circadian rhythm 
effects. A total of fifteen flies were dissected per sample. Flies were anaesthetized on CO2 and 
dissections were carried out on ice-cold phosphate buffer saline solution and transferred immediately 
to RNAlater (Life technologies, USA) to prevent enzymatic protein degradation. Crosses, expression, 
ageing-spans and dissections were carried out as a collaborative effort with Dr Fiona Kerr, Healthy 
Ageing Department, UCL.       
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2.2.3 SDS-PAGE Separation and Tryptic Digestion.  
Samples were prepared for SDS-polyacrylamide gel electrophoresis (PAGE) by homogenisation in 30 
µl of x2 Laemmli sample buffer (Life technologies,USA) containing β-mercaptoethanol (Sigma,USA). 
Samples were then boiled for 5 minutes just prior to SDS-PAGE. Proteins were separated on pre-cast 
10 % SDS-PAGE gels (Bio-Rad, USA and visualised by staining with Coomassie brilliant blue R-250 
(Pierce, USA). Samples from the four conditions from the same biological repeat were batched on the 
same gel in order to reduce variability. Each of the 8 lanes were excised from the gel and cut into ten 
bands. The size of each band was decided based upon the amount of protein present, as indicated by 
the extent of staining. The size of each band was kept consistent across all samples prepared. 
Bands were cut into small sections for efficient digestion, destained and dehydrated with acetonitrile. 
Disulphide bonds were reduced by covering gel pieces with 100 µl of 10 mM DTT (Sigma Aldrich, 
St.Louis, MO) with heating at 56°C for 30 minutes. Free thiols were alkylated with 100 µl of 55 mM 
IAA (Sigma Aldrich, St.Louis, MO). The reaction was left for 30 minutes in the dark. Gel pieces were 
washed with 50 mM ammonium bicarbonate (Sigma Aldrich, St.Louis, MO) and dehydrated with 
acetonitrile. This step was repeated twice. Gel pieces were rehydrated with 100 µl of a 10 ng ul
-1
 
trypsin solution in 50 mM ammonium bicarbonate. Samples were left overnight at 37°C. Post 
digestion peptides were extracted by addition of 100 µl of extraction solution (97% water, 2% 
acetonitrile, 1% formic acid). The supernatant was collected and 70 µl of acetonitrile added to the gel 
pieces to extract remaining hydrophobic peptides. The supernatant was added to the previous 
solution and dried down by vacuum centrifugation. Samples were re-solubilised in 10 µl of 0.1 % 
formic acid. Samples were frozen at -20 °C prior to analysis.  
 
2.2.4 Quantification of Total Aβ42  
Total Aβ42 was extracted based upon a published method.[31] Fly heads were homogenised in 50 µl 
guanidine hydrochloride extraction buffer (5 M GnHCl, 50 mM Hepes pH 7.3, protease inhibitor 
cocktail (Sigma) and 5 mM EDTA). Homogenate was centrifuged at 21,000 g for 5 minutes at 4°C 
before extracting the supernatent for total Aβ42 measurment. Aβ42 concentration was measured 
using the High Sensitivity Human Amyloid Aβ42 ELISA kit (Millipore, Bilerica, MA, USA). Samples 
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were diluted 1:100 in sample dilution buffer and the immunoassay was performed according to the 
manufacturer’s instructions. A Bradford protein assay (Bio-Rad laboratories Ltd, UK) was used to 
quantify total protein levels from each extraction to allow the calcualtion of Aβ42 concentration as a 
ratio to total protein (pmoles/g).   
 
2.2.5 Reverse Phase Liquid-chromatography Mass Spectrometry Analysis  
For each sample 1 µl was loaded using a split-less nano-Ultra Performance Liquid Chromatography 
(10 kpsi nanoAcquity Waters Corporation, Milford, MA, USA). Buffers used were (A) water + 0.1% 
formic acid (J.T. Baker, PA, USA) and (B) acetonitrile + 0.1% formic acid (J.T. Baker, PA, USA). 
Samples were desalted using a reverse-phase SYMMETRY C18 trap column (180 µm internal 
diameter, 20 mm length, 5 µm particle size, Waters Corporation) at a flow rate of 5 µl/min for 3 
minutes.  Peptides were separated by a linear gradient (0.3 µl/min, 40 °C; 97-60% Buffer A over 90 
minutes) using a BEH130 C18 nano-column (75 µm internal diameter, 150 mm length, 1.7 µm particle 
size, Waters Corporation).  
The nanoLC was coupled online through a custom built nanoflow sprayer to a quadrupole time-of-
flight (QToF) hybrid mass spectrometer (HDMS Synapt; Waters UK) tuned to a mass resolution of 10 
000 (full width half height). The ToF analyser was externally calibrated from m/z 175.11 to 1285.54 
using the fragment ions of a 500 fmol/µl solution of [Glu
1
]-fibrinopeptide B (GFP, Sigma Aldrich, 
St.Louis, MO). Data were lockmass-corrected post acquisition using the monoisotopic mass of the 
doubly charged precursor of GFP (785.8426 m/z), delivered at 500 fmol/µl to the mass spectrometer 
via a NanoLockSpray interface. The reference sprayer was sampled every 60s. Accurate mass 
measurements were made using a data independent mode (LC-MS
E
) of acquisition.[32], [33] Briefly, 
energy in the collision cell was alternated from low energy (4 eV) to high energy (energy ramp from 
15-35 eV) whilst continuously aquiring MS data. Measurements were made over a m/z range of 100-
1990 Da with a scan time of 0.6 s and an interscan delay of 0.05s. One cycle of MS and MS
E  
data 
were acquired every 1.3 s. A radio frequency was applied to the quadrupole mass analyser to facilate 
the efficient transmission of ions with an m/z range of 300-2000. This ensured that ions below 300 
m/z and observed in the MS
E
 spectrum were known to be derived from collision cell fragmentation. 
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Biological replicates were analysed in technical duplicate. Sample analysis was batched so that 
conditions from the same biological repeat were analysed during the same analytical run.  
 
2.2.6 Database Processing 
Databases were searched using PLGS v2.5.2 (Waters Corporation). The computational methods 
used to process the data are explained in detail by S.J. Geromanos  [27]. Briefly raw data is 
lockmass-corrected, smoothed, background subtracted and deisotoped. This provides a single 
centriod accurate mass for the monoisotopic of each peptide and respective fragment ions. Peptide 
are associated with fragment ions through time aligment. Data were searched against an Uniprot 
complete protein database for Drosophila melanogaster. Carbamidomethyl-C was specified as a fixed 
modification.  Oxidation (M), phosphorylation (S,T,Y), acetylation (K, N-terminus) and deamidation (N 
and Q) were specified as variable modifications. A maximum of two missed cleavages of the protease 
were allowed for semi-tryptic peptide identification. For peptide identification two corresponding 
fragment ions were set as a minimum criterion whereas for protein identification a minimum of one 
corresponding peptide identification and two fragment ions were required. Protein level false 
discovery rate was maintained at < 5% estimated based upon the number of proteins identified from a 
randomised database. The false discovery rate was minimised further by applying the additional 
criteria that for a successful identification a protein must be identified in a minimum of two biological 
repeats and three technical repeats. This criterion is based on the assumption that false positives, 
from chemical noise, are random in nature and should not replicate across injections. Database 
search results were outputted in .csv format for further analysis. These data are provides in the 
appendix file.  
 
2.2.7 Protein Quantification 
Relative protein quantification was achieved using the Hi3 technique as detailed elsewhere [34]. 
Briefly, it has been shown that the combined intensity for the three most intense peptides for each 
protein in a proteomics run directly correlates (R
2
=0.99) to the protein amount loaded onto to column 
[35]. This observation allows the direct comparison of conditions without the need for isotopic labelling 
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or isobaric tagging techniques. To account for run to run instrumental variation, a normalisation 
technique was applied across runs to be compared.  
 
2.2.8 Peptide Intensity Normalisation 
Within condition normalisation was achieved by an in-house R script based upon locally weighted 
scatterplot smoothing (LOESS) and was conducted on data at the peptide level [36], [37]. LOESS-
based normalisation is founded upon the assumption that when comparing conditions, even in the 
presence of differential expression, the majority of protein abundances stay constant. The result of 
this is that if samples are compared with an MA plot (where M is protein abundance ratio, between 
samples, and A is average protein intensity, both plotted on a log2 scale) the fit of a locally weighted 
regression line across the intensity range should perfectly dissect 0 on the y-axis. In reality this does 
not always hold true.  The LOESS approach normalises data by applying correction values to raw 
peptide intensities such that the locally weighted regression line better fits the desired y=0 equation 
post correction. The script used to perform the normalisation is provided in Appendix A.  
 
2.2.9 Effect Size Calculation 
Effect size was calculated based upon the method used previously by M.D Hoos et. al in their label-
free quantitative proteomic study of an Alzheimer’s mouse model [29]. Briefly, a moving average of 
data variance across protein intensity distribution was calculated. Data variance was calculated as a 
coefficient of variation (%) for all proteins that had three or more quantitative values in a condition. 
Data from all conditions were included in the calculation and CVs from proteins identified in more than 
one condition were treated independently. A 100 point moving average was calculated. Using these 
data, effect size (as Cohen’s d) was calculated for each quantified protein. Proteins taken forward for 
statistical analysis were required to have a calculated Cohen’s d >1.0. This represents a difference in 
mean which is larger than one standard deviation of the calculated data variance.  
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2.2.10 Statistical Analysis 
Data deemed significantly different, based upon effect size, were taken forward for statistical analysis. 
An unpaired Student’s t-test, assuming equal variance, was carried out on log2 transformed Hi3 
protein intensities. Conditions were subject to pairwise comparison. Significance levels were chosen 
based upon the false discovery rate due to multiple hypothesis testing. P values deemed significant 
were chosen to ensure statistically less than one protein per comparison should be a false positive. 
An additional definition of differential expression was included which took advantage of missing 
protein identifications. During pairwise comparison if a protein was successfully quantified in one 
condition, based on previously mentioned criteria, but was not quantified in any of the replicates from 
the second condition, it was deemed to be differentially expressed. These data are provided in the 
appendix file.  
 
2.2.11 Western Blotting 
Drosophila heads were pooled and homogenised in 2x Laemmli sample buffer (Life 
technologies,USA) sample buffer containing β-mercaptoethanol (Sigma Aldrich, St.Louis, MO) and 
heated at 95°C for 5 minutes. Proteins were separated on SDS-PAGE gels and blotted onto 
nitrocellulose. Membranes were incubated in a blocking solution containing 5% milk protein in Tris-
Buffered Saline-Tween20 (TBST) solution for 1 hour at room temperature. Primary antibodies were 
diluted in TBST according to previous literature or manufacturer’s  instructions (ranging between 
1:500 & 1:2000) and blotted nitrocellulose were incubated in primary antibody overnight at 4°C. 
Following incubation with the appropriate HRP-conjugated secondary antibodies (Abcam, Cambridge, 
UK) for one hour at room temperature blots were developed using an ImageQuant LAS 4000 (GE 
Healthcare Life Sciences, Little Chalfont, UK). Quantitation was performed using ImageQuant 
software. 
Primary antibodies used were Rab-3 (Dr Aaron DiAntonio), Ran (Cell Signaling Technology, Danvers, 
MA, USA), AP50 ( BD Transduction Laboratories, New Jersey, USA), EndoA (Dr Patrik Verstreken)    
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2.3 Results 
2.3.1 Comparative Analysis of the Drosophila Head and Brain Proteome 
Few previous studies looking at global levels of protein or RNA upon neurodegeneration in 
Drosophila, have specifically analysed brain tissue. Commonly fly head homogenate is sampled due 
to the ease of obtaining large amounts of sample with a relatively quick protocol. This approach is 
based on the assumption that analysis of the head is representative of the brain. The Drosophila 
brain, however, only represents a proportion of the total head mass, with the eyes and cuticle 
contributing a large percentage of protein mass. We hypothesised that using a mass spectrometry 
workflow that is unable to identify the complete head proteome, to analyse head samples, might 
dramatically reduce the number of identifiable brain specific proteins. We carried out a direct 
comparison of between an extract from 10 Drosophila heads to an extract from 10 Drosophila brains, 
Figure 2.4A. Using our 1D-gel-MS
E
 workflow we identified similar numbers of proteins from the head 
and brain sample following triplicate analytical replicates. Proteins were classed as successfully 
identified if they were present in 2 out of 3 replicates. Based on the total number of proteins identified, 
1221, around 1/3 were attributable as specifically expressed in the head whilst a similar number were 
only identified from the brain sample. Due to the stochastic nature of MS analysis the replicate 
analysis of a sample can identify different sets of proteins. In order to validate our results we 
examined whether the use of three technical replicates gave results that were consistent enough to 
draw comparisons between the two different samples, Figure 2.4B.  A level of reproducibility was 
observed between technical replicates which provided confidence that results seen in Figure 2.4A, 
were truly representative of the samples analysed and were not a result of technical variations. Based 
on these data it was decided that the analysis of brain tissue would provide results more 
representative of age-related vulnerability to Aβ42 toxicity.  
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Figure 2.4 Results from the GeLC-MS
E 
analysis of Drosophila heads and brains. A) Overlap between proteins identified from 
technical replicate analysis of protein extracts from 10 heads vs protein extracts from 10 brains. B) Overlap between 
proteins identified from technical replicate analysis of brain samples     
          
 
 
2.3.2 Experimental Design  
We wished to identify proteins directly involved in age-related vulnerability to Aß42 toxicity. To 
achieve this we compared the brain proteomes of an adult-onset AD-Drosophila model, where Aß42 
expression had been induced at two different ages, 5-12 days (young) and 20-27 days (old). Brains 
had been dissected 14 days post initial induction, a time point at which it would be expected for a 
climbing phenotype to be detectable. To allow us to probe Aß specific and age specific proteome 
responses in parallel, age matched controls were included where Aß42 expression had not been 
induced, Figure 2.5A. Prior to analysis by mass spectrometry levels of Aβ42 were quantified by 
enzyme-linked immunosorbent assay (ELISA). Data confirmed that both induced samples had similar 
levels of peptide, Appendix B. Biological repeat A was not included in the proteomic analysis due to 
higher levels of Aβ levels than the 4 other samples.   
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2.3.3 Proteomic Workflow 
In order to obtain robust quantitative data, for each biological condition studied by our 1D-gel-LC-MS 
workflow, Figure 2.5B, four biological repeats were analysed, with each repeat being analysed by LC-
MS in duplicate. Database searching was performed at a protein false discovery rate (FDR) of 5 %. 
Data were additionally filtered based on replication, with a protein being successfully identified if it 
was detected in a minimum of 2 biological replicates and three technical replicates. As instrumental 
noise is random in nature, true peptide signals should replicate, allowing the FDR to be reduced 
further. 
 
2.3.4 The Mass Spectrometry-Based Proteome is Representative of the Genome 
A common criticism of mass spectrometry-based proteomics is that methods used to prepare samples 
for analysis produce peptide solutions that are not fully representative of the original samples being 
interrogated. Due to the incompatibility of electrospray ionization (ESI) with high concentrations of 
detergent, protein extractions and digestions are commonly carried out at low detergent 
concentrations. Highly hydrophobic proteins such as membrane proteins are underrepresented as a 
direct result of not being soluble during proteolysis. Recently a method was introduced by JR 
Wisniewski et. al, that enables the use of high concentrations of detergent during sample lysis, prior to 
in-solution digestion enabling the solublisation and subsequent digestion of highly hydrophobic 
proteins prior to MS analysis [38]. This method however, requires larger amounts of starting material 
due to sample loss on molecular weight cut-off filters used for buffer exchange. If peptide level 
fractionation is performed-post digestion (commonly strong cation exchange) further sample loss 
would occur. Gel-based fractionation methods also facilitate the use of high concentrations of 
detergent, typically 4 % sodium dodecyl sulcate. Due to the low amount of starting material for the 
analysis, ~15 µg, it was hypothesized that the use of a gel-based method where fractionation is prior 
to digestion and extraction would limit possible sample loss by minimizing protocol steps, whilst 
solubilizing proteins in an unbiased manner. 
In parallel to proteomic analysis, microarray mRNA transcriptional profiling was performed to examine 
gene expression profiles in relation to age and Aß expression. Microarray analysis was performed on 
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brain tissue and therefore provided the ideal benchmark for comparison with our proteomic dataset. 
All proteins identified from MS analysis, at a 5 % protein level FDR, and all genes detected in the  
 
Figure 2.5 Experimental design and proteomic workflow for the unbiased screen of age-related vulnerability to Aβ toxicity. 
A) Experiment conditions examined. B) GeLC-MS
E
 workflow. Following arrows from top left, 15 Drosophila brains were 
homogenised in 30 ul SDS-PAGE loading buffer. Extracted proteins were separated by SDS-PAGE and each sample lane was 
separated into 10 bands. Bands were tryptically digested. Resultant peptide solutions were separated over an 80 minute 
gradient prior to analysis by MS
E 
on a Synapt HDMS. Database search results were stored in a custom built MySQL database 
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and peptide intensities were merged for gel bands common to a sample  by summation based on protein accession. Data 
were normalized at the peptide level using an in-house written R script using locally weighted scatter point smoothing 
(LOESS). Relative quantification was achieved using the Hi3 technique.  
microarray analysis were taken forward for gene ontology analysis. The two physiochemical 
properties, molecular weight and isoelectric point, were also calculated and compared between the 
two datasets. Gene ontology analysis and physiochemical property analysis was able to confirm that 
the two datasets compare well, Figure 2.6. The proportion of membrane proteins identified from mass 
spectrometric analysis agrees extremely well with that of the microarray results, confirming that the 
use of gel-based proteomic methods negates possible bias during the solubilisation process, Figure 
2.6A. Our data suggests that the proteomic method preferentially identifies lower molecular weight 
proteins in comparison to the microarray results, Figure 2.6D. As proteins are proteolytically cleaved 
prior to analysis, protein size should only affect the number of possible peptide fragments that can be 
produced. This would suggest that MS analysis might preferentially identify larger proteins. Indeed it 
has been shown that quantification strategies, such as Hi3, can underrepresent the quantity of smaller 
proteins, or present a much larger measurement error [39]. It was hypothesized that the observed 
preferential identification of smaller proteins may be a result of the gel fractionation method, where 
proteins are separated based on their molecular weight. Better resolution is observed for proteins of a 
lower molecular weight, which would, therefore, aid their identification through decreased sample 
complexity. Testing our gel-based results against an in-solution method without any protein level 
fractionation, on the same samples, would be able to better explore this hypothesis.  
 
2.3.5 Protein Quantification 
Quantification was achieved using the previously described Hi3 technique. Hi3 is based on the 
observation that the summed intensity of the top 3 best ionizing peptides, as enzymatically derived 
from a protein, are directly proportional to the original protein concentration. A requirement for 
quantification is, therefore, the identification of a protein by three or more constituent peptides. A total 
of 1203 proteins were quantified, of all quantified proteins 478 proteins were common across all four 
conditions. Both technical and biological precision were found to be high, with a median Pearson’s   
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Figure 2.6 Comparison of proteomic and transcriptomic profiles by gene ontology and physiochemical properties. A) 
Comparison of proteomic and transciptomic datasets by gene ontology analysis; biological process terms. B) Comparison 
by cellular compartment terms. C) Kernel density plot of isoelectric point distributions. D) Kernel density plot of protein 
molecular weight distributions  
correlation coefficient of 0.95 for technical repeats and 0.92 for biological repeats, representing a 
median coefficient of variation (CV) of 25.5% on repeat measurements. Based upon mean CV, power 
analysis indicated that four biological repeats would successfully identify fold changes of > 2 fold 
increase using a power of 0.8 as the threshold, Figure 2.7. Differential expression was based on 
calculated p values from each binary comparison and statistical power analysis that has been 
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Figure 2.7 Power analysis. Power calculations were based on a mean coefficient of variance of 40 % and 2-10 biological 
repeats. Power of analysis has been calculated at four different predicted fold changes.   
previously shown to provide an effective estimation of the appropriate effect-size cutoff (Cohen’s d) as 
a function of protein intensity. Briefly, CV values of repeat quantitative measurements, of proteins 
identified within a condition, were plotted against their respective protein intensity, Figure 2.8. A 
rolling mean of CV values was plotted as a function of Hi3 protein intensity. This approach assessed 
global measurement error in reference to protein intensity. Interestingly our data did not display any 
observed reduction in measurement error with increasing protein intensity, a correlation which has 
been observed in previous label-free studies. This would suggest that the most significant source of 
error in our measurements was biological variability, which would not be affected by peptide intensity. 
As such we took forward the average of the rolling mean, 33 % CV, for effect size calculations. 
Proteins in each binary comparison that had an effect size larger than 1, indicating the mean of one 
group is found in the 85
th
 percentile of that of the second group, were consider as displaying a large 
enough effect size abundance change to be taken forward for p value calculation. P values were 
calculated using a two tailed students t-test. Expression change was deemed significant at a p value 
<0.01, thereby limiting the number of false positives to less than one protein per comparison, based 
on the number of proteins tested. Results of the pairwise comparisons are supplied in Appendix C.   
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Differential protein expression was also defined based on a protein’s absence from one condition, in a 
binary comparison, Appendix D. The rationale behind this approach is that if a protein is confidently 
identified in one condition, but is not detected in the other condition to which it is being compared, 
then an expression change must have resulted in a protein concentration below the limit of detection 
of our analysis. To reduce the number of false positive arising from these criteria, a protein was only 
differentially expressed if it met the criteria for protein identification in one condition and was 
completely undetected in all four biological repeats of the other condition.  
 
Figure 2.8 Estimation of global measurement error, as a function of Hi3 protein intensity, for effect size calculations. Data 
points represent measured data variance (% CV) of protein quantification (combined technical and biological replicates). 
The thick black line is a superimposed rolling mean  
 
2.3.6 Age-Related Protein Expression Changes in the Presence of Aß42 Toxicity   
We initially examined the relative protein expression levels in the brains of old Aß42 flies in 
comparison to young Aß42 flies. This pairwise comparison allowed the identification of 38 proteins 
that are a dysregulated as a result of age in the presence of Aß42 toxicity. These proteins represent 
potential candidates for contributing to age related vulnerability, Table 2.1. Gene ontology analysis of 
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these proteins did not identify any enriched GO terms for this subset of proteins, Figure 2.9A. 
Proteins involved in metabolic processes, a wide ranging term that encompasses both biosynthetic 
and catabolic processes were by far the most common. When compared to the background of all 
proteins identified in the screen, it is clear this does not represent true enrichment as a result of a 
cellular response but a tissue specific enrichment. Pathway analysis confirmed gene ontology results, 
showing a wide variety of functions for the 38 proteins but no particular enrichment of function, Figure 
2.9B. 
 
Figure 2.9 Gene ontology analysis results for differentially expressed proteins (Young Aβ42 vs Old Aβ42). A) Biological 
Process Terms. B) Panther Pathway Terms  
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Table 2.1 Differentially expressed proteins from the binary comparison, old + vs young + flies 
Protein Fold Change Effect Size P value 
Glycyl-tRNA synthetase 1.531583695 1.24 0.0002925 
L-lactate dehydrogenase 0.466199122 2.07 0.00747528 
Clathrin-associated protein AP2 (AP50) 0.61110634 1.42 0.00929865 
RH04549p 0.684319892 1.12 0.01020012 
Peroxiredoxin 5 1.643725092 1.43 0.01078999 
NAP1 Unique to Young Aβ 
 
14-3-3 protein epsilon Unique to Young Aβ 
 
HSP27 Unique to Young Aβ 
 
Heterogeneous nuclear ribonucleoprotein A1 Unique to Young Aβ 
 
Microtubule-assocaited protein Jupiter Unique to Young Aβ 
 
cAMP-dependent protein kinase type I Unique to Young Aβ 
 
Eukaryotic translation initiation factor 3 subunit F-
1 
Unique to Young Aβ 
 
Heat shock protein 26 Unique to Young Aβ 
 
Heat shock 70 kDa protein cognate 2 Unique to Young Aβ 
 
Myosin regulatory light chain 2 Unique to Young Aβ 
 
CG9090 Unique to Young Aβ 
 
Proteasome subunit beta type Unique to Young Aβ 
 
Eb1, isoform F Unique to Young Aβ 
 
Sec22 Unique to Young Aβ 
 
Myofilin Unique to Young Aβ 
 
Myosin heavy chain, muscle Unique to Young Aβ 
 
Dihydroorotate dehydrogenase Unique to Young Aβ 
 
Flightin Unique to Young Aβ 
 
Troponin1 Unique to Young Aβ 
 
Tetraspanin 42Ef Unique to Young Aβ 
 
CG11474 Unique to Young Aβ 
 
Sarcoplasmic calcium-binding protein 1 Unique to Young Aβ 
 
IA-2 Unique to Young Aβ 
 
cg991 Unique to Young Aβ 
 
40s ribosomal protein s5a Unique to Young Aβ 
 
cg9512 Unique to Young Aβ 
 
Glycogen Synthase Unique to Young Aβ 
 
cg12237 Unique to Old Aβ 
 
sd22712p Unique to Old Aβ 
 
40s ribosomal protein s24 Unique to Old Aβ 
 
Putative peptidyl-prolyl cis-trans isomerase dodo Unique to Old Aβ 
 
Acetylcholinesterase Unique to Old Aβ 
 
Replication factor C subunit 3 Unique to Old Aβ 
 
Annexin B11 Unique to Old Aβ   
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2.3.7 A Subset of Motor-Related Proteins are Upregulated in Young Aβ flies  
Following gene ontology analysis results, differentially expressed proteins were search against known 
protein-protein interactions (PPIs) databases using the online tool, Search Tool for the Retrieval of 
Interacting Genes/Proteins (STRING) [40]. Proteins were searched against a Drosophila specific 
database and only interactions with medium confidence were included in the output, Figure 2.9. 
Although the majority of proteins do not have any known interaction partners, two clusters of interest 
were identified. The main cluster contains six proteins that display large amounts of coordination with 
one another and a seventh protein, which interacts with a single protein within the main cluster. To 
test for the functional significance of these clusters enrichment analysis was conducted within 
STRING, to test for PPIs that have common biological functions, molecular functions and/or cellular 
components. After correction for multiple hypothesis testing no molecular or biological functions were 
enriched, however a number of cellular components categories reached significance (p < 0.05), Table 
2.2. A common theme among the enriched categories is that they are integral to cytoskeleton 
structure and function, indeed cytoskeleton part is found to be significantly enriched (p = 0.003). 
Linking this data with the interaction network, Figure 2.10, it is found that the main protein cluster are 
all classified as a cytoskeleton component. Interestingly analysis of expression profiles confirms that 
proteins within this cluster display similar expression levels.  All proteins were highlighted  from their 
confident detection in samples from  young +RU flies but their absence in samples derived from old –
RU flies. Further examination of the data from the screen determined that they are in fact almost 
exclusively identified in young +RU flies. These results suggest a unique and coordinated response to 
amyloid expression that changes with age.  
Examination of the 7 protein cluster identified Wings up A (WupA) as the protein to coordinate with 
the highest number of partners. It was found to directly interact with five other proteins within the 
interaction cluster and therefore makes an interesting target to explore. WupA encodes Troponin I, a 
key protein in muscle cells that regulates the sliding of thin over thick filaments, but more interestingly 
is thought to be involved in the development and maintenance of the nervous system [41], [42]. 
Troponin I, is well characterized in patients with heart disease, where it is a well-known stress marker 
but there is little information on its function within the brain [43]. Second to WupA, in terms of number 
of interacting partners is myosin regulatory light chain (RLC), for which there is more known about its 
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function within the central nervous system. Myosin RLC is normally associated with the neck region of 
the myosin II protein complex and is best characterized in its role in the regulation of myosin-based 
contraction in muscle cells. Myosin II is also found post-synaptically and has been demonstrated to 
directly interact with NMDA receptors [44]. Importantly the myosin II complex has been found to be 
directly involved in mediating the tau toxicity mechanism, through this interaction [45]. 
Table 2.2 Enrichment analysis for cellular components from STRING analysis. Proteins included were identified as 
differentially expressed (old + vs young +)    
Cellular Compartment N
o
 Genes P value 
P 
value_fdr 
muscle myosin complex 3 4.90E-07 4.80E-04 
myosin II complex 3 4.10E-06 2.00E-03 
myofibril 4 1.10E-05 2.70E-03 
contractile fiber part 4 1.30E-05 2.70E-03 
contractile fiber 4 1.40E-05 2.70E-03 
intracellular part 28 2.20E-05 3.50E-03 
cytoskeletal part 10 2.50E-05 3.50E-03 
intracellular 28 3.40E-05 4.20E-03 
cytoskeleton 10 5.10E-05 5.60E-03 
cytoplasm 20 8.50E-05 8.40E-03 
cytoplasmic part 17 1.00E-04 9.00E-03 
cell 29 1.30E-04 9.90E-03 
cell part 29 1.30E-04 9.90E-03 
myosin complex 3 1.50E-04 1.10E-02 
myofilament 2 2.90E-04 1.90E-02 
sarcomere 3 3.20E-04 2.00E-02 
intracellular organelle 24 3.90E-04 2.20E-02 
organelle 24 5.00E-04 2.70E-02 
actin cytoskeleton 4 6.80E-04 3.50E-02 
macromolecular complex 18 7.00E-04 3.50E-02 
A band 2 7.40E-04 3.50E-02 
non-membrane-bounded organelle 13 8.10E-04 3.50E-02 
intracellular non-membrane-bounded 
organelle 
13 8.10E-04 3.50E-02 
intracellular organelle part 17 9.00E-04 3.70E-02 
organelle part 17 1.10E-03 4.20E-02 
 
Models have shown tau to be essential for Aβ-induced NMDA dependent postsynaptic dysfunction 
[46]. In Drosophila loss of function mutants, for Zipper and spaghetti squash, the genes encoding 
heavy chain (HC) and RLC of myosin, display increased tau toxicity. These results suggest an age-
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related loss of myosin RLC in the presence of Aβ that could be directly involved in the increased 
toxicity observed in older flies.      
Little is known about the function of many of the seven proteins’ functions within the brain and the 
results from the screen could represent an interesting avenue of research that has little to no focus 
currently in the AD research field. It is possible that the identified protein network could be closely 
linked to myosin RLC toxicity mediation; however this is based purely upon PPI data and requires 
significant validation. Prior to this, validation of the results from the screen for this subset of data by 
an orthogonal quantative/semi-quantitative method should be carried out.  
 
Figure 2.10 Annotated output from the protein-protein interaction analysis of 38 proteins identified as differentially 
expressed in the binary comparison of old + flies vs young + flies. Analysis carried out using STRING. Lines indicate a 
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protein-protein interaction and thickness of lines is representative of the confidence. Only PPIs with medium or higher 
confidence are included in the output 
 
2.2.8 Heat Shock Proteins Show a Mixed Response to Aβ Expression and Age 
Pathway analysis of the results from the old Aβ42 flies vs young Aβ42 flies binary comparison 
identified expression changes for 4 chaperone proteins that are known to directly interact. 
Dysregulated chaperone expression is an expected cellular response to the increase in misfolded 
protein load caused by Aβ42 aggregation. Interestingly these proteins show an age-related response 
in addition to an Aβ42 response. This led us to further investigate the expression profiles of the 4 
proteins across all tested conditions. Three of the chaperone proteins were found to be heat shock 
proteins (Hsp), namely Hsc 70, Hsp 27 and Hsp 26, with the fourth protein being the third isoform of 
14-3-3 protein epsilon. Heat shock proteins are a set of highly conserved molecular chaperones that 
are induced in response to a variety of physiological and environmental stresses, allowing cells to 
survive potentially lethal conditions. When acting as molecular chaperones, Hsps bind to misfolded 
proteins and catalyze, often in an ATP-dependent manner, proper re-folding of proteins to prevent 
potential aggregation. The family of Hsp 70 proteins’ main function is to assist in the folding of 
nascent polypeptides under normal conditions. The chaperone family additionally aids the assembly 
of protein complexes and the transport of proteins across membranes. They act by holding translated 
or nascent peptide chains in a state suitable for folding when released into the medium. Hsp 70 is 
commonly observed to be upregulated in disease states as studied by proteomics. It can be seen that 
as predicted, Hsp70 is upregulated in response to Aß expression, Figure 2.11A. Interestingly the data 
shows a small reduction in expression in response to Aß, with age, however for the conditions tested 
this did not reach significance (p = 0.11). This is in contrast to expression levels quantified in the two 
non-induced controls, with Hsp70 expression elevated (p= 0.038) in the older flies. This is in contrast 
to previous studies where global levels of Hsp70 during Drosophila ageing have been observed to 
reduce with increasing age, an observation that has been hypothesised to be an explanation for 
reduced stress resistance in aged Drosophila [47].
 
Our data, however, detects significant alterations in 
heat shock 70 kDa protein cognate 3 (Hsc70-3) levels but no other members of the Hsp70 family. The 
data therefore indicates a more specific cellular response than previous publications have monitored. 
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Hsc70-3 is the functional counterpart of binding immunoglobulin protein (BiP) the endoplasmic 
reticulum (ER) resident chaperone that binds newly synthesised proteins as they are translocated into 
the ER. If misfolded protein load increases BiP is a key component of the ER associated degradation 
response (ERAD). Increased levels of BiP following the induction of a variant of Aβ42 that is known to 
rapidly aggregate could, therefore, be indicative of the activation of ER stress pathways in response 
to increased levels of misfolded protein.  
The Hsp70 chaperone family’s association with neurodegenerative diseases has been previous 
examined and the overexpression in a polyglutamine disease and an AD model has been 
demonstrated to successfully suppress protein aggregation and ameliorate the corresponding disease 
phenotypes [48]. Our results potentially implicate Hsc70-3 levels upon ageing with increased 
vulnerability to Aβ peptide. 
Hsp26 and Hsp27 are small heat shock proteins (sHsp), have distinct roles in response to stress but 
share 48% sequence identity. sHsps are characterised by the presence of a highly conserved “α 
crystallin” domain. Functionally sHsps bind to partially unfolded proteins, thereby stabilising the 
structure rather than actively refolding proteins themselves. Hsp26 is known in yeast, upon 
temperature change, to switch from an inactive state to an active chaperoning state. In addition to 
chaperoning activity Hsp27 protects against cell death, which can be induced by various stimuli 
including oxidative stress, a well-documented stage of the amyloid cascade hypothesis. Interestingly 
Hsp27 has been shown to reduce the production of reactive oxygen species (ROS) caused by tumour 
necrosis factor- α (TNF- α), a protein that has long been linked with the inflammatory response in AD 
and is a proposed therapeutic target [49], [50]. The potential of Hsp27 as a potential therapeutic target 
in AD is enhanced by its known ability to prevent apoptosis through its protective function against  
cellular stressors including heat and reactive oxygen species [51]. Hsp27 has been shown to 
inactivate Bax, a pro-apoptotic molecule, in addition to its well characterised interaction with 
cytochrome c, through which Hsp27 can negatively regulate cell death [52].  
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Figure 2.11 Relative protein expression levels for three differentially expressed heat shock proteins A) Expression levels for 
Hsc70-3. B) Hsp 26. C) Hsp 27. Error bars represent standard error of mean (SEM) 
Our proteomic results quantify both an age and Aβ expression response from Hsp26 and 27, however 
their relative expression levels are distinct from one another, Figure 2.11B&C. Hsp26 is identified in 
only one of the four conditions, young Aβ flies.  These data would suggest ageing reduces the level of 
Hsp26 in response to aggregation of Aβ42. Based on the known function of Hsp26 it is likely this 
would have a deleterious effect on cellular function. Unfortunately due to the limits of detection of our 
method, we were unable to ascertain the effects of ageing on the expression of the protein under 
normal physiological conditions. In contrast Hsp27 does not show any detectable response to Aβ but 
expression levels are dramatically reduced with age. In the samples obtained from old Drosophila, 
due to both conditions being below the limit of detection, nothing is known about expression in 
response to Aβ. Apoptosis is thought to be a major pathway to neuronal death in AD and a reduction 
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in basal expression levels of Hsp27, could cause an increase in apoptotic cell death in old Aβ flies. 
Further to this, it has been previous demonstrated that overexpression of Hsp27 successfully 
ameliorates AD symptoms in an APP/PSI mouse model.[53] Behavioral assays found learning and 
memory to be significantly improved upon Hsp27 overexpression, which was attributed to a reduction 
in amyloid deposits in both the hippocampus and cortex regions of the mice. 
Small heat shock proteins have also been shown to have beneficial effects in wild-type organisms. 
Overexpression of either Hsp26 or Hsp27 has been shown to extend Drosophila lifespan by up to 30 
%.[54] As expected there was an increased resistance to paraquat, along with an observed reduction 
in fecundity. Importantly lifespan extending effects are still present when neuronal specific expression 
is undertaken [55]. Interestingly the extent of extension was, as in the previous study, found to be 
around 30% suggesting that all or the majority of the observed lifespan extension can be attributed to 
better control of neuronal homeostasis. The same study also found Hsp27, but not Hsp26, to 
attenuate mild polyglutamine-induced toxicity and reduce parkinsonism movement disorder as studied 
in a Drosophila model.     
 
2.3.9 GTPase-Related Protein Expression Changes are Enriched in Old Aβ Drosophila 
Results from gene ontology analysis and PPI analysis of the pairwise comparison of old control flies 
vs old Aβ flies revealed a number of GTPase-related proteins were quantified with statistically 
significant differences. Enrichment analysis for biological processes based on identified PPIs found 
small GTPase mediated signal transduction to be most enriched, Table 2.3. Functional analysis of 
these proteins found a number to belong to the Rab family. Rab proteins are the largest family of 
small Ras-like GTPases with 29 predicted Rabs in Drosophila  and over 70 Rab or Rab-like proteins 
thought to be encoded in humans. Highly conserved across species, the Rab family serves a number 
of biological functions, but are best known for their involvement in membrane trafficking circuits [56]. 
Such proteins are present in all compartments of cell, including nucleus, mitochondria, plasma 
membrane, endoplasmic reticulum and Golgi. Many Rab proteins have been well characterised for 
their role in endocytic and exocytic membrane trafficking which is integral to proper synaptic function 
[57]–[59]. Rab proteins are able to cycle between membrane bound and cytosolic depending on their 
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nucleotide bound state. When GDP-bound, also referred to as “inactive”, rab proteins insert to the 
respective compartment membrane. Upon conversion into the “active”, GTP-bound state interactions 
with effector proteins involved in trafficking pathways are possible.  
It is well known that for proper neuronal function, specialized intracellular membrane trafficking must 
be maintained. This is especially true at synaptic junctions. It was recently reported that half of all 
Drosophila Rabs function within neurons and that these neuronal Rabs are predominately active at 
synapses where they mark synaptic recycling of endosomal compartments.[60] With Rab proteins so 
closely linked to the tight control of synaptic membrane trafficking it could be hypothesized that the 
observed abundance alterations could potentially have direct effects on neuronal function. Analysis of 
our proteomic results has revealed seven of these GTPase related proteins display significant protein 
expression changes both in response to Aβ and age, Figure 2.12. Interestingly, although some 
common expression patterns are present, particularly between Rab 10, Rab 30 and Ran, expression 
responses have varied profiles. 
One notable protein, Rab3, is highly conserved across species and in humans, consists of four 
isoforms (A-D), all of which are enriched within the brain and in particular synaptic vesicles. The 
subfamily have a well characterized functional role in the endocytic pathway and account for >25% of 
total rab GTP-binding activity. Drosophila only express one form of Rab3; Rab3A and is of particular 
interest as our proteomic results reveal expression changes linked to both Aβ and ageing phenotypes. 
It can be seen from Figure 2.12 that no expression changes are observed across the two young fly 
conditions (+/- RU), however older control flies (-RU) show a significant upregulation (p <0.05), which 
is reduced upon Aβ induction. Although Rab3A has already been implicated in synaptic dysfunction in 
late stage AD patients, through the reduction in expression levels compared to healthy controls, the 
functional consequence of this loss in AD has not yet been studied [61]. Rab3A’s link with age-related 
vulnerability to AD is currently unknown. Interestingly it has been proven in Drosophila that Rab3A 
plays a key role in regulating the distribution of presynaptic components to active zones [62]. In 
Rab3A mutants the resultant phenotype was more localized active zones, with higher release 
probabilities. Knockouts of the Rab3 subfamily in different model organisms, however have been 
found to have  
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Table 2.3 Enrichment analysis for biological process terms from STRING analysis. Proteins included were identified as 
differentially expressed (old + vs old-)     
Biological Process Term No Genes P value fdr 
small GTPase mediated signal transduction 6 1.80E-06 8.50E-03 
intracellular signal transduction 8 3.20E-06 8.50E-03 
Ras protein signal transduction 5 4.40E-06 8.50E-03 
cytoskeleton organization 10 1.10E-05 1.60E-02 
single-organism cellular process 27 1.70E-05 2.00E-02 
microtubule cytoskeleton organization 8 2.30E-05 2.20E-02 
cellular process 29 2.80E-05 2.40E-02 
establishment of protein localization 7 3.60E-05 2.70E-02 
microtubule-based process 8 1.30E-04 8.10E-02 
organelle organization 13 1.50E-04 8.10E-02 
Rab protein signal transduction 3 1.50E-04 8.10E-02 
protein transport 6 2.70E-04 1.30E-01 
response to stimulus 17 3.00E-04 1.30E-01 
macromolecule localization 8 3.60E-04 1.40E-01 
cellular component organization 16 3.60E-04 1.40E-01 
protein localization 7 4.30E-04 1.40E-01 
organic substance transport 7 4.60E-04 1.40E-01 
single organism signaling 12 4.90E-04 1.40E-01 
axis specification 5 5.40E-04 1.50E-01 
cell communication 12 6.70E-04 1.80E-01 
spindle organization 5 1.00E-03 2.50E-01 
single-organism process 28 1.10E-03 2.60E-01 
cellular calcium ion homeostasis 2 1.50E-03 3.40E-01 
regulation of biological quality 9 1.60E-03 3.40E-01 
calcium ion homeostasis 2 1.60E-03 3.40E-01 
cellular divalent inorganic cation 
homeostasis 
2 1.60E-03 3.40E-01 
signal transduction 9 1.80E-03 3.50E-01 
single-organism organelle organization 9 1.90E-03 3.70E-01 
oocyte microtubule cytoskeleton 
polarization 
2 2.00E-03 3.80E-01 
divalent inorganic cation homeostasis 2 2.40E-03 4.40E-01 
cell cycle process 7 2.80E-03 4.90E-01 
biological regulation 18 3.30E-03 5.70E-01 
RNA interference 2 3.60E-03 6.00E-01 
mitotic spindle organization 4 4.20E-03 6.50E-01 
protein targeting to mitochondrion 2 4.40E-03 6.50E-01 
protein localization to mitochondrion 2 4.40E-03 6.50E-01 
cellular localization 7 4.70E-03 6.80E-01 
endomembrane system organization 3 4.90E-03 6.90E-01 
cellular response to stimulus 10 4.90E-03 6.90E-01 
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more serious effects. Mice knockouts for all four Rab3 isoforms have been shown to be unviable as 
they die during development, demonstrating a key role for the Rab3 subfamily in neuronal function 
[63].  
The expression profile of the GTPase related proteins, Figure 2.12, also identifies three proteins that 
have similar quantification profiles both in terms of the measured response across the four conditions 
and absolute expression levels. The proteins in question, Rab 10, Rab 30 and Ras-related nuclear 
protein (Ran) have different known membrane trafficking roles, however, our data indicates their 
response to be coordinated. Rab 10 is localized in the Golgi and ER and is known to function in Golgi 
to basolateral membrane transport [64]. Rab 30 is also Golgi localized and is required for the integrity 
of the apparatus morphology itself [65]. Rab10 has been identified by a previous proteomic study of 
AD patients to be down regulated in post synaptic density (PSD), however its role in the disease has 
not been studied further [66]. 
 
Rab30 has not been previously reported in AD studies and represents a 
novel finding. Ran again functions as a molecular switch to control cellular transport and mitotic 
spindle assembly amongst others. High levels of Ran have been directly correlated with human 
tumourigenesis, however the reverse is seen in cases of AD [67]. Similar to Rab10, although 
downregulation has been seen in AD patients, the cause and subsequent consequence of this 
change is unknown. All three of the proteins display downregulation in the presence of Aβ, which 
agrees well with current literature. The quantification of EndoA, shows an expression profile that is 
different to the other 6 GTPase related proteins. The protein is only identified in the old Aβ42 flies and 
with a high total intensity. These data indicate a large upregulation upon Aβ induction but only for 
aged flies. EndoA, therefore, represent an interesting target for affecting age-related vulnerability to 
Aβ42. Interestingly Endophilin I (a homologue of EndoA) has been previously linked to AD, in both 
mice and humans. A study by Y. Ren and co-workers initially used quantitative proteomics to identify 
increased levels of Endophilin I in transgenic mice that overexpress Aβ [68]. These findings were the 
validated in humans with increased levels in AD patients confirmed by western blot quantification. The 
functional significance of this increase was subsequently investigated and was found to induce 
neuronal death through the increase of the stress kinase c-Jun N-terminal kinase. Our data expands 
upon these previous findings by linking these cellular alterations to ageing in addition to Aβ42 levels.  
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2.2.10 The Proteome and Transcriptome Show Low Correlation 
 
Numerous studies have investigated the correlation between mRNA transcription and protein 
abundance. Early studies, often looking at simple organisms such as yeast found low levels of 
correlation between protein abundance and mRNA levels (R
2 
= 0.3-0.6) [68]. These studies were 
limited by the available proteomic technologies that could only quantify hundreds of proteins unless 
extensive fractionation was employed. It was hard to discern from such studies whether the low 
correlations reported were indeed providing evidence for significant amounts of pre and post 
translational controls or were the result of instrumental bias/limitations. Indeed it is known that a large 
number of post-translation mechanisms exist that influence protein turnover rates and ultimately 
abundance. These mechanisms include proteasomal degradation and endocytic lysosomal systems. 
Phosphorylation, a highly dynamic post translational modification, is known to modulate cell division 
and differentiation. MicroRNA’s (miRNA) on the other hand, represent pre translational 
 
Figure 2.12 Expression levels for 7 small GTPase related proteins that display differential expression with respect to age. 
Expression levels with 0 counts is indicative of the protein not being successfully quantified. Error bars represent SEM.  
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control mechanisms. These endogenous short RNAs (~22 nucleotides) act as a class of regulatory 
elements to dampen the expression of protein coding genes [70]. It has also been demonstrated that 
miRNAs also reduce the levels of many targeted mRNAs [71]. What is not known is how much each 
of these elements contributes to final protein abundances.  
Improvements in proteomic technologies have dramatically increased proteome coverage, however 
the majority of studies still report a correlation of protein and mRNA levels in the region of R
2
 = 0.6, 
suggesting that just over half of protein level variability can be explained by the regulation of mRNA 
abundance.  
Alongside proteomic analysis microarray analysis was conducted on all four conditions to identify 
differentially regulated mRNA levels. Samples were dissected at exactly the same time as those taken 
forward for proteomic analysis. The data therefore represents the ideal experimental design for 
determining the correlation between mRNA and protein levels in Drosophila brain tissue. For 
calculation of protein-mRNA correlation, the average protein Hi3 intensity across replicates was 
correlated with average microarray fluorescence, both plotted on log2 scale. Unfortunately proteome 
coverage achieved in this study was significantly lower than the number of mRNAs quantified by 
microarray analysis. To improve protein coverage and with the aim of reducing analysis bias, protein-
mRNA levels were calculated at a 5 % protein FDR level (no filtering for replication). Spearman’s rank 
correlations were calculated for each condition individually and when combined, Figure 2.13. 
Protein to mRNA correlation was found to be low for each condition, Figure 2.13A and for the 
combined dataset, Figure 2.13B. Average Spearman’s rank correlation across conditions was low at 
0.28. Calculated correlations are indeed lower than those presented in many other recent proteomic 
studies. A major difference, however, between the majority of publications presenting mRNA to 
protein abundance correlations and our current study is that quantitative data is derived from a 
complex tissue rather a homogenous cell line. Tissue is a heterogeneous population of different cells 
types which for Drosophila brain tissue includes neurons, cortex glia and surface glia. It is known that 
different cell types will have inherently different mRNA to protein translation rates. mRNA to protein 
ratio calculations for tissue samples  will therefore be an average of all these rates, leading to reduced 
overall correlation. Adding weight to this hypothesis are data from two research labs who have 
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recently presented the first drafts of the entire human proteome as defined by mass spectrometric 
analysis [72], [73]. The data from M. Wilhelm and co-workers has been compiled from a number of 
different laboratories and consist of a total of 16,857 LC-MS/MS experiments yielding 18,097 protein 
identifications. In the process proteomic results from a number of different tissues were compiled. 
This allowed the authors to determine mRNA-protein correlations for 12 different human tissues. 
Spearman’s rank correlations ranged from 0.31 up to 0.56 for the different tissues which the authors 
acknowledged was lower than expected and agrees with the data presented here. Interestingly, 
despite the low correlation and the high variation of protein to mRNA levels across different tissues, 
mRNA-protein ratio was found to be consistent across tissue types. It would be interesting to 
determine if this held true in model organisms such as Drosophila, this, however, is beyond the scope 
of our experimental data.   
 
 
 
Figure 2.13 mRNA and protein levels show low correlation in Drosophila brain tissue. mRNA levels based on microarray 
florescent level and protein levels based on the Hi3 method. A) mRNA- protein level correlation plot for a single condition, 
Young +Aβ. B) mRNA- protein level correlation plot using results combined from the four different conditions. 
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Validation of Quantitative Results 
Despite vast improvements in mass spectrometry-based proteomics quantitative accuracy, the most 
common approach to validate discovery derived results is still the semi-quantitative immunoassay 
technique, Western blotting. There is now a move towards using targeted mass spectrometry analysis 
workflows, such as SRM, to validate previous discovery results. Unfortunately the lab was not 
equipped with instruments that were able to perform targeted analysis and we therefore attempted to 
validate a small number of our statistically significant results with immunoassay quantitation. 
Antibodies for Rab-3, Ran, EndoA, AP50 and Hsc-70 were either obtained from other labs or where 
available purchased.  
Western blot quantification of protein levels in Drosophila brain is almost exclusively carried out on 
head homogenate due to the number of brains required for detection by Western blot. We therefore 
tried to validate a set of our quantitative results by repeating the same experimental design as used 
previously, Figure 2.5A and subsequently quantifying protein levels from head homogenate extracts, 
Figure 2.14. Pleasingly similar expression profiles were observed for number of the proteins tested 
including Ran, AP50 and Rab3. Unfortunately only one statistical comparison reached significance, 
mostly likely due to a combination of the lower levels of precision offered by Western blotting, in 
comparison to quantitative mass spectrometry, and the increased sample complexity when analyzing 
head homogenate instead of brain.  
Data for Hsc70-3, Figure 2.14E, were only collected for the young + & - as these two conditions were 
found to have the largest difference in expression levels, based on the proteomics data. Again similar 
expression alterations were observed for the blotting results when compared to those from the 
proteomics, with a slight increase as a result of Aβ42 expression, however the difference is not 
statistically significant. For all western blots a total of four biological repeats were analysed, and, 
based on the resulting data, this does not appear to be sufficient to provide the power to detect 
protein abundance alterations as confidently quantified by mass spectrometry. It is likely that if further 
biological repeats were carried out results would reach statistical significance. This is especially true 
for Ran, AP50 and Hsc70-3 were measured protein levels were found to be fairly consistent. 
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Results from EndoA blotting, Figure 2.14C found very little change in protein abundance across the 
four conditions in comparison to the mass spectrometry derived results.   EndoA, in addition to playing 
a key role in synaptic endocytosis has also been shown to localise the photoreceptors of eye imaginal 
disc [74] Based on this information, the results, which do not demonstrate what is recorded by mass     
 
Figure 2.14 Validation of proteomic results by Western blotting analysis. Results shown are levels of A) Ran B) Clathrin 
associated  protein AP2 (AP50) C) Endophillin A D) Rab3 and E) Heat shock cognate 70 isoform 3 normalised to levels of 
actin. For all analysis n=4. Statistical testing was by student t-test with unequal variance.    
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spectrometry, might be a result of expression levels in the eye effecting the quantitation. Overall the 
western blotting results, although promising, demonstrate the difficulty in validating in vivo results by 
immunoassay blotting. Ideally results could be validated by SRM or PRM analysis however this is 
currently beyond the abilities of the lab due to available instrumentation.       
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2.4 Conclusion 
 
Ageing is the major risk factor for Alzheimer’s disease, however the correlation between age and AD 
prevalence is not well understood. With an ageing population it is important that the association 
between age and neurodegeneration is studied in more detail. Here a label-free mass spectrometry-
based quantitative proteomic approach was used to successfully reveal a set of proteins that could 
potentially be implicated in the age-related vulnerability to Aβ42 expression, as has been previously 
published, in an adult onset Drosophila AD model. Three heat shock proteins, Hsp70, Hsp26 and 
Hsp27 were identified as differentially expressed from the screen. Hsp26 and 27 displayed robust 
expression changes as a result of ageing whilst Hsp70 showed differential regulation in response to 
Aβ expression and slight but not statistically significant downregulation with age in the presence of 
Aβ. Interestingly HSP70 over-expression has been previously shown to ameliorate symptoms in AD 
models but has not been linked to ageing in AD patients. These findings suggest that age-related 
changes in proteostasis, in particular chaperone activity, may well contribute to the close link between 
ageing and late-onset Alzheimer’s disease. Enrichment analysis of differential expressed proteins 
from the binary comparison of old - RU flies vs old Aβ flies established a set of seven GTPase- 
related proteins for follow up validation. Closely linked to endo/exocytosis, these proteins, though their 
diverse roles in membrane trafficking, help to maintain proper synaptic function. Their potential 
dysregulation upon ageing and Aβ expression could, therefore, have significant implications on brain 
function. Although western blotting was not able to confidently validate the mass spectrometry data, 
most likely due to the lower levels of precision provided by the immunoassay technique and an 
inability to analyse brain tissue, a number of the proteins tested had expression profiles that 
correlated well. This, taken together with the consensus of our data and previous literature, provides 
confidence that our results are truly representative of age-related vulnerability to Aβ42 aggregation. 
Transgenic lines for all of the seven GTPase-related proteins have been obtained to conduct follow up 
research. Flies have been backcrossed into the w118 background to ensure a homogenesis stock 
genetic background. A lifespan screen is intended to be carried out to allow the identification of 
genetic alterations that extend lifespan in the presence of Aβ42 expression.  
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 Longitudinal Label-Free Quantitative Proteomics of Chronic Aβ Induction and Wild-
Type Ageing in D. melanogaster to Deconstruct Ageing as a Major Risk Factor for Alzheimer’s 
Disease 
 
3.0 Abstract 
Alzheimer’s disease (AD) is a complex neurodegenerative process whose aetiology is thought to be 
increased levels of Aβ peptide species. The biggest risk factor for late-onset AD is age, though the 
cellular basis behind this link is thought to be multifaceted and requires further investigation. Using a 
well-studied, inducible, D. melanogaster AD model, longitudinal profiling of brain specific protein 
expression levels, in response to wild-type ageing and chronic Aβ peptide induction, was performed. 
Protein abundance levels for approximately 2000 proteins were consistently quantified across 
successive time points using a label-free data independent acquisition LC-MS/MS approach, termed 
HDMS
E
.  Around 15% of the quantified brain proteome across the six time points measured was 
found to be significantly altered due to ageing. A large number of metabolic proteins were found to be 
differentially expressed suggesting an alteration of mitochondrial function during ageing. Protein-
protein interaction data further complements this theory with multiple proteins involved in the electron 
transport chain identified as being downregulated upon increasing age. Quantification of the brain 
proteome across the complete Drosophila lifespan, in the presence of chronic Aβ peptide, found little 
direct overlap with our ageing control when considering statistically significant changes in abundance. 
Soft cluster analysis of protein profiles, however, indicated similar biological processes to be affected 
between the two conditions. Cross-referencing our data with mRNA profiles from a previous study 
successfully highlighted common expression changes at the mRNA and protein level. These data 
represent a high confidence set of cellular responses to Aβ toxicity in the presence of increasing age 
for follow up functional studies. Direct comparison of abundance levels measured in the two 
conditions identified a smaller number of differentially regulated proteins that can be confidently 
attributed as a direct cellular response to Aβ peptide toxicity. Based on these identifications gene 
ontology analysis indicates alterations in chaperone levels, neurogenesis and learning/memory. 
Together our data provide a unique resource to better dissect the complex aetiology of AD and the 
functional links with age-related cellular alterations.  
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3.1 Introduction 
Alzheimer’s disease has a well-known but largely uncharacterised preclinical phase where AD-related 
neuropathological abnormalities are present but cognitive ability remains normal [1], [2]. This 
preclinical phase is best described by an accumulation of APP-derived Aβ peptide species within the 
brain, although there is still debate as to whether this is the main aetiology of the disease or part of a 
more complex pathological process. Indeed a number of high profile late-stage clinical trials targeting 
the production or aggregation of amyloid-beta peptide have failed to reduce symptoms [3]–[5]. A 
major problem for such drug development is the gradual nature of the disease pathology with 
extracellular deposition of Aβ aggregates known to predate clinical symptoms by at least ten years. 
Limitations in obtaining representative samples during the preclinical phase have prevented the 
characterisation of early stage AD beyond what can be determined from cerebrospinal fluid (CSF) or 
plasma [6], [7]. The analysis of CSF or plasma provides a readily available and relatively uninvasive 
method for developing biomarkers to improve the ability to diagnose AD but is limited in the 
information it can provide in terms of disease progression. With evidence now indicating that the 
oligomers that precede the characteristic extracellular plaques to be the more toxic Aβ species in AD, 
it is important that more is done to dissect the cellular consequences of early stage Aβ accumulation 
and to correlate this with the later stages of the disease [8], [9]. Model organisms such as Drosophila 
melanogaster and Mus musculus are used to study human diseases and are particularly common in 
the study of neurodegenerative diseases and ageing [10], [11]. Although vertebrae models have 
pathological hallmarks that more closely reflect human disease disadvantages include longer 
experimental timescales and cost-intensive handling. Shorter lived animal model systems including 
Drosophila provide the ability to perform relatively short lifespan and negative geotaxis experiments 
that can facilitate large-scale screening experiments. A downside is that such models can lack some 
pathophysiological characteristics of AD. Despite being relatively short lived, Drosophila have a well-
studied, complex brain and central nervous system which along with the ease of genetic manipulation 
make them an ideal model for neurodegeneration. Indeed, there are a range of fly models for 
neurodegenerative diseases including Parkinson’s disease, amyotrophic lateral sclerosis and AD 
[12]–[14]. For AD there are several different models that over-express either Aβ peptide species or 
tau protein [15]. Recently, an adult-onset fly model for AD, which uses an inducible pan-neuronal 
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driver, elav GeneSwitch, to over-express the Arctic mutant Aβ42 peptide in the fly central nervous 
system, has been developed and used to highlight that the inhibition of GSK-3 ameliorates Aβ 
pathology [16]. Expression of Aβ42 within fly neurons causes protein aggregation into an insoluble, 
fibrillary form similar to those seen in human AD patients. Additionally, an increase in mortality is 
observed alongside neuronal dysfunction, as measured by negative geotaxis (climbing), without an 
observed loss of neuronal cells. It was also used to identify age-related vulnerability to Aβ42 induction 
in aged flies, successfully validating the model for use in studies aiming to better understand age-
related susceptibility to AD [17]. 
Mass spectrometry-based quantitative proteomics is the chosen method for characterising cellular 
disease states in an unbiased manner [18]–[20]. Proteomics has been used extensively in studies of 
neurodegenerative diseases to identify differentially expressed proteins/modifications by comparing 
disease to an appropriately matched control state [21]–[23]. Results either provide information to 
better model the pathology of the disease or can be used to identify potential biomarker candidates 
for improved disease diagnosis.  Label-free quantification currently offers the technical precision and 
accuracy required to study biological systems (see Chapter 1.14) [24].  
Time and sample handling constraints have limited the majority of discovery proteomic experiments to 
focus on a single time point that is thought to best represent the disease in question. This is an 
obvious simplification but allows for follow up targeted experiments across a more representative time 
period for the proteins identified as being of biological interest. The continued development of mass 
spectrometry instrumentation has reduced sample analysis time whilst concurrently increasing 
proteome coverage [25], [26]. It is now feasible to undertake a longitudinal analysis of disease 
progression by mass spectrometry, where, analysis timescales are measureable by weeks rather than 
the months older instruments would require to achieve comparable results.  
Here quantitative time-course analysis of an adult-onset D. melanogaster model for Alzheimer’s 
disease was performed. Differentially regulated proteins were identified across the fly lifespan in 
response to the neuronal specific expression of Arctic Aβ42 peptide. Drosophila brains were analysed 
using a recently developed label-free mass spectrometry technique HDMS
E 
(see Chapter 1.16). Using 
our DIA approach approximately 2000 proteins were successfully quantified across successive time 
points and in both conditions. The data represent a unique resource for dissecting brain specific 
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proteome alterations to ageing and Aβ peptide toxicity. Soft clustering of protein time-course profiles 
in response to normal ageing identified a number of biological processes that had a coordinated 
proteome response. Alterations in processes involved in energy production, sexual reproduction and 
oxidoreductase activity were found to be enriched in specific clusters. Indeed, around 15% of all 
quantified proteins were significantly altered (q < 0.05) across the time-course. Protein-protein 
interaction analysis identified a complex network of differential regulation. In comparison, although 
clustering of protein profiles in response to chronic Aβ expression suggested similar biological 
processes to be altered, little overlap of differentially regulated proteins between the two datasets was 
observed. Regulated proteins were involved in a wide range of cellular process including neuronal 
stem cell maintenance, oxidoreductase activity and the protein folding/translation. Our results were 
successfully validated by comparison with mRNA levels measured in a similar Drosophila AD model. 
A subset of proteins where both mRNA and protein levels are significantly altered by Aβ peptide 
misfolding was successfully highlighted. Finally direct comparison of expression levels measured in 
the two conditions identified a small number of proteins that are altered as a direct response to Aβ 
expression. Functional analysis identified proteins implicated in chaperoning, neurogenesis and 
learning all of which are thought play key roles in neurodegeneration.  
Overall our unbiased and longitudinal approach has successfully collected data that represents a 
unique resource for follow-up functional studies on both normal ageing and Aβ peptide toxicity. 
Biological processes previously implicated in neurodegeneration have been highlighted and better 
characterised by our longitudinal approach. As mass spectrometric instrumentation improves further 
sill, in terms of speed and sensitivity, time-course characterisation of protein expression levels will 
become commonplace.   
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3.2 MATERIALS AND METHODS 
3.2.1 Fly stocks and Maintenance 
All fly stocks were maintained at 25 °C on a 12:12 hrs light:dark cycle at constant humidity on a 
standard sugar-yeast (SY) medium (15 g/l agar, 50 g/l sugar, 100 g/l autolysed yeast, 100 g/l nipagin 
and 3 ml/l propionic acid). Adult onset neuronal-specific expression of Arctic mutant Aβ42 peptide was 
obtained with the use of the elav GeneSwitch (elavGS)-UAS system.[27] This line was derived from 
the original elavGS 301.2 line and was a gift from Dr H.Tricoire. The UAS-ArcAβ42 line was obtained 
as a generous gift from Dr D Crowther. All transgene lines were backcrossed six times into the w118 
genetic background. For all experiments female flies carrying UAS-ArcAβ42 were crossed with male 
flies expressing elavGS. Expression of Aβ peptide in female progeny was achieved by treatment with 
mifepristone (RU486) added to the SY medium.     
 
3.2.2 Ageing-span and Lifespan 
Flies were raised at a standard density on SY medium in 200 mL bottles. Two days post eclosion, to 
ensure flies were once-mated, female flies were split to experimental vials containing SY medium with 
or without RU486. For the lifespan, flies were split at a density of 10 flies per vial whilst for the ageing 
experiments flies were split at a density of 25 flies per vial. Flies were transferred to fresh food three 
times a week at which point deaths were scored for the lifespan. Lifespan data are presented as 
cumulative survival curves.  
 
3.2.3 Protein Isolation and Tryptic Digestion  
Brains were obtained for induced and non-induced flies by dissection at each chosen time point (six 
for non-induced and four for induced). Time points were chosen to span the majority of the lifespan. 
Dissections were carried out following CO2 anesthetisation on ice cold PBS. For each biological 
repeat 10 brains were collected, snap frozen and stored at -80 °C until required. 
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All chemicals unless otherwise stated were obtained from Sigma Aldrich, MO, USA. Proteins from 
brain samples were extracted by homogenisation on ice into 50 µl of 50 mM Ammonium Bicarbonate  
0.25% Rapigest (Waters Corporation, MA, USA) and 10 mM DTT. Proteins were solubilised and 
disulphide bonds reduced by heating at 80 °C for 20 minutes. Free cysteine residues were alkylated 
by the addition of IAA to a final concentration of 20 mM and incubation at room temperature in the 
dark for 20 minutes. A 1 µl aliquot was taken from each sample for protein concentration 
determination using the Qubit protein assay kit (Thermo Fisher, MA, USA). Samples were diluted with 
50 mM Ammonium bicarbonate to a final concentration of 0.1% Rapigest. Tryptic digestion was 
carried out overnight at 37 °C overnight by the addition of sequencing grade trypsin at a 1:50 
enzyme:protein ratio. To ensure efficient digestion a further addition of trypsin (Promega, 
Southampton, UK) at a ratio of 1:100 was performed the following morning and each sample 
incubated for a further hour. Detergent was removed post-digestion by sample acidification with 0.1% 
formic acid and incubation at 60 °C for 60 minutes. Insoluble detergent and sample debris was 
removed by centrifugation at 14,000 x g for 30 minutes. Supernatant was collected, lyophilised to 
dryness and stored at -80 °C. 
 
3.2.4 LC-HDMS
E
 Analysis  
Nanoscale UPLC separation of tryptic peptides was performed using a nanoAcquity UPLC system 
(Waters Corporation, MA, USA) equipped with a UPLC HSS T3 1.7 µm, 75 µm x 250 mm analytical 
reverse phase column (Waters Corporation, MA, USA). Prior to peptide separation, 300 ng of tryptic 
peptides were loaded onto a 2G, V/V 5 µm, 180 µm x 20 mm reverse phase trapping column (Waters 
Corporation, MA, USA) at 5 µl/min for 3 minutes. Mass spectrometric analysis of tryptic digests was 
performed using a Synapt G2S-Si HDMS mass spectrometer (Waters, Manchester, UK) equipped 
with a T-Wave-IMS device. Mass measurements were made in positive ion-mode ESI with the 
instrument operated in resolution mode with a typical resolving power of 20,000 FWHM (full width at 
half maximum). Prior to analysis the time-of-flight mass analyser was externally calibrated with the 
fragment ion of [Glu1]-Fibrinopeptide B (GFP) from m/z 175 to 1285. The data were post-acquisition 
lock mass corrected using the double charged monoisotopic ion of GFP. To achieve lock mass 
correction a 100 fmol/ul solution of GFP was infused at a 90° angle to the analytical sprayer. This 
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reference sprayer was sampled every 60 seconds. Accurate mass LC-IM-MS data were collected in 
the DIA mode of analysis, HDMS
E
. IMS was performed by applying a constant wave height of 40 V 
whilst a constant wave velocity of 650 m/s was maintained. Wave heights within the trap and transfer 
were both set at 4 V whilst the wave velocities were 311 and 175 m/s respectively. MS data were 
acquired over 50-2000 m/z for each mode. Spectral acquisition time for each mode was 0.5 s with a 
0.015 interscan delay. During the low energy MS mode data were acquired whilst applying a constant 
collision energy of 4 eV within the transfer travelling wave region. High energy MS/MS data were 
acquired by ramping the collision energy within the transfer region, post IMS, between 15 V and 40 V. 
One cycle of low and elevated energy data were acquired every 1.1 s. To ensure that ions with m/z 
less than 350 observed in the LC-MS data were derived exclusively from peptide fragmentation within 
the transfer region the radio frequency applied to the quadrupole mass analyser was adjusted to 
optimise transmission within the region of 350 – 2000 Da. Each biological replicate was analysed 
three times. Samples were kindly run by Lee Gethings and Chris Hughes at Waters, Manchester.  
 
3.2.5 Digestion Reproducibility 
Proteins were extracted and digested from Drosophila brain tissue as described earlier in the 
experimental section. Prior to digestion, lysate concentration was adjusted to 1 µg/µl and three 
proteins, alcohol dehydrogenase, luciferase and lysozyme were spiked in at concentrations of 300 
fmol/µl, 167 fmol/µl and 958 fmol/µl respectively. For each of the three proteins two surrogate 
isotopically labelled peptides were spiked into the lysate at as close to equimolar concentration as 
possible. The sample was aliquoted and digested in triplicate overnight. Post-digestion samples were 
acidified with formic acid and dried to completion. Prior to analysis samples were resolublised at 0.5 
µg/µl in 0.1% formic acid. Samples were analysed in technical triplicates using the same conditions as 
detailed in Chapter 2 with the only difference being that a total of 1 µg was loaded on column.  
Data analysis was carried out based on extracted ion chromatograms of unlabelled and labelled 
peptides. Peak top intensities were compared after combining scans across the entire 
chromatographic peak. Prior to peak top intensity calculation data were smoothed (3 scan window, x2 
smooth), baseline subtracted (Polynomial order:10, 80% below curve, 0.10 Tolerance) and centroided 
(90% top peak). Processing steps for all samples were identical. 
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3.2.6 Time-course Data Analysis 
Data were processed using Progenesis QI v2.0 (Waters Corporation, MA, USA). Data were imported 
into Progenesis to generate a 3D representation of the data (m/z, RT and peak intensity). Samples 
were then time aligned with the software allowed to automatically determine the best reference run 
from the dataset. Briefly alignment is based upon the placement of landmarks called alignment 
vectors where each vector connects the location of a peptide ion on the reference run to the location 
of the same ion on the run to be aligned. Using a non-linear algorithm the retention times between the 
reference run and the run to be aligned are mapped. Initially a gross alignment is calculated by finding 
the smallest number of retention time shifts that bring the two chromatograms into close alignment. 
Following this, small changes to the alignment are made with the impact of the adjustments measured 
in order to achieve the best alignment possible. Peak picking was performed on MS level data. A 
peak picking sensitivity of 4 (out of 5) was set. To ensure consistent peak picking across multiple runs 
and to reduce the number of missing values across replicates and conditions, an aggregate peak data 
set is created from aligned runs. This aggregate data set includes RT, m/z and drift time information 
allowing the utilisation of the increased peak capacity offered by HDMS
E
 analysis. The process is 
somewhat analogous to ‘match between runs’ which is implemented in the MaxQuant software 
developed by J. Cox and colleagues [28].   
Post alignment and peak picking, peptide features were noise subtracted and ion current integrated 
by the Apex3D algorithm. The pep3D algorithm subsequently de-isotoped and charge state reduced 
features into resultant EMRTs. Peptide features were tentatively aligned with their respective 
fragment ions based primarily on the similarity of their chromatographic and mobility profiles. 
Requirements for features to be included in post-processing database searching were as follows; 300 
counts for low energy ions, 50 counts for high energy ions and 750 counts for precursor EMRT 
integrated intensity. 
Subsequently, data were searched against the Uniprot canonical Drosophila database (20,049 
sequences) appended with common contaminants. Trypsin was specified as the enzyme of choice 
and a maximum of two missed cleavages were permitted. Carbamidomethyl (C) was set as a fixed 
modification whilst oxidation (M) and acetylation (N-term) were set as variable modifications. 
Requirements for successful peptide identification were at least 1 fragment ion whilst for protein 
Chapter 3. Longitudinal Label-Free Quantitative Proteomics of Chronic Aβ Induction and Wild-Type 
Ageing in D. melanogaster to Deconstruct Ageing as a Major Risk Factor for Alzheimer’s Disease    
[110] 
 
identification a minimum of 3 fragment ions and 1 peptide was required. Protein level FDR was set to 
a 4% threshold based upon the search of an automatically generated reversed database. 
Three different methods of relative protein quantification were tested prior to any data analysis. Hi3, 
all peptide summation and all non-conflicting (unique) peptide summation were compared. Prior to 
quantification proteins were grouped according to peptide identifications. Where more than one 
protein was identified with common peptides, the protein with fewer peptides was subsumed into that 
with the greater number of peptides and not reported for quantification. Where proteins could not be 
distinguished based on detected peptides a protein group was reported. To control for instrumental 
sensitivity run to run variability and LC loading variation, peptide intensities were normalised prior to 
quantification. Briefly, based upon the assumption that the majority of peptides do not change in 
abundance across different biological samples and conditions, a scalar factor is calculated. To 
calculate the scalar factor a reference sample is first calculated. Following this, peptide intensity ratios 
(sample/ratio) are calculated for each sample and log10 transformed to ensure a normal distribution. 
The mean and median of this distribution of ratios is used to define the data suitable for calculating 
the scalar factor. This ensures that outlying ratio values do not skew the data. Calculated scalar 
factors are applied to each sample on a non-logarithmic scale. 
 
3.2.7 Statistical Testing 
Differential expression across individual time-series was tested for using an ANOVA and the optimal 
discovery procedure. ANOVA analysis was performed in Progenesis QI where time point was set as 
the variable. The optimal discovery procedure was implemented within the Bioconductor package, 
Extraction of Differential Gene Expression (EDGE) [29]. For each time-course dataset the degrees of 
freedom were set to one less than the number of time points sampled. For all tests, FDR was 
controlled by the calculation of q values from the p value output. Briefly, q values control the FDR in 
large datasets, where multiple hypothesis tests are performed, based on the observed p value 
distribution. By plotting a histogram of all calculated p values and calculating the height of the 
histogram, at the point at which the larger p values become evenly distributed, an FDR adjustment 
factor can be calculated. Differential expression was defined as q ≤ 0.05. All quantitative data and 
statistical results are provided in the appendix file.  
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Comparison of the two time-course datasets (Aβ vs age matched control) was achieved using a two-
sided student’s t-test with unequal variance. Expression values were compared between the two 
conditions at matched time points. Differential expression was defined as a protein having a p value < 
0.05 in 2 or more time points out of the 4 tested.  
 
3.2.8 Enrichment Analysis 
Enrichment analysis was performed in both DAVID and Panther where biological process, molecular 
function, cellular compartment and panther class (Panther) were tested for enrichment.[30], [31] 
Briefly, although using slightly different algorithms, the two software, calculate enrichment based on 
the number of gene ontology terms present in your chosen background (usually organism specific). A 
p value can be calculated by comparing the number proteins with a specific gene ontology term 
present in your data to the number present in the background, in relation to the total number of 
proteins tested. Enrichment analysis within DAVID was performed using all identified proteins as a 
background and enrichment was defined as a p value < 0.005 or an FDR < 0.05. Panther analysis 
was performed against the D. melanogaster background, as defined in Panther, and enrichment was 
defined as a p value < 0.05 as bonferonni correction.  
 
3.2.9 Cluster Analysis 
Prior to grouping expression profiles, proteins were filtered to only include those that were found to 
have a high level of expression change across time points. Briefly, the correlation between protein 
intensity and quantitative CV was calculated using the same approach as detailed in Chapter 2. Effect 
sizes for quantified proteins were calculated from the largest fold change observed, again as detailed 
in Chapter 2. Proteins with an effect size larger than 0.7 were taken forward for cluster analysis using 
the R package Mfuzz [32]. The default fuzzification factor of 1.25 was used in all cases. Cluster 
numbers were optimised by varying the cluster number from 5-15 and plotting the resultant principle 
component analysis (PCA) plot. The minimum number of clusters that best described the data 
variation was taken forward for analysis. Results clustering analysis are provided in the appendix file.  
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3.2.10 Protein-Protein Interaction Analysis 
Proteins of interest were queried in STRING for known protein-protein interactions [33]. All types of 
interaction were included. Interactions were filtered based on confidence of the interaction with either 
medium confidence (score of ≥ 0.4) or high confidence (score of ≥ 0.7) taken forward for analysis. 
Score are calculated by the STRING database. Data from all sources (including experimental, 
computational prediction and text collections) is weighted and integrated prior to confidence 
calculations. Data were imported into Cytoscape for visualisation [34]. Where cluster analysis was 
performed the EAGLE algorithm was used to define clusters and was implemented within the 
ClusterViz application available through Cytoscape [35].       
 
3.3 Results & Discussion 
3.3.1 Comparison of GeLCMS
E 
and In-Solution-HDMS
E
 Protocols 
Previously Drosophila brain tissue was analysed with the use of SDS-PAGE to aid protein 
solubilisation and to increase protein identification numbers by sample fractionation prior to LC-MS
E 
analysis on a Synapt HDMS instrument (Chapter 2). Following the release of the Synapt G2 by 
Waters Ltd all subsequent Synapt instruments have the ability to separate peptides by ion mobility, 
post LC separation and prior to ToF mass analysis, with a data independent acquisition approach, 
commonly referred to as HDMS
E
. The Synapt G2S a few years later saw the introduction of the 
StepWave technology, an off-axis ion source which increases signal by up to 25-fold. The StepWave 
consists of a stacked-ring ion guide that is designed with two stages that are set off-axis from each 
other. This offset design ensures the removal of neutral molecules that enter the source from the 
atmosphere thereby allowing a far larger source orifice to be used without the issue of neutral 
contaminant build up. With the increase in peak capacity afforded by HDMS
E
 and the increased 
sensitivity provided by the introduction of the StepWave technology it was expected that analysis of 
brain tissue by HDMS
E
 could provide a similar number of protein identifications than the GeLCMS
E
 
protocol with an order of magnitude reduction in analysis time.       
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Figure 3.1 Comparison of protein identifications from three MS protocols used to analyse Drosophila brain tissue 
Two samples that were representative of the samples to be analysed during the planned time-course 
experiment were prepared from w118 Drosophila of mixed ages. To test the HDMS
E
 protocol a total of 
10 brains were dissected and pooled prior to sample homogenisation, protein extraction and tryptic 
digestion. To test the GeLCMS
E
 protocol a total of 10 brains were pooled, homogenised in x 2 sample 
buffer and separated on an SDS-PAGE gel as detailed in Chapter 2. Fractionated and un-fractionated 
samples were separated by identical C18 columns and across the same 90 minute analytical RP-LC 
gradient to reduce possible sources of bias. 
Results demonstrated that HDMS
E
 analysis of Drosophila brain tissue identified over 100 more 
proteins than the GeLCMS
E
 protocol in a total analysis time of 120 minutes compared to 1200 
minutes (after filtering for proteins identified in all three technical replicates), Figure 3.1. Interestingly, 
when all identified proteins from technical replicates were considered (not filtering based on 
replication) the HDMS
E
 and GeLCMS
E
 protocol identified a more similar number of proteins at 5% 
FDR. The data, therefore, provides evidence for the shotgun approach providing more reproducible 
protein identifications, which is beneficially for the statistical analysis of label-free quantitative results. 
The results demonstrate the applicability of HDMS
E
 to provide adequate proteome coverage at an 
acquisition time short enough to make the analysis of time-course data feasible. Without prior SDS-
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PAGE fractionation, analysis by MS
E
 alone was only able to identify around 200 proteins in all three 
technical replicates. Surprisingly when the quantitative reproducibilities of technical replicates were 
compared, the two methods gave very similar results with an average CV of 20%. It would be 
expected that the gel-based method would give less precise results due to the added source of 
experimental error during gel fractionation. The result of this would however be most pronounced 
when measuring biological reproducibility which was not examined in this comparison. 
Another result of note from this experiment was that the HDMS
E
 and GeLCMS
E
 protocols identified a 
large number of proteins unique to the respective protocols. It can be seen in, Figure 3.1, that this is 
not observed when comparing the two shotgun methods (G1 vs G2S-i), indicating that the differences 
are largely caused by sample preparation rather than during analysis. Differences in the amount of 
detergent used in the two protocols (4% vs 0.25%) are likely to cause the solubilisation of proteins 
(and subsequent efficient digestion) with different hydrophobicities. Additionally carrying out the 
digestion in-gel in contrast to in-solution is likely to cause difference in digestion efficiencies and 
peptide recovery. Alternatively some differences could be caused by the fact that the two protocols 
carry out the fractionation at different stages of the sample preparation protocol. Whilst gel-based 
methods fractionate based on protein size, HDMS
E
 fractionates based on peptide size and charge. 
This could be expected to effect the peptides/proteins identified and indeed in Chapter 2, it was 
observed that the GeLCMS
E 
method over represents larger proteins, which was hypothesised to be 
caused by the gel-based separation employed.  
 
3.2.2 Assessment of Digestion Reproducibility 
A common assumption in proteomic sample preparation protocols is that the tryptic digestion of a 
sample has proceeded to completion, with all proteins being enzymatically digested into peptides at 
equimolar concentration to the original protein concentration. Another assumption in quantitative 
proteomics is that the digestion is reproducible and that there is therefore little to no error associated 
with digestion variability. This second assumption is paramount to the accuracy of label-free relative 
quantification and has been previously shown to be an over simplification [36]. In-gel-based protocols, 
digestion efficiency benefits from the ability to use high concentrations of detergent in the presence of 
a protease. In-solution protocols are limited to concentrations of detergent/denaturant that retain 
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enzyme activity and are therefore more susceptible to being incomplete or irreproducible. We wanted 
to assess the suitability of an in-solution digest protocol commonly employed within the lab and to 
confirm that reproducibility across biological samples was high enough for use in a label-free 
quantitative study. Our approach used isotopically labelled peptides as internal standards for proteins 
spiked into a Drosophila brain tissue background at known concentrations. Three proteins, hen egg 
white lysozyme, yeast alcohol dehydrogenase (ADH) and firefly luciferase, along with two isotopically 
labelled peptides per protein were employed as detailed in Table 3.1. 
Table 3.1 Synthetic peptides used to assess the extent and reproducibility of tryptic digestion. Three standard proteins 
were spiked into a Drosophila brain homogenate background. Peptide position, in reference to its parent protein, and 
details of isotopic labelling are included 
 
Protein Peptide Position Sequence and isotopic labelling 
ADH T25 EALD[13C9,15N-F]FAR 
ADH T28 V[13C5,15N-V]GLSTLPE[13C6,15N-I]YEK 
LUCIFERASE T36 VVP[13C9,15N-F]FEAK 
LUCIFERASE T47 E[13C6,15N-I]VDYV[13C3,15N-A]SQVTTAK 
LYSOZYME T5 HG[13C6,15N-L]DNYR 
LYSOZYME T7 FESN[13C9,15N-F]NTQATNR 
 
Each protein was spiked into the background sample at different concentrations to test the 
applicability of the digestion protocol over a concentration range equating to roughly an order of 
magnitude. ADH was spiked in at a final concentration of 300 fmol/µl, luciferase at 167 fmol/µl and 
lysozyme at 958 fmol/µl. The background sample was prepared at a concentration of 1 µg/µl (total 
protein) as the in-house digestion protocol is commonly performed at a final concentration between 
0.1-1 µg/µl. Three aliquots were prepared from a single stock for tryptic digestion. The digestion 
protocol was based upon the use of the mass spectrometry compatible surfactant, Rapigest and post-
digestion two isotopically labelled peptides per protein were spiked into samples at an equimolar 
concentration to their respective protein analogues. Isotopic standards had been quantified by amino 
acid analysis to ensure the correct concentration assignment. Each sample was analysed in triplicate 
to facilitate the calculation on technical precision. After data acquisition, extracted ion chromatograms 
(XICs) were used to calculate peptide peak height intensity for ratio calculations. Continuum peptide 
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peaks were smoothed, subjected to baseline subtraction and were centroided. An example of the raw 
data and processing steps is shown in Figure 3.2.  Alongside ratio measurements an assessment of 
signal to noise (S/N) was carried out for each peptide pair based upon the monoisotopic peak of the 
isotopically labelled peptide analogue, Table 3.2.  
 
Figure 3.14 Data analysis steps for the calculation of digestion efficiency and reproducibility. A) An extracted 
chromatogram for the spiked peptide is combined to form the average spectra for light and heavy peptides. B) Data is 
smoothed, background subtracted and centroided. Ratios are then calculated from peak intensities 
Signal to noise was calculated within Masslynx. All spiked peptides and their unlabelled counterparts 
were successfully identified and quantified with signal to noise varying from 2 up to 80. Interestingly 
the signal to noise did not appear to correlate with peptide concentration and was dependent on either 
the extent of enzymatic release and/or peptide ionisation efficiency. This is not unexpected as these 
are two properties that are commonly considered when choosing peptides for targeted protein 
quantification by SRM or parallel reaction monitoring (PRM). Reproducibility of digestion was found to 
be high for all peptides included in the study with an average coefficient of variance of only 5%. If the 
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average standard error of the mass spectrometry ratio measurement is considered (4%), then the 
digestion clearly contributes a small percentage of uncertainty for relative quantitative proteomics by 
MS.  
 
Table 3.2 Summary of results from digestion reproducibility assessment 
Peptide Position S/N 
Average 
Ratio 
STDEV CV (%) 
T25 80 0.63 0.012 1.9 
T28 34 1 0.05 5.2 
T36 2 0.55 0.05 9.3 
T47 32 0.79 0.03 4 
T5 3 0.72 0.006 0.9 
T7 38 0.7 0.06 9.7 
 
The biggest source of error was peptide to peptide variability with a ratio range of 0.45. Although this 
should not impact relative quantification these results should be considered if the data were required 
to measure absolute amounts of protein. Absolute quantification is dependent on complete or close to 
complete sample digestion for accurate results. As an example, if protein quantification was based on 
the peptides producing low ratios (T36, T25) alone then the data would underestimate protein 
concentration for the respective parent proteins.  
 
3.2.3 Experimental Design 
As previously mentioned, Alzheimer’s disease is characterised by its long gestation period and its 
strong link with ageing as a risk factor [37]. Studies to better understand the disease should therefore 
ideally be able to probe the development of the disease across an organisms lifetime and link this to 
possible age-related changes. This is an obvious limitation of AD studies on human patients. The use 
of an inducible system such as the elavGS-UAS construct, as used in this study, allows an 
experimental design such that it was possible to interrogate longitudinal protein expression levels of 
both normal ageing and chronic Aβ42 expression at multiple time points. This facilitated the 
comparison of two conditions to detect expression changes that were attributable to Aβ peptide 
toxicity, age-related physiological changes or were due to a combination of the two.  
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The Aβ flies used in this experiment carry one copy of the transgene expressing the Arctic mutant of 
human Aβ42. This mutation is associated with decreased levels of Aβ40 & Aβ42 in patient plasma 
and has been shown to form protofibrils at a much higher rate than wild-type Aβ [38], [39]. Similarly in 
Drosophila this mutation has been shown to cause the peptide to almost exclusively aggregate and 
accumulate into an insoluble fibril form [40]. Due to the toxic nature of the Arctic mutation, the RU486 
induced flies (Aβ) have a median survival far shorter than the non-RU486 induced flies (control). The 
first four time points at which samples were collected were chosen to span the Aβ fly lifespan. 
Subsequently results from this experiment were representative of the cumulative effects of chronic 
Aβ42 expression, Figure 3.3A. A further two time points that covered the remaining lifespan of the 
control flies were included. These were most representative of normal age-related decline. Indeed the 
final two time points capture the point at which mortality first begins to increase (time point 5) and the 
time at which mortality is close to its most pronounced (time point 6). If the lifespan of the Aβ flies is 
considered it can be observed that time points 3 & 4 capture a similar level of mortality to time points 
5 & 6 for the control flies. 
AD is a neurodegenerative disease and we were therefore interested in profiling brain-specific protein 
expression. Analysis was performed on dissected Drosophila brain tissue, an approach not commonly 
used when studying Drosophila models [41], [42]. The benefit of this protocol was two-fold; firstly it 
ensured that measurements were truly representative of neurological changes occurring, whilst 
secondly, it reduced sample complexity through the removal of proteins specifically expressed in the 
eye, cuticle and fat body.  For each time point four biological repeats were included and each of these 
were then analysed three times to ensure statistical confidence. Dissections for each time point were 
conducted within the same hour each day to reduce circadian effects on protein levels. Following 
protein extraction and tryptic digestion, resultant peptide solutions were separated based on 
hydrophobicity by RP-UPLC, Figure 3.3C, prior to HDMS
E
 analysis on a Synapt G2S-i mass 
spectrometer. HDMS
E 
is a DIA method that
 
separates peptides by ion mobility, post LC separation 
and prior to MS analysis, Figure 3.3D. The increase in system peak capacity afforded by IM has been 
shown to increase peptide identification rates by up to 50% in comparison to MS
E
 analysis.[43] All 
data were processed using Progenesis v2.0 including non-linear retention time alignment of runs and 
peptide level intensity normalisation, Figure 3.3E.  Data were processed in three separate cohorts to 
allow for different questions to be probed within each dataset using the same settings each time. The 
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three different data cohorts were all data collected from Aβ flies, all data collected from control flies 
and finally the data as an entirety. Prior to label-free quantification proteins were grouped based on 
the parsimony principle, a form of Occam’s razor, where protein identification are reported as the 
minimum identifications that can be used to account for all peptides detected. Progenesis offer three 
main modes of label-free quantification, Hi3, all peptides and all unique peptides. The all peptides 
quantification method utilises all peptides matched to a protein, post protein grouping, whilst Hi3 uses 
the top three most ionising peptides per protein. We were interested in comparing the quantitative 
precision of the three methods to determine which would provide the highest level of precision. It can 
be seen from Figure 3.4A, that although Hi3 and all unique peptides provide a similar level of 
precision, the use of all peptides for relative quantification clearly provides higher reproducibility with 
over 80% of quantified proteins having a biological CV of 50% or less. The increased precision is 
most likely a combined effect of increased protein intensity signal for low abundant proteins and the 
averaging out of peptide intensity fluctuations for proteins with a large number of identified peptides. 
The all peptides method, although offering higher precision, is likely to offer less accurate results due 
to the use of shared peptides for quantification. It was noted that a large number of quantified proteins 
had no unique peptides assigned, with quantification solely based on peptides that are shared 
between multiple proteins (shared peptides). The effect of including shared peptides in quantification 
calculations is shown in Figure 3.4B. Here the all peptide method of quantification was found to 
quantify over a 1000 more proteins than the two alternative methods. As the unique peptide method 
and all peptide method quantify using an inherently similar method, the proteins quantified only by the 
all peptide method represent proteins for which there are no unique peptides detected. As we were 
more interested in quantification accuracy across biological conditions than precision we opted to 
quantify using the Hi3 method.  Analysis found subsequent quantitative data to have a high level of 
technical and biological linearity at >0.92 R
2  
and >0.89 R
2
 respectively, Figure 3.3F.     
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Figure 3.3 Workflow for the longitudinal quantitative proteomic analysis of Aβ induced toxicity in comparison to wild-type 
ageing. A&B)  Brain tissue was dissected at 4 (Aβ induced) and 6 (ageing control) time points that spanned > 80% of the 
two conditions lifespan. C&D) Post-protein extraction and digestion peptide solutions were separated by UPLC prior to HD-
MS
E
 analysis. E) Raw data were processed in Progenesis which included retention time alignment, and peptide intensity 
normalisation and protein inference. F) Normalised data were found to have a high level of technical and biological 
reproducibility     
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Figure 3.4 Comparison of three methods for relative label-free quantification. A) Cumulative frequency plot of protein 
intensity CV across repeat measurements (technical and biological). B) Number of proteins successfully quantified 
    
2.3.4 Peak Picking Optimisation 
Apex3D, the algorithm within PLGS that identifies features within the low/high energy data and 
subsequently clusters precursors with their respective fragment ions, requires three thresholds for 
defining what constitutes a true peptide feature. A high energy and low energy peak height intensity 
threshold must be met for a peak to be defined and an integrated area under the peak threshold also 
needs to be reached. Although suggested settings are provided, the best thresholds can be sample 
dependent and should be optimised prior to analysis. Somewhat counterintuitively reducing the 
thresholds does not always increase the number of proteins that are identified from the downstream 
database search. This is most likely due to the false discovery rate threshold being reached more 
quickly as a result of incorrectly defining noise as peptide and fragment features. Choosing the correct 
values for optimal protein identifications based on the raw data is not possible as the input values do 
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not readily relate to raw peak intensities. Apex3D thresholds instead represent post-processing values 
and can only be optimised by repeat data processing whilst varying processing parameters. Using the 
freely available software PLGS Threshold Inspector, high energy (HE) and low energy (LE) thresholds 
were optimised for maximum protein identifications, Figure 3.5A.  
 
Figure 3.5 Optimisation of Apex3D peak picking settings for maximum protein identifications. A) Protein identification rates 
at four different low energy thresholds and two different high energy thresholds. B) Peptide mass error as a function of low 
energy Apex3D thresholds   
It was found for the very low thresholds, LE = 50 and HE = 10 minimal protein identifications were 
made. This number rapidly increased when using the thresholds of LE=100 and HE=50 suggesting 
that these values represent a rough S/N threshold for the data. This threshold is validated by Figure 
3.5B where it can be seen that increasing the LE threshold from 50 to 100 resulted in the sharpest 
increase in peptide mass accuracy. An increase in peptide mass accuracy is indicative of defined 
features being true peptides rather than isobaric noise.     
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2.3.5 Experimental Features 
A number of features were tested to ensure that the data obtained was of sufficient quality to be taken 
forward for statistical and biological analyses. These included number of missed cleavages, precursor 
charge, ppm error and chromatographic peak width, Figure 3.6. The efficiency of proteolytic digestion 
has been previously shown to be an important factor in proteome coverage and quantitative precision 
[44]. One measure of the extent of tryptic digestion is to compare the proportion of semi-tryptic 
peptides that are identified from the database search. As seen in Figure 3.6A over 70% of peptides 
identified from the Aβ-induced time-course were fully tryptic peptides, a proportion that compares well 
with previous literature [45]. An alternative method for assessing the extent of digestion, thus 
providing a second degree of confidence, is the observed charge state distribution for identified 
peptides. An efficient tryptic digestion should produce peptides that predominately retain 2 or 3 
positive charges during ESI. Data shown in Figure 3.6B clearly follows this trend with the vast 
majority of identified peptides being either doubly or triply charged. An alternative parameter that can 
influence quantitative precision is chromatographic separation. Label-free quantification is calculated  
 
Figure 3.6 QC metrics taken from the Aβ time-course. A) Peptide missed cleavage distribution. B) Peptide charge state 
distribution. C) Peptide mass accuracy density plot. D) Peptide (Pass one only) peak width (FWHM) histogram.     
using the area under the chromatographic peak and is therefore strongly dependent on 
chromatography quality. UPLC separation of peptide solutions has been previously shown to produce 
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peaks which have a width (FWHM) of between 6-18 seconds [46]. Our data compares favourably to 
this, Figure 3.6D, with the vast majority of peptides eluting with a peak width of around 12 second 
and little to no peptides having a peak width > 30 seconds. Potential sources of experimental error 
were examined with the use of a scatterplot matrix, whereby all protein intensities across biological 
samples are correlated, Figure 3.7. Prior analysis demonstrated technical reproducibility to be high 
(R
2 
> 0.92) and were therefore not included in the plot for clarity. Reproducibility across five orders of 
magnitude was seen to be high: however it was observed that the best correlated samples were not 
biological repeats. High quantitative correlation was found between samples processed (sample 
homogenisation and tryptic digestion) on the same day indicating that the highest source of error 
within the analysis workflow was day to day sample preparation variability.  Within Figure 3.7, two 
examples of this high correlation between samples processed on the same day are highlighted 
(indicated by grey and blue shading). These data is contrary to previous results assessing digestion 
reproducibility within the same day. The data therefore highlights the importance of assessing and 
potentially optimising day to day sample preparation variation in a label-free workflow. Experimental 
design was such that the influence of this variability on experimental bias had been minimised. 
Biological repeats were processed on different days, i.e. processing all time points from one biological 
repeat together. This ensured that the day-to-day variability only increased measurement error as 
opposed to the biasing of quantitative comparisons. 
 
2.3.6 Assessment of Progenesis Peak Picking Algorithm 
Label-free quantification is complicated by run-to-run LC peptide separation variability. Although LC 
reproducibility is now far more robust than in the past, peptide elution times can vary by seconds to 
minutes, with peptide-to-peptide variability not necessarily being a linear relationship. Retention time 
alignment is commonly performed across a dataset to improve the reliability and reproducibility of 
label-free results. A number of different algorithms have been developed to align peptide retention 
times across analytical runs. Two such algorithms have been developed with HDMS
E
 and MS
E 
as 
their main applications. The first, developed by the Tenzer lab, implements retention time alignment 
within the IsoQuant software and aims to improve the reproducibility of quantitative results derived  
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Figure 3.7 Log2 protein intensity matrix scatterplot of Aβ+ time-course data. Each scatterplot represents a biological sample 
(protein intensity averaged from technical replicates). Highlighted in grey and blue are two examples of different biological 
conditions, prepared (homogenisation and digestion) on the same day displaying high correlation.   
from MS
E
 derived data [46]. Here a Dynamic-Time-Warping algorithm aligns all runs to a reference 
run that is chosen based upon the highest number of detected signals. The second algorithm is built 
into the Synapter program developed by the Lilley lab which facilitates the merging of MS
E
 and 
HDMS
E
 quantitative data [47]. Synapter performs alignment by LOESS fitting, to model retention time 
deviations, when comparing two samples. Retention time deviations are then corrected according to 
this model in a similar approach to those used for peptide intensity normalisation. Progenesis uses a 
third method to improve peptide LC time alignment. A 2D representation of each MS run is created by 
plotting m/z against RT. Alignment is based upon the placement of alignment vectors which act as 
landmarks that connect a peptide ion location from the two runs being aligned. By placing a number of 
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vectors within the 2D data representation a non-linear map can be produced. Alignment is then 
performed in two stages, firstly a small number of retention time shifts that reduce the vector deviation 
to an acceptable amount are calculated and then this initial alignment is optimized by performing 
stepwise adjustments and assessing the quality of alignment until an optimal condition is identified.  
After alignment Progenesis performs an additional peak picking step prior to invoking the algorithm 
APEX3D which is also used in PLGS. In order to minimise the problem of missing data, which is 
common in proteomic datasets, an aggregate dataset is created from all aligned runs. This data is 
then applied to each sample to transfer protein identifications in a similar manner to the ‘match 
between runs’ application employed within the MaxQuant software [48]. A benefit of using Progenesis 
with HDMS
E
 data is that the aggregate dataset also employs ion mobility drift time as an extra data 
dimensionality resulting in increased peak matching. 
The benefits of alignment and peak picking within Progenesis in comparison with use of PLGS on its 
own were examined, Figure 3.8. Initially the number of proteins identified at a 4% protein level FDR 
across a set of triplicate analytical replicates were compared. Analysis by PLGS was found to 
consistently identify over 1000 proteins in each replicate however when the data were filtered based 
on replication (3 out of 3) this number reduced to little over 900. The use of the Progenesis peak 
picking algorithm reduced the number of missing values to only 1 across the triplicate analysis, 
demonstrating the power of identification transfer in proteomics datasets. A notable difference in the 
use of PLGS alone to the use of Progenesis is that unlike the PLGS APEX3D algorithm, peak picking 
within Progenesis estimates baseline noise to improve peak identification rates from the raw data. A 
result of this is that unlike APEX3D there are no intensity thresholds for peptide identification within 
Progenesis. Indeed it was noted that some peptides identified within Progenesis were well below the 
750 count threshold set within PLGS. The effects of this peak processing difference was examined by 
filtering Progenesis data for proteins that had an integrated intensity of ≥ 750 counts multiplied by the 
number of peptides identified. Interestingly it was found that less than 10 protein identifications were 
found to be below this threshold indicating that the main data metric influencing the presence of 
missing values was incomplete or low quality fragmentation data. Finally the effects of identification 
transfer across the dataset as a whole were measured. To do this protein identifications rates for the 
triplicate technical replicates were compared but after peak picking was performed, using aggregate 
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data produced from the entire time course. It can be seen that when using data from the time-course 
as an entirety protein identification numbers increase by over 3-fold. The data were filtered as 
previously described, based upon total protein intensity, resulting in an 8% reduction in protein 
identifications (312 proteins). This increase in low intensity protein identifications, in comparison to 
previous results where protein identifications were transferred from the same biological sample, most 
likely represents proteins that demonstrate a degree of expression change across the time-course 
experiment.  
 
 
Figure 3.8 Comparison of protein identifications for three technical replicates, analysed by PLGS alone or by 
Progenesis  
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3.3.7 In-Solution Digest Provides Protein Identifications That are Representative of Starting 
Material 
Previous mass spectrometric analysis of Drosophila brain tissue using a GeLCMS
E 
workflow was 
shown to be representative of starting material. Comparison of the physicochemical properties of 
proteins identified by GeLCMS
E
 to those genes detected by microarray analysis found little difference 
(see Chapter 2, Figure 3.2). In this study the use of an in-solution digestion protocol, although 
providing more reproducible sample preparation than a gel-based method, did not facilitate the use of 
high concentrations of detergent for protein solublisation. The same analysis as performed in Chapter 
2 was conducted to compare the results from the in-solution protocol , the GeLCMS
E 
protocol and the 
micrroarray analysis, Figure 3.9. Interestingly it was observed that the use of lower concentrations of 
detergent (0.2% vs 4%) did not drastically reduce the representation of membrane proteins. For two 
other properties tested, pI and biological process gene ontology, minimal differences were observed 
between all three methods. Prior analysis had identified the biggest difference between the GeLCMS
E
 
and microarray data to be the molecular weight distribution of proteins/genes identified. It was 
hypothesised that this was due to the use of gel seperation pior to MS analysis providing a higher 
resolving power for low molecular weight proteins than for larger proteins. The data derived from the 
in-solution protocol provides the ideal basis for testing this hypothesis. If indeed the gel-based protein 
separation did lead to the observed bias towards lower molecular weight proteins this should not be 
observed within the in-solution data set. Figure 3.7D confirms that as expected, the in-solution 
protocol did identify more high molecular weight proteins in comparison to the GeLCMS
E
, however the 
protocol still underepresented proteins with a molecular weight > 25000 Da in comparison with the 
transcriptomics data. The results suggest that the apparent bias towards lower molecular weight 
proteins for proteomic analysis may in fact be sample-dependent rather than a result of 
instrumental/sample preparation bias. The results may be representative of a true difference between 
the expression levels of mRNA and the subsquent protein translation rates. However, without the 
comprehensive detection of proteins expressed within Drosophila brain tissue this cannot be 
confirmed.   
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Figure 3.9 Comparison of protein gene ontology classifications and physiochemical properties of 
proteins/genes identified by either GeLCMS
E
, HDMS
E 
or microarray analysis of Drosophila brain tissue. A & B) 
Proteins classified by biological process or cellular compartment respectively. C) Density plot of protein pI 
distribution. D) Density plot of protein molecular weight distribution 
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3.2.8 Peptide Filtering Post Database Search 
The PLGS software uses a protein-centeric database search that has been shown to identfiy up to 
20% more identfications than other peptide-centric database search algorithms [49]. A result of this is 
that PLGS controls the FDR at the protein level but not at the peptide level. As protein identfication 
rates have increased in proteomics it has now become commonplace to control both the protein and 
peptide level FDR. In order to control the peptide level FDR, peptide scores from the complete and 
randomised databases were compared, Figure 3.10A, in an approach that has previously been 
shown to be effective for PLGS-dervived protein identifications [50]. It can be seen that the peptide 
scores obtained from the randomised database produce a Gaussian peak centered about a score of 
4.25. The results from the complete database have an additional tail that begins at around a peptide 
score of 6 and represents scores from peptides almost exclusively identified from the forward 
database. Using these data it was possible to plot the peptide level FDR as a function of peptide 
score, Figure 3.10B. A peptide score threshold of > 5.4 was applied to the entire dataset based on 
the calculation of a maximum peptide false identfication rate of 4% (dotted line). 
 
Figure 3.10 Peptide score filtering by false identification estimation using a decoy database strategy. A) 
Distribution of peptide score from the complete protein database (solid line) and the randomised database 
(dashed line). B) FDR plotted as a function of peptide score. Dotted line represents an peptide FDR of 4%  
 
3.2.9 The Ageing Brain Proteome 
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Ageing is an almost universal biological process and is of interest in the context of neurodegeneration 
as ageing is often the biggest risk factor [51]. Proteomic studies of ageing have almost exclusively 
focused on the latter stages of an organism’s life span [52], [53]. The initial aims of our study were to 
define the Drosophila brain proteome in relation to wild-type ageing in a more fine grained approach 
to previous publications. Brain tissue samples were collected at six different time points that spanned 
> 80 % of the Drosophila life span, analysed by a DIA quantitative proteomics approach and resulted 
in the collection of expression profiles for > 2500 proteins across the lifespan. From the protein 
dataset it was found <15 % were quantified with a value of zero, which is indicative of a missing value 
again highlighting the benefits of identification transfer in mass spectrometry-based proteomic 
experiments.   
We took an initial unbiased approach to better understand brain proteome alterations in the context of 
ageing by conducting cluster analysis on proteins that demonstrated a significant fold change at any 
point during the time-course. A significant fold change was defined as an effect size larger than 0.7, 
where effect size was calculated as previously (see Chapter 2). Briefly quantitative coefficients of 
variation were calculated from biological repeats for each protein. CVs were plotted against the mean 
protein intensity and a rolling average was calculated, Figure 3.11. In contrast to previous data 
collected using a GeLCMS
E 
workflow, the data demonstrates a direct correlation between increasing 
protein intensity and quantitative precision. The correlation validates the use of effect size as a filter 
for label-free data as opposed to fold-change which fails to take into account measurement variation. 
Filtering successfully identified just over 1000 proteins as significantly altered across the six time 
points and these were taken forward for soft clustering based on the fuzzy-c algorithm [32]. The use 
of a soft clustering method, where elements are not confined to a single cluster, is well suited to 
biological time-course data where clusters are not necessarily well separated and proteins/genes can 
belong in multiple clusters. Clustering was implemented within the statistical environment R using the 
Mfuzz package. The optimal number of clusters was chosen with the use of principal components 
analysis, as provided by Mfuzz. Cluster numbers were varied from 5-15 and subsequent PCA plots 
were examined to determine how well each number of clusters represented the data. Using this 
method a final number of 9 clusters was chosen. Proteins with a membership score of > 0.5 were 
defined as being present in a cluster and z-score normalised expression profiles of proteins from each 
cluster were visualised, Figure 3.12. The functional annotation tools DAVID and Panther were used 
Chapter 3. Longitudinal Label-Free Quantitative Proteomics of Chronic Aβ Induction and Wild-Type 
Ageing in D. melanogaster to Deconstruct Ageing as a Major Risk Factor for Alzheimer’s Disease    
[132] 
 
to annotate proteins in each cluster based on gene ontology and to test for significant enrichment of 
any biological process, molecular function or protein classes [30], [31].  
Clustering successfully identified 9 distinct proteome expression profiles and of these, 7 displayed 
enrichment of at least one gene ontology term therefore indicating a link between ageing and defined 
cellular responses. The profile of cluster 1 showed a distinct reduction in protein levels with ageing. 
Enrichment analysis showed the cluster to be significantly enriched for proteins that function within 
the mitochondrion and that are directly involved in energy production. Mitochondrial dysregulation has 
been previously implicated in driving the ageing process and our data indicates that this may be 
particularly pronounced within the brain [54], [55]. A decrease in mitochondrial function is known to 
lead to reduced ATP production, impaired calcium buffering and an increased generation of reactive 
oxygen species. Interestingly our data suggests that for a number of proteins involved in mitochondria 
energy production this decline does not occur only at the later stages of the Drosophila lifespan but is 
instead a gradual process that occurs throughout the lifespan and at a steady rate. In addition to 
mitochondria-related protein enrichment in ribosomal proteins was also noted. A reduction in 
ribosomal protein and transcript levels in relation to age has previously been reported in C. elegans 
suggesting that this reduction is conserved across species [56]. Within cluster 1 a large number of 
proteins, although displaying consistent downregulation, do not display large fold changes. Less than 
7 % of proteins have a measured downregulation, when comparing T1 to T6, of more than 2-fold. The 
benefits of a clustering-based approach to probe global changes is therefore apparent in this instance 
where many of the changes detected by clustering are too small to validate with traditional statistical 
testing. Of the larger fold changes detected a number are linked to interesting biological functions 
including No extend memory (nemy) an oxidoreductase expressed predominantly in brain mushroom 
bodies that has direct effects on memory and locomotory behaviour  [57]. Interestingly nemy is not the 
only highly downregulated protein that is implicated in memory and neuronal function. Numb- 
associated kinase (Nak) is found to be almost 4-fold less abundant at T6 and is involved in a number 
of neuronal specific biological processes including dendrite morphogenesis and the regulation of 
clathrin-mediated endocytosis [58].  
Cluster 3 represents another set of proteins that display a consistent reduction in concentration in 
relation to the first time point, T1. The set of proteins are, however, found to drop in concentration  
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Figure 3.11 Scatterplot of quantitative biological variation as a function of protein intensity. The rolling mean of biological 
CV is represented by the black line   
between the two earliest time points and remain at this level for the remaining lifespan. These 
proteins are of particular interest as the observed decline in protein levels occurs long before any 
ageing phenotypes are typically present and could therefore represent the earliest stages of the 
ageing process. Enrichment analysis found the cluster to be enriched in a number of different 
processes including sexual reproduction, signal transduction and the ubiquitin proteasome pathway. 
Sexual reproduction in Drosophila is known to have direct links to longevity with an underlying trade-
off between lifespan and early fecundity [59]. The trade-off is thought to be governed by negatively 
pleiotropic genes based upon the evidence that many of the mutations that extend lifespan also 
negatively affect fecundity. An early decline in sexual reproduction levels is therefore not unexpected 
in a Drosophila line selected for use in ageing studies due to maximal longevity. More interesting is 
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the decline in a subset of proteins involved in the ubiquitin proteasome system which is contrary to a 
recent C.elegans ageing study which found a consistent increase in the proteasome subunit levels 
[56]. Distinct differences between the two studies could however account for the disparity in results. 
The study by Dirk M. Walther and colleagues examined the global protein changes across all tissue 
types rather than our brain specific profiling approach. Indeed it has been previously found that 
 
Figure 3.12 Clustering of time-course expression levels from proteins that were found to display a 
significant expression change (effect size >0.7) across the data. Levels were clustered using the fuzzy 
c-means algorithm and colours indicate the cluster membership score for each protein. Labelled 
clusters indicate significant enrichment (EASE score (modified Fischer Exact p Value) < 0.005 or FDR < 
0.05) of a biological process or molecular function. Enrichment analysis was performed in DAVID and 
Panther 
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the activity and expression levels of the proteasome complex within the central nervous system of rat 
decline as a result of ageing are thought, in part, to be due to the high levels of reactive oxygen 
species produced within the brain [60]. Unlike cluster 1, cluster 3 contains a far larger number of 
proteins that decrease by 2-fold or more (36 %) with up to a 33-fold decrease in the levels of Aldose-
1-epimerase, a protein directly involved in glycolysis and gluconeogenesis. Within this cluster subset 
reside proteins directly involved in neurogenesis and central nervous system development and could 
suggest the presence of neurogenesis in the early stages of the adult brain which is reduced or 
arrested at an early age. Until recently it was not thought that the formation of new neurons occurred 
within the adult Drosophila brain but a recent paper by Fernandez-Hernandez and co-workers 
suggest a level of plasticity that might provide a mechanism for brain regeneration [60]. Our results 
provide an insight into why levels of neurogenesis might be low in the adult fly brain.   
Conversely we were interested in proteins that were consistently upregulated as a result of ageing, 
represented by clusters 7 and 9. Both clusters contain fewer proteins than their downregulation 
counterparts but were still found to be enriched for gene ontologies. Cluster 7 contains proteins that 
are almost exclusively upregulated between T1 and T2. The clusters were enriched in proteins that 
act as either an oxidoreducatase or dehydrogenase. Of these proteins, CG30375 is highly 
upregulated (> 20-fold) and is known to have serine-type endopeptidase activity. Cluster 9 which 
displays a consistent and progressive increase in protein concentration is enriched for organic acid 
catabolic processes. An increase in catabolism during ageing has been previously reported and is 
thought that this, alongside a decrease in anabolic signals, to contribute to age-related cellular 
degeneration through a loss of catabolic-anabolic homeostasis.[61] Further to this branched chain 
amino acid catabolism has previously been shown to effect lifespan in Drosophila.[62] Interestingly 
catabolic malfunction in ageing has been implicated in mitochondrial damage and would fit with our 
previous findings [63]. 
Following cluster analysis a more traditional approach to identify statistically significant protein-level 
changes across the six time points was taken. More established statistical tests such as the Student’s 
t-test or linear models for microarray data (Limma), although well suited to the pairwise comparison of 
different biological conditions, are not designed to be used for modelling time-course data and 
therefore lack statistical power. Recently a new statistical algorithm, Extraction of Difference Gene 
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Expression (EDGE), which has been implemented as a Bioconductor package, was developed by the 
Jon Storey lab with strategies specifically designed for analysing results derived from time-course 
experiments [29]. Statistical testing was performed using the optimal discovery procedure and was 
implemented within the EDGE Bioconductor package. Using this powerful approach to multiple 
hypothesis testing, our ageing dataset was tested for differential expression. At a q value of 0.05 just 
over 340 proteins were determined to be differentially expressed representing around 10% of the total 
number of proteins successfully quantified across all time points. To validate the EDGE approach, we 
undertook a comparison to the more traditional time-course analysis approach of conducting an 
ANOVA where time is included as a variable, Figure 3.13.  
 
Figure 3.13 Venn diagram of the overlap between proteins identified as differentially expressed from the ageing data by an 
ANOVA test or by the Bioconductor package EDGE  
Pleasingly EDGE was found to outperform the ANOVA test by 80% and successfully identifies all 
proteins identified by the ANOVA method. 
Enrichment analysis confirmed the presence of a large number of proteins involved in metabolic 
processes, as indicated by previous cluster analysis. The large number of metabolic proteins (>140) is 
unsurprising considering the energy-intensive nature of neural processing. It has been previously 
estimated that the brain accounts for around 20% of a human bodies resting metabolism. A 
dysregulation of brain metabolism has long been postulated for being a cause of age-related decline 
and many neurodegenerative disease symptoms, AD included, have been linked to a metabolic 
imbalance, toxicity and dysfunction [64]–[66]. Our data confirms changes in metabolic protein levels 
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represent a large proportion of proteome alteration induced upon ageing. Proteins implicated in 
translation were also found to be enriched within the differential expressed subset. Translation rates 
from mRNA to protein are known to mediate life span extension in both C.elegans and Drosophila. 
Indeed the inhibition of mTOR, a major signalling pathway in ageing research, increases longevity in 
part by reduced protein synthesis rates [67], [68]. Interestingly a proportion of the regulated proteins, 
including four translation factors and ribosomal subunits, decrease in concentration in relation to age. 
Previous cluster analysis had indicated this for ribosomal proteins but did not find enrichment in 
translation factors. Protein synthesis levels have been previously found to decline in respect to 
increasing age and the downregulation of translation factors Ef1-beta, EF1-delta and eIF-5A all of 
which are involved in translation elongation is indicative of this phenotype. 
To allow a more global view of differential expression in respect to increasing age, statistically 
significantly altered proteins were queried for protein-protein interactions within the STRING database 
[33].  All proteins confirmed to interact with at least one other protein, of medium confidence or higher, 
were retained for visualisation within Cytoscape. Mean abundance ratio values, in reference to T1, 
were calculated for each of the 5 time points and were represented by node colour within the network. 
This allowed the visualisation of the PPI network expression levels with respect to time, Figure 3.14 
and Appendix E. A total of 263 proteins were found to form an extensive network with the visible 
presence of multiple sites of highly coordinated interactions. Interrogation of the largest of those sites 
confirmed results from previous analysis indicating a systematic decrease in translation-associated 
proteins. PPI network analysis was also able to expand upon previous translation control alterations 
that were occurring upon increasing age. Within the network a large number of mRNA binding 
proteins including mapmodulin, hoip, rump and mub were found to interact or cluster close to 
ribosomal proteins. Perhaps more significantly was the presence of proteins that are directly 
implicated in chromatin remodelling and the Wnt signalling pathway. A loss of function of the Wnt 
signalling pathway has been previously proposed to lead to the onset of many of the hallmarks of AD 
and has been linked to a number of other diseases including cancer.[69] The pathway is a key 
activator of neuronal development but the regulation of the pathway in relation to age is not well 
understood. Our data suggests a differential regulation of the pathway which could have implication 
for gene transcription and cell fate.  
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The second site of high PPI coordination was found to correlate with the high levels of mitochondrial 
and metabolic enrichment we observed during cluster analysis. Again we observed a downregulation 
across each time point for the majority of proteins found within this site. Functional analysis of the 
proteins within this cluster identified NADH dehydrogenase activity to be a common biological 
process. The differential expression of this set of proteins, altered levels of COX6B and altered 
cytochrome-c oxidase activity is strong evidence for the potential dysregulation of the electron 
transport chain with respect to age. 
As previously mentioned, recent work by DM Walther and colleagues from the Mann and Hartl labs 
was published on a comprehensive proteomic time-series analysis of ageing in C.elegans [56]. 
Although there are significant differences between the aims and experimental workflow of the Mann 
and Hartl labs and our study we thought it of interest to examine whether any of the findings of the 
study were validated in our data, Figure 3.15. The work by DM Walther and co-workers finds 
evidence for a dysregulation of the proteostasis network with a downregulation of ribosomal subunits 
and an upregulation of proteasome constituents. Our data confirms that an average reduction in 
ribosomal levels is conserved in Drosophila brains, however, the measured reduction is less 
pronounced and for a small number of subunits we actually observe a large increase in abundance, 
Figure 3.15A. Proteasome levels on the other hand show the opposite trend to that seen in 
C.elegans tissue with a downregulation in our data, Figure 3.15B. More interestingly we measure a 
large amount in variation in proteasome subunit abundances, a trend also seen the C.elegans study, 
and which might provide evidence for a dysregulation of the proteasome rather than a more general 
reduction in proteasomal activity. In Figure 3.15C it can be seen that our data agrees well for 
detected HSP70 and HSP90 chaperone proteins, which remain largely unchanged across the 
lifespan. An exception is found for Hsc70-interacting protein (HIP) which is significantly and 
consistently downregulated with increasing age (q < 0.0005). Evidence suggests that HIP through its 
own chaperone activity, where it stabilises the ADP state of Hsc70, contributes to the chaperone 
activity of Hsc70 [70]. Finally proteins involved in oxidative stress protection, were found to show no 
general trends upon ageing whereas the Mann and Hartl labs measured increases for two oxidative 
stress defence proteins. Where the two data might successfully validate a large age-related change is 
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for superoxide dismutase [Cu-Zn] (SOD-3). The current study measures a large reduction in protein 
 
Figure 3.14 Longitudinal protein-protein interaction network of brain specific differentially expression across the 
Drosophila lifespan. PPI’s included are as defined in STRING as medium confidence or higher. Expression data is 
represented by node colour and was visualised in Cytoscape    
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concentration at T4. This reduction remains at least 2-fold less in comparison to levels at T1 for the 
duration of the lifespan. The data from the Mann and Hartl labs is less conclusive with no change 
observed up to 12 days after which the protein is no longer successfully quantified. The loss of 
detection after day 12 is likely to be due to protein levels being reduced below the instrument limit of 
detection. The data therefore can be taken to be indicative of a very large reduction in SOD-3 levels 
after day 12. SOD-3 has been previously implicated in longevity, through enhanced resistance to 
oxidative stress and a decline in levels with increasing age could contribute to increased mortality 
rates [71], [72]. Across the entire two sets of data we observed little overlap between proteins 
detected with an observed fold change > 2, although this does represent a statistically significant 
overlap (p < 0.0001), Figure 3.15E. This is perhaps not surprising considering that the data obtained 
by the Mann and Hartl labs was collected from whole worms and quantitative data, is therefore, an 
average value for all tissues present in the organism. Higher abundance tissues are likely to be better 
represented with this approach. As worms have a limited central nervous system (302 total neurons), 
neuronal specific expression changes are likely to not be fully represented in the Mann and Hartl labs 
dataset.    
 
3.2.10 Brain Proteome Alterations Resulting from Chronic Abeta Induction 
The commonly accepted aetiology of Alzhiemer’s disease is an increase in production and/or the 
accumulation of Aβ42 peptide which causes peptide oligomerization and the formation of extracellular 
aggregates. It was the initial discovery of extensive brain plaques in AD individuals, which were 
composed primarily of Aβ42, which led to the amyloid cascade hypothesis being proposed.[73] The 
hypothesis describes the downstream events following Aβ accumulation and deposition, resulting in 
synaptic and neuronal dysfunction. In the 10 years since the discovery, research into AD has focused 
on the effects of Aβ peptide aggregation. The approach taken has been primarily to study animal 
models, which, including D. melanogaster, either directly express Aβ42 or express genetic variants of 
PS1 and PS2 that indirectly produced Aβ peptide species through altered APP processing. In our 
study we measured brain proteome changes in an adult-onset AD Drosophila model that 
encompassed the majority of the lifespan. Initially, we were interested in defining proteins that 
displayed expression changes in the presence of Aβ42 induction and to group them based on their 
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profiles. As with the ageing data a fuzzy-c clustering algorithm was used, after filtering for proteins 
that had an expression change across the time-series with an effect size larger than 0.7, Figure 3.16. 
As previously the optimal cluster number was determined by varying the allowed cluster numbers 
between 
 
Figure 3.15 Comparative analysis of ageing data with the results published by DM Walther and co-workers studying the 
ageing in C. elegans. A) Abundance changes of ribosomal proteins. B) Abundance changes of proteasome subunits. C & D) 
Abundance profiles of HSP 70/90 homologues and oxidative stress related proteins. E) Venn diagram of the overlap 
between the two data set including only proteins with a measured fold change of >2. Number in brackets indicates the 
number of Drosophila specific proteins    
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5-15. Resultant PCA plots were then visually inspected. Using this method an optimal number of 7 
clusters was determined, two less than used for the ageing study. The lower number of clusters for 
these data is unsurprising considering the lower degree of freedom afforded from a four point time-
course. Initially apparent from the Aβ data clustering was that the data showed less protein to protein 
abundance variation than the ageing data, with each cluster having a more coherent expression 
profile. It was possible to quantify the visual trend by comparing the average membership score within 
each Aβ cluster to the ageing data clusters. Membership scores from the Aβ-induced clusters were 
found to be significantly higher (p < 0.00001) than those from the ageing data with an average score 
of 0.93 and 0.87 respectively. The cellular response to an extensive protein aggregation event, as is 
seen upon Aβ induction, could be expected to be more consistent than those changes characterised 
by the ageing process, a process known to be complex and driven by a multitude of deleterious 
mechanisms. Our data, therefore, is suggestive that our experimental protocol has identified protein 
abundance changes that are the direct result of Aβ42 induction toxicity. Although a large amount of 
overlap is observed between the cluster enrichment analysis for the ageing and Aβ data, differences 
present may provide information on the cellular response to Aβ aggregation. Cluster 2 follows the 
same profile as Cluster 1 from the ageing expression, with a consistent reduction in protein 
abundance across the lifespan. Similar to that seen in the ageing data the cluster is enriched in 
mitochondrial proteins, specifically those involved in the electron transport chain. Such an overlap is 
unsurprising considering a reduction in mitochondrial function has been reported in both ageing and 
Alzheimer’s disease previously [55], [74]. Interestingly cluster 2 is also found to be enriched in actin 
proteins that form cytoskeleton structures, an enrichment term not observed in any of the age-related 
clusters. Cytoskeletal abnormalities have been reported to be present in AD brains and are thought to 
be associated with dystrophic neurites, where amyloid plaques induce a transformation of neuronal 
cytoskeletal proteins [75]. Indeed tau is a major neurotoxic aggregating protein that is implicated in 
the later stages of the amyloid cascade hypothesis [76].  Reduction in cytoskeletal abundance may be 
representative of an increased formation of dystrophic neurites that are likely not to be solubilised by 
our protein extraction method. A major difference between the two clusters from the two respective 
time-course datasets were the number of proteins detected with a large reduction (> 2-fold) in 
abundance in the presence of Aβ peptide. Notably the protein CG5334, a polyubiquitination  
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Figure 3.16 Clustering of expression profiles for Aβ induced time-course. Only included are proteins that had an 
expression change with an effect size > 0.7. Labelled clusters indicate a significant enrichment (EASE < 0.005 or 
FDR < 0.05) of a gene ontology as determined by enrichment analysis with DAVID or Panther respectively 
associated protein, had reduced in abundance by over 100-fold by T4, whilst pck which aids in the 
establishment of the glial blood brain barrier had a 9-fold reduction across the time-series. 
Cluster 3 conversely contains upregulated proteins many of which are involved in fatty acid oxidation, 
a process which is closely tied to AD pathology [77], [78]. Interestingly increases in abundance for the 
majority of proteins are not observed until T3, a point at which the mortality rate is soon to start to 
rapidly increase. This suggests that the cluster may highlight proteins whose abundance change 
either contributes or is a compensatory mechanism to an increase in mortality. Maximum protein 
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levels are quantified at T4, the point at which mortality is at its peak, Figure 3.3A. It is thought that 
increasing levels of oxygen radical formation in mitochondria is present in AD brains due to fatty acid 
breakdown, which are susceptible to free radical damage in a process called lipid peroxidation [79]. 
Our data demonstrate a correlation between fatty acid oxidation levels and mortality rate which could 
help validate this theory. 
Both metabolic processes and catalytic activity were found to be enriched in two clusters, both of 
which showed variable abundance levels across the time-course. This could be due to the 
dysregulation of different metabolic pathways and indeed previous metabolomics studies have 
identified the perturbation of numerous different pathways in the cerebrospinal fluid taken from AD 
patients [79].  
Differential expression was, as previously, calculated using the EDGE package. The same settings as 
those used for statistical testing of the ageing data were used excluding the degree of freedom which 
was set to 1 less than the number of time points measured, 3. Using this method, 124 proteins were 
identified as having a statistically significant abundance change across the time-course (q < 0.05). We 
initially wished to confirm that our data captured the cellular response to Aβ peptide toxicity by using 
the ageing data as a reference. We therefore examined the overlap between differentially expressed 
proteins identified in each of the two data sets, Figure 3.17. Little overlap was observed, with 124 out 
of a total of 141 proteins found to be specific to the Aβ data set. This indicates that the majority of 
proteins identified as differentially expressed from the Aβ data are either a direct result of Aβ toxicity 
or expression changes not detectable in our ageing data are exacerbated by Aβ expression to a 
detectable level.  
Gene ontology analysis of differentially expressed proteins found that a large number were involved in 
metabolic processes, confirming the results from cluster analysis (59). One proposed mechanism for 
neurodegeneration in AD is the onset of brain metabolic dysfunction and indeed metabolic profiling of 
AD brains, primarily with the use of LC-MS has identified the dysregulation of various metabolic 
pathways [80], [81]. Within our data there were no highly represented pathways suggesting a non-
specific effect on metabolism. There was however a number of dehydrogenase (14) and transferase 
(11) related proteins. Of the dehydrogenase proteins, aldehyde dehydrogenase was found to be 
upregulated with age (q = 0.0005) with its highest abundance measured at T4. Interestingly the same 
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upregulation was observed in the ageing data but with a larger fold change which initially suggested 
that the observed expression change is most likely to be as a result of ageing. Mitochondrial aldehyde 
dehydrogenase has however has been previously linked to AD, where it has been observed that a 
deficiency is a significant risk factor for late-onset AD [82]. It is also known 
   
 
Figure 3.17 Venn diagram of the overlap of differentially expressed proteins identified from the ageing data and the Aβ 
induction data   
that aldehyde dehydrogenase is protective against oxidative stress, a proposed mechanism of 
pathogenesis in AD. When directly comparing protein levels between the two datasets no statistically 
significant difference was measured, indicating that differential regulation is not linked to Aβ toxicity in 
our model. The data, therefore, may be indicative of an upregulation as a protective mechanism 
against increasing oxidative stress as a result of ageing instead of Aβ aggregation but one which may 
incidentally protect against Aβ induced oxidative stress in AD. Other metabolic proteins to note due to 
large abundance alterations were the protein scaf, a serine protease (30-fold downregulated), rhi a 
transcription factor (30 fold downregulated) and Eukaryotic translation initiation factor 3 subunit L (8 
fold downregulation).  
Also highly enriched (FDR < 0.001) were proteins with oxidoreductase activity, where a large overlap 
with proteins also having dehydrogenase activity was observed. Within this subset the enzyme 
cytochrome P450 4e2 was quantified at 5–fold less after T1 (q = 0.04), an effect not observed in the 
ageing data. Interestingly it is known that cytochrome P450 enzymes metabolise a wide range of 
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exogenous and endogenous compounds and are found in a range of tissue types. It is thought that 
alterations in cytochrome P450 metabolism could regulate brain behaviour, disease pathology and 
treatment outcome through altered drug metabolism [83]. Decreased levels of P450 4e2 could likely 
contribute to neurotoxicity through decreased clearance of toxic compounds which would otherwise 
have been cleared. A similar hypothesis has been proposed for the link between pesticides and the 
risk of PD, where farmers with a Cytochrome P450 2D6 variant that metabolises compounds at a 
slower rate were found to be at an increased risk of PD.[84] Global alterations in oxidoreductase 
activity could contribute to changes in detoxification pathways thereby increasing neuronal 
susceptibility to damage.  
In a similar approach to the previous data, differentially expressed proteins were queried in STRING 
to identify protein-protein interactions and protein subsets that might be performing similar cellular 
functions. Although the resultant network was not as expansive as that observed from the ageing 
data, with the use of ClusterViz, we were able to identify at least four distinct clusters of PPIs, Figure 
3.18. Cluster I, labelled in red, is the largest of the clusters and contains proteins with a range of 
cellular functions including neuronal stem cell maintenance, locomotory behaviour and actin 
cytoskeletal binding, corresponding to the proteins Trehalase, Tdc2 and Moesin/ezrin/radixin homolog 
1 respectively. Well represented in this cluster are oxidoreducatase related proteins including Sodh-2, 
CG2064 and CG1548. Cluster II, labelled in yellow, is highly represented by proteins either involved in 
the maintenance of protein folding or the control of protein translation. HSP23 and 27 are both 
identified as downregulated across the time-series, but interestingly HSP23 is also downregulated 
with age. This taken with the identification of age-related expression changes of HSP27 in previous 
experiments (Chapter1) indicates that these changes are for the most, induced by ageing. A reduction 
in chaperone concentrations to aid protein refolding could, however, have dramatic implications for a 
misfolding disease such as AD. Another protein closely linked with protein folding is ref(2)p, which is 
found to be 3-fold upregulated, and is involved in both ubiquitin-dependent protein catabolism and the 
positive regulation of macroautophagy. Interestingly ref(2)p has been shown to be a key component in 
the formation of protein aggregates in D. melanogaster models of neurodegenerative diseases.[85] 
Our results therefore fit well with this model.  Two other proteins within the cluster were found to be 
common between the two datasets, elav and banacal. Elav is a neuron specific mRNA binding protein 
required for central nervous system maintenance and is used in the Elav-GS expression system  
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Figure 3.18 Protein-protein interaction network of proteins identified as differentially expressed across the Aβ induced 
time-course. Interactions are those defined as of medium confidence or higher as defined with STRING. Clusters (as 
labelled by colour) have been calculated using the EAGLE algorithm from the ClusterViz application and as applied within 
Cytoscape 
[16], [86] Reduced amounts are seen across both time-course datasets and are likely a signal of 
neuronal death in both cases. The expression profile for bancal is similar to elav, with a reduction 
seen across both time-series. Bancal is a transcription factor binding protein that is linked to cell fate 
and proliferation.[87] Elevated levels of bancal and other heterogeneous nuclear ribonucleoproteins 
(hnRNPs) have been previously correlated with improved neurodegenerative phenotypes in flies.[88] 
Reduction as a result of ageing could therefore contribute to increased vulnerability to Aβ toxicity.  All 
other proteins within the interaction network were found to be specific to the Aβ data and are almost 
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exclusively involved in the regulation of transcription/translation, mainly by mRNA or tRNA interaction. 
A reduction in translation rates has been linked previously to neurodegeneration in prion disease via 
eIF2-α activation, however, little has been published in the context of AD.[89] Interestingly, however, 
neuronal death in AD has been proposed to as a result of ER stress and dysfunction.[90] The 
unfolded protein response (UPR) is major ER stress mechanism and causes an overall reduction in 
mRNA translation.[91] Our data in addition to the identification of a downregulation of eukaryotic 
translation initiation factor 3 subunit L (eIF3l) demonstrate a degree of protein synthesis control in 
response to Aβ induction which could be attributed, in part, to increased ER stress. Cluster III, 
labelled in pink, contains proteins involved in signal transduction, learning and rhabdomere 
development and therefore represent alterations in brain and eye function as a result of protein 
aggregation. Two actin related proteins are also present, Actin-57B and Actin-related protein 2, both 
of which regulate growth at the neuromuscular junction. Interestingly both are downregulated 2-fold 
across the series, suggesting dysregulation at the neuromuscular junction. Finally Cluster IV contains 
cuticle and chitin cuticle-related proteins that are the major structural constituents of the exoskeleton 
that surrounds the Drosophila brain. Although these could be viewed as contaminant proteins that 
were not effectively removed during dissection, the consistent nature of their downregulation suggests 
that the results may have some biological relevance. Alongside this, the identification of only one 
differentially abundant cuticular protein from the ageing dataset demonstrates an Aβ specific 
response. The differential abundance of a set of cuticular proteins has not to our knowledge been 
previously reported for fly models of neurodegeneration but could be hypothesised to be caused by 
the degeneration of brain tissue and therefore the association between brain tissue and cuticle. 
Another approach taken to prioritise differentially expressed proteins was to compare our data to data 
obtained from a similar but orthogonal approach conducted at the transcript level. The data as 
collected by G. Favrin and colleagues compares both age-matched and survival matched flies either 
absent of Aβ (control) or chronically expressing the peptide [92]. Here three time points were 
analysed per experimental design. It is a reasonable conclusion that an expression change measured 
at both the protein and mRNA level from experiments performed at different times and by different 
labs can be confidently assigned as a cellular response to Aβ misfolding. A total of 29 differentially 
abundant proteins from the protein dataset were found to overlap with genes identified as significantly  
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Figure 3.19 Comparison of differentially expressed proteins identified in the Aβ time-course proteomic analysis to genes 
found to be regulated in microarray analysis by G. Favrin and co-workers in their Aβ time-course data. A) Venn diagram of 
gene overlap. B) Heatmap of direction of regulation (for mRNA and protein) for genes common between the two dataset. 
Red indicates an upregulation and blue indicates downregulation    
altered in the microarray dataset, Figure 3.19A. Taking into account the size of the average D. 
melanogaster microarray gene set (18,500)  and the number of differentially expressed proteins 
identified in the two datasets this overlap represent a statistically robust overlap (p < 4x10
-34
) and 
successfully validates our approach for prioritising proteins of interest based on prior unbiased 
experiments. We were subsequently interested in the proportion of common identification where 
regulation at the gene and protein level was analogous, Figure 3.15B. Pleasingly it can be seen that 
for the majority of genes both mRNA and protein abundance are regulated in the same direction in the 
presence of Aβ peptide expression. This would indicate for those genes, protein abundance is 
controlled mainly by transcriptional regulation. These include the upregulated lipid storage droplets 
surface-binding protein 1 which is involved in lipid storage and neurogenesis and the downregulated 
calphotin protein that is key to rhabdomere development and photoreceptor cell survival [93]. Proteins 
where mRNA and protein levels do not correlate could potentially represent a situation where protein 
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abundance levels are regulated at a post-transcriptional level through, for example, protein 
degradation or other known regulators of translation rates. Validation of these results with orthogonal 
techniques such as immunoassay assay quantification and quantitative polymer chain reaction 
(qPCR) is required to confirm this hypothesis.     
Finally, although some of the proteins did feature in previous analyses, proteins common between the 
ageing and Aβ data were examined for their function and regulation. We were interested in identifying 
whether these shared proteins exhibited the same behaviour across the two time-series and whether 
the degree of abundance changes were similar, Figure 3.20A. Similar expression changes across  
 
Figure 3.20 Comparison of proteins identified as differentially expressed in both the ageing and Aβ time-course. A) 
Heatmap of fold change at each time point (in reference to T1).B) Protein class (Panther) analysis    
time were observed in each of the datasets. Notably, when comparing samples obtained at the same 
time point, abundance alterations measured in the Aβ induced samples were almost entirely more 
pronounced than in the ageing samples. Indeed T4 abundance from the Aβ time-course correlates 
better, in terms of fold change, with T6 abundance from the ageing time-course than it does with its 
respective counterpart. These data indicate that, at least for this protein subset, the aggregation of Aβ 
speeds up cellular processes observed during ageing. The common proteins were found to belong to 
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a number of different protein classes as defined by Panther, Figure 3.20B. As previously observed 
during cluster analysis, the most well represented classes were oxidoreductase and transferase 
activity. This may reflect shared response to increases in oxidative stress which is known to contribute 
to neurodegeneration in both AD and normal ageing [94]. 
 
3.2.11 Characterisation of Aβ Toxicity in Reference to Age Matched Controls 
A third approach taken to extract information from our quantitative time-series was to directly compare 
protein abundances measured from the two time-courses. This allowed us to identify differentially 
expressed proteins upon Aβ induction with reference to an exact age-matched control. Prior to the 
comparison, data were processed and normalised together in order to reduce the contribution of any 
global differences between the samples. This meant, therefore, that we focused on only the most 
confident protein abundance differences in our analysis. 
Data at each time point were compared using a two sided Student’s t-test with unequal variance. 
Statistical tests were performed on log2 transformed Hi3 protein intensities extracted from Progenesis 
post alignment, normalisation and protein grouping. To reduce the false discovery rate differential 
expression was defined as a protein having a P value < 0.05 in a minimum of two out of the four time 
points tested. Using these criteria minimal differences were observed between the two datasets with 
44 proteins identified as having a statistically significant abundance difference between the two 
conditions. The cause for these smaller measured differences may be two-fold. Firstly the use of a t-
test is likely to reduce the power of the analysis in comparison to the previous approach used [29]. 
Secondly it may be that the majority of expression differences between the two conditions are smaller 
than is possible to confidently distinguish with the chosen number of biological repeats. If this is the 
case, as is often found in transcriptomics, enrichment analysis (based on alterations in abundance) 
can indicate whether small expression changes are common to biological processes. To test for this, 
enrichment analysis was performed (Panther) using calculated ratios of Aβ vs age matched control at 
T4. This was based on the assumption that upon chronic induction of misfolded peptide the most 
pronounced differences between the two conditions are likely to occur at the latest time point. After 
Bonferroni correction no gene ontologies were found to be significantly enriched. Our data therefore 
indicates that for the set of proteins quantified by our methodology there are no processes that are 
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commonly regulated in response to Aβ misfolding, when compared to normal ageing controls. 
Uncorrected p values obtained for enrichment analysis were subsequently considered as an approach 
to prioritise differentially expressed proteins. The biological process, response to endogenous 
stimulus, had the lowest p value (p = 0.0045, upregulation) and was based on ratio values quantified 
from 4 small GTPase proteins. This was of particular interest because of its relation to previous 
findings (Chapter 2) where a set of GTPase proteins were found to be differentially expressed in aged 
flies expressing Aβ peptide. Although the proteins identified from enrichment analysis are not those 
identified in previous work it may be further evidence of a common dysregulation upon Aβ misfolding. 
Other upregulated pathways (p < 0.05) were three different metabolic pathways, phospholipid, 
monosaccharide and cyclic nucleotide, which collectively accounted for 75 proteins. 
Differentially expressed proteins were manually queried in Uniprot and Flybase for annoted biological 
processes which resulted in the identification of a number of proteins that performed cellular functions 
that were known to be directly relevant to AD based on previous publications, Figure 3.21. 
Expression of Hsc70-3 is observed to increase significantly as a result of Aβ misfolding in three out of 
the four time points, Figure 3.21A. Interestingly this trend is similar to that observed in the previous 
proteomic study (Chapter 2) and is therefore of particular interest. Hsc70-3, the functional counterpart 
of BiP is thought to play a role in facilitating the assembly of multimeric protein complexes and its 
upregulation upon Aβ induction is likely to be a protective mechanism against increasing misfolded 
protein load.[95] The upregulation of BiP is a key component in ER stress responses and this data, 
therefore, is further evidence towards the expression of Aβ42 inducing ER stress, most likely as a 
result of a large increase in misfolded protein load.  
Another differentially expressed protein which plays a direct role in maintaining protein fold 
homeostasis is the upregulated ubiquilin, Figure 3.21C. Ubiqulin physically associates with the 
proteasome and ubiquitin ligases and is therefore thought to link the ubiquitination machinery to the 
proteasome to aid misfolded protein degradation. Ubiqulin has many direct links to misfolding 
neurodegenerative disease including AD. Overexpression has been shown to promote presenilin 
accumulation and is known to directly interact with both PS1 and PS2 [96], [97]. Using 
immunohistochemistry it was found that ubiqulin was prominent within the neurons of human brains  
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Figure 3.21 Functional analysis of differentially expression proteins as a result of Aβ toxicity in comparison to age matched 
controls. A) Hsc-70 ratios (Aβ/control) across the time-course. B) Heatmap of ratios for proteins involved in learning, 
memory and/or locomotor behaviour. C) Ubiquilin ratios across the time-course. D) Lineplot of calculated ratios for 
proteins implicated in neurogenesis.  E&F) Gene ontology annotation all 44 differentially expressed proteins. * donates p 
<0.05 **denotes p <0.005     
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and was also identified to co-localisation with neurofibrillary tangles [96]. Interestingly the 
overexpression of ubiquilin has been shown to negatively modify the lifespan and motor neuron 
phenotypes of a Drosophila model for ALS [98]. Our findings alongside previous literature provide 
strong evidence towards ubiquilin being a potentially key modifier of Aβ toxicity through its increasing 
abundance in respect to age. A small set of proteins implicated in learning, memory and/or locomotor 
control were identified as differentially expressed and calculated ratios (Aβ/control) are shown in 
Figure 3.21B. It can be seen that all proteins are downregulated in response to Aβ induction and 
notably this reduction in abundance is first identified, for all 5 proteins, prior to any increase in 
mortality rates. This is unsurprising as the functions of these proteins are likely to be more closely 
linked to the negative geotaxis phenotype which occurs weeks prior to an increase in mortality [99]. 
The identification of bruchpilot is of interest due to its close relation with Rab-3 which was identified as 
downregulated in the presence of Aβ peptide in the previous study (Chapter 2). Rab-3 has been 
shown to effect the localisation of bruchpilot at active sites thereby reducing neurotransmitter release 
[100]. Together the data from the two studies indicate Aβ toxicity to be affecting synaptic dysfunction 
through the dysregulation of active zone site composition. Three proteins involved in neurogenesis 
were found to have variable expression levels; however a trend of upregulation at the later time points 
was observed Figure 3.21D. As previously mentioned neurogenesis was until recently not thought to 
occur in the adult Drosophila but recent data is now challenging that assumption [101]. The 
upregulation of proteins implicated in neurogenesis could, therefore, represent a late compensatory 
mechanism for Aβ toxicity. Gene ontology analysis of the molecular function and biological process 
ontologies of all 44 proteins identified a range of different cellular processes but no particular 
processes dominated the findings. Figure 3.21 E&F. A large proportion of proteins identified either 
had binding or catalytic activity for molecular function characterisation whilst metabolic processes 
were again seen to be well represented by the data.    
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3.4 Conclusion 
The cellular mechanisms that link ageing to the probability of developing Alzheimer’s disease are an 
important avenue of research to help tackle the socioeconomic challenge of an ageing population. 
Using a recently developed acquisition method, that uses ion mobility to separate peptide ions prior to 
ToF mass analysis, HDMS
E
, longitudinal quantitative proteomics was undertaken to probe brain 
proteome alterations as a result of wild-type ageing and chronic Aβ42 misfolding.  Approximately 
2000 proteins were confidently and consistently quantified across time points than spanned >80% of 
each of the lifespans from the two conditions. The experimental designed was such that the data were 
tested in three distinct approaches, allowing protein expression alterations to be successfully 
correlated with ageing and Aβ toxicity. 
Analysis of protein abundances across six time points corresponding to wild-type ageing were 
interrogated using a soft clustering approach. A coordinated decrease in levels of proteins involved in 
energy derivation was identified alongside decreased levels of proteins that play a role in signal 
transduction and sexual reproduction. Potentially decreased levels of energy production and signal 
transduction could have serious implications for neural plasticity and neural development. Indeed both 
have been previously linked to neurodegeneration during ageing [54], [74], [102], [103]. Conversely 
increased abundances for proteins involved in oxidoreducatase activity, endopeptidase activity and 
catabolic processes were quantified. Data, therefore, is suggestive of increased levels of oxidative 
stress and degradative processes both have which have been reported to be a cellular consequence 
of ageing [37], [23], [79]. Following this, a statistical approach that has been optimised for time-course 
data successfully identified >300 differentially regulated proteins, representing ~15% of all proteins 
quantified. PPI analysis found >200 of the regulated proteins to directly interact with at least one other 
protein. A site of high coordination was found to relate to mitochondrial and metabolic proteins, 
validating the soft clustering results. A second highly coordinated site was found to contain mRNA 
and ribosomal proteins suggesting translation rates to be a contributing factor in the ageing process. 
Comparison of our results with data from a quantitative proteomic time-course analysis of ageing in 
C.elegans, recently published by the Mann and Hartl labs, identified conserved ageing processes 
including reduced ribosomal levels, a dysregulation of the proteosome complex and a large reduction 
in Sod-3 levels. 
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A similar approach was used to identify cellular responses to the neuronal expression of an Aβ2 
variant with a high aggregating propensity. Soft cluster analysis identified some similarly enriched 
processes to those found in the ageing data. Again a reduction in mitochondrial and reproductive 
levels alongside an increase in oxidoreducatase activity was identified. Interestingly proteins involved 
in actin cytoskeleton organisation were found to reduce in abundance throughout the 4 time points 
examined. Cytoskeletal abnormalities have long been linked to AD and other neurodegenerative 
disease [75], [76]. Our data indicates that these processes begin at the very initial stages of AB42 
aggregation. Finally, an increase in fatty acid oxidation was observed after T2 as process that has 
been previously linked to AD [77]. Statistical analysis identified fewer differentially expressed proteins 
than found from the ageing data. PPI analysis produced a smaller interaction network but four distinct 
clusters were identified within Cytoscape. Small heat shock proteins (similar to those identified in 
Chapter 2), cytoskeletal proteins, and proteins involved in neuronal process were all identified and 
represent interesting targets for follow-up functional studies. Differentially regulated proteins common 
to both the ageing and Aβ datasets were examined. It was found that expression levels almost 
exclusively correlated between the two conditions. Interestingly the induction of AB42 appears to 
amplify the rate of expression changes suggesting that the aggregates may aggravate some of the 
cellular process that occur during ageing. A number of proteins were successfully validated against a 
transcriptomic study of Aβ42 expression in Drosophila. mRNA and protein levels were found to 
correlating extremely well across the two studies. These proteins are, therefore, strong candidates for 
protein expression changes that occur during the pre-clinical and clinical stages of AD. Follow-up 
functional studies should help determine how they related to the link between ageing and AD 
prevalence.    
The third and final analysis approach was to identify significantly altered protein abundances between 
the two conditions. Due to the experimental design the approximately 40 proteins identified by this 
approach can be attributed to be a direct cellular response to Aβ42 expression. Whether these 
changes are protective or deleterious is unfortunately beyond the scope of these experiments but can 
be estimated based on prior functional information. Proteins involved in neurogenesis were all 
upregulated in response to Aβ42 whilst proteins implicated in learning, memory and locomotor 
behavior were all downregulated. These are likely to directly relate to common phenotypes observed 
in this AD model [11]. Two proteins of particular interest were identified based on gene ontology 
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information. Firstly, Hsc70-3, which was also identified in the previous study (Chapter 2) was 
consistently upregulated in response to Aβ42 expression. Based on the known function of Hsc70-3 its 
upregulation is likely a protective response to ER stress [90], [95]. Also upregulated was ubiquilin, 
which has been previously linked to AD through its interaction with PS1 and PS2 and its 
colonialization with neurofibrillary tangles.[96] Upregulation of ubiquilin has been shown to reduce 
proteosomal degradation rates and our data identifies it as a potential key modulator of Aβ42 toxicity 
[97].  
Our longitudinal approach has successfully identified cellular alterations in D. melanogaster 
associated with the ageing process, chronic Aβ42 toxicity upon ageing and Aβ42 toxicity alone. Data 
has identified known regulators of ageing and Aβ42 toxicity but has also implicated previously 
unknown responses. Collectively our data is a rich and unique resource for future reductionist and 
functional studies on the link between ageing and AD in D. melanogaster.    
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Subcellular Proteomics of α1-Antitrypsin Misfolding in a Mammalian Cell Model of ER Stress 
and Disease 
 
4.0 Abstract 
Folding of secreted proteins within the endoplasmic reticulum (ER) requires interaction of ER quality 
control mechanisms with the folding polypeptide chain. The metastable antiprotease α1-antitrypsin is 
synthesised in large amounts in the liver and is one of the most highly secreted human proteins. The 
NullHongKong (NHK) variant has a major C-terminal deletion and so grossly misfolds in the ER. The 
proteostatic challenge generated by its expression makes this an important model for ER stress and 
triggering of the unfolded protein response. We have used label-free (MS
E
), ER-focused proteomics in 
the CHO-K1 mammalian cell model, to define the molecular response to folding and secretion of high 
levels of wild-type (M) protein. These were compared with the ER-associated proteome obtained with 
expression of the NHK variant to identify subcellular responses to α1-antitrypsin misfolding. The data 
indicate changes affecting regulation of proteostatic load, protein folding and protein processing within 
the ER. Fascinatingly our studies also indicate altered bioenergetics and mitochondrial behaviour. 
Data derived from live cell fluorescence microscopy validate these changes by demonstrating that 
misfolding within the ER induces dramatic changes in mitochondrial morphology between cells 
expressing M, NHK and the common severe disease variant Z α1-antitrypsin. The changes show 
genotype:phenotype correlation and indicate that the cellular response to α1-antitrypsin misfolding 
within the ER may include modulation of the balance between mitochondrial fusion and fission.  
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4.1 Introduction 
Discovered in 1965 by Laurell and Erikssoon, the folding of the archetypal serpin (serine protease 
inhibitor) 1-antitrypsin within the hepatocyte endoplasmic reticulum (ER) has been observed to 
challenge human proteostatic quality control mechanism [1]. 1-antitrypsin’s main physiological 
function is to inhibit neutrophil elastase but also functions to inhibit two other proteases, also from the 
neutrophil family, cathepsin G and proteinase 3. Circulating levels of 1-antitrypsin carefully maintain 
homeostatic levels of neutrophil elastase to facilitate the removal of damaged or ageing lung tissue 
cells whilst preventing the uncontrolled breakdown of healthy lung tissue. 
Common with other serpins it displays a distinctive suicidal mechanism for inhibiting proteases. A 
result of this is that the 45 kDa polypeptide chain adopts a complex native fold. Unlike most proteins, 
the native conformation of 1-antitrypsin does not represent the polypeptide’s most stable globular 
fold.  Instead, for it to function as an enzyme inhibitor it must remain kinetically trapped in a 
metastable conformation [2]. The protein is small and relatively polar, allowing the movement into 
tissue fluid such as the lungs. In its metastable conformation, as shown in Figure 4.1, the protein 
presents an exposed reactive loop, whose centre is focused around Met358-Ser359. This reactive 
centre loop acts a substrate for a neutrophil protease. After docking of the target protein, the centre of 
the target loop is cleaved, leaving the loop more conformationally flexible. Increased flexibility leads to 
the insertion of the loop as an addition strand within the center of β-sheet A. This insertion forms the 
inhibitory complex that renders both the protease and serpin inactive, following a conformational 
translocation of the protease. The opening of the β-sheet A alongside the insertion of the reactive loop 
leads to local and global stabilization interactions resulting in a highly stable complex.   
1-antitrypsin is synthesised by and secreted from hepatocytes in large quantities (1-2 g/d) and as 
such is one of the most abundant proteins in human serum (20-48 µM). The protein is of particular 
interest due to the monogenic disorder 1-antitrypsin deficiency (AATD), a disease which clinically is 
found to be relatively common in European populations. AATD is linked to chronic liver disease in 
childhood and hepatocellular carcinoma/cirrhosis in adulthood [3]. The main clinical symptom is 
however early onset pulmonary emphysema.  
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Figure 4.1 Energy diagram illustrating the different conformation states of α1-antitrypsin during enzyme inhibition   
 
Circulating levels of 1-antitrypsin lower than 11 µM are insufficient to properly inhibit neutrophil 
elastase. This allows the progressive destruction of alveoli and if left untreated can lead to 
emphysema. The pathophysiology of AATD in relation to liver disease is far less well understood but it 
is known that deficient variants can accumulate in the endoplasmic reticulum due to inefficient 
secretion. This accumulation results in protein aggregation of 1-antitrypsin variants and causes 
subsequent hepatocyte damage. AATD is caused by point mutations within the SERPINA1 gene, that 
encodes for 1-antitrypsin. More than 100 alleles have been identified at the time of writing; however 
we will focus on three of the more common variants. 
PiM type alleles account for more than 95 % of Caucasian individuals. Individuals that are 
homozygotes for M alleles produce normal plasma levels (> 20 µM). The NullHongKong (NHK) variant 
results from a frameshift mutation affecting residue 318 that introduces 15 new residues before 
Chapter 4. Subcellular Proteomics of α1-Antitrypsin in a Mammalian Cell Model of ER Stress and 
Disease  
[169] 
 
introducing a premature stop codon after position 333, giving rise to a 61 amino-acid C-terminal 
truncation.[4] These changes cause it to grossly misfold, saturating the ER-associated degradation 
(ERAD) response with resultant ER stress. Indeed NHK α1-antitrypsin expression is widely used as an 
experimental trigger in studies characterising these responses [4]–[9]. ERAD involves the recognition 
of misfolded protein substrates and their retrotranslocation from the ER into the cytosol for 
ubiquitination and degradation by proteasomes. ER degradation-enhancing α-mannosidase (EDEM) 
selectively recognizes misfolded protein by immature N-linked glycosylation, and targets these for 
ERAD. The mechanism underlying protein retrotranslocation is poorly defined, but may involve the 
action of the Sec61 complex, Derlin-1 and the HRD1-SEL1L complex.[9]–[11] Further complexity is 
suggested by the finding that NHK α1-antitrypsin can be cycled via the Golgi, and that mannose 
modifying and non-modifying roles of mannosidase proteins may also contribute to the overall ERAD 
process [12], [13]. 
Saturation of the ERAD pathway causes the ER unfolded protein load to rise, initiating the unfolded 
protein response (UPR) that generally reduces the rate of polypeptide synthesis and increases ER 
chaperone capacity [14]. This is triggered by activation of the ER stress sensors inositol-requiring 
IRE1, double-stranded RNA–activated protein kinase-like ER kinase (PERK), and activating 
transcription factor ATF6.   When UPR and ERAD together fail to adapt the cell to its ER synthetic 
load, uncontrolled ER stress can result in apoptosis [15].  
The PiZ allele is the most common cause of AATD and is associated with very low serum 
concentrations of protein. Homozygotes for the Z variants possess circulating levels of 1-antitrypsin 
in the range of 5-6 µM. It has been shown that 85 % of Z homozygous children have liver function test 
results outside the expected range, however only 10 % will present clinical symptoms whilst only 1-3 
% will develop cirrhosis during childhood [16]. The Z variant is a result of a point mutation of 
Glu342Lys. Northern Europeans have a high incidence of this mutation with 1 in 2000 being 
homozygous and 1 in 27 a heterozygote carrier [17]. In Z homozygotes 15 % of 1-antitrypsin that is 
synthesized is successfully trafficked to the Golgi for secretion. Retained protein forms self-associated 
polymer chains and eventually results in hepatocyte inclusion bodies.  
Unlike the NHK variant, retention of the Z variant within the ER does not appear to initially activate the 
UPR, when studied using cells that recapitulate hepatocyte phenotypes [18]. In fact, further to the 15 
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% of secreted protein roughly 70 % is degraded in the ER with the remaining protein forming polymer 
aggregates. It is found, however, that cells are instead sensitized to UPR activation upon an 
additional insult. Serpin polymer accumulation in the ER can trigger an alternative stress response, 
the ordered protein response or more commonly the ER overload response. Interestingly studies 
suggest that accumulation of the Z variant activates this response to a far greater degree than the 
NHK form. The ER overload response is poorly annotated at the present time but studies suggest it to 
be calcium-dependent and a downstream result is the activation of the transcription factor NF-kB [19]. 
Quantitative proteomics has been previously used to good effect to study the response of cellular 
systems to the assault of protein aggregation. A large majority of these studies have recorded the 
global cellular response, in order to define a disease phenotype. These data however, do not allow 
the separation of responses from differing cellular compartments. This is of particular importance 
when the aggregating protein, in our case 1-antitrypsin is known to localise in a subcellular manner; 
namely the endoplasmic reticulum.  
Sub-cellular fractionation, a commonly employed technique in cellular biology, coupled to mass 
spectrometry-based proteomics allow the enrichment of cellular components to better define a 
subcellular proteomic response. The Lilley group have used their technique, localization of organelle 
proteins by isotope tagging (LOPIT) to good success to better annotate the proteomes of sub cellular 
compartments [20]. As with much subcellular proteomics it uses a density gradient, whereby 
organelles are separated following centrifugation across a sucrose or iodixanol gradient. Organelles 
can be successfully separated based on their different physical properties. This preparation technique 
allows the direct use of cellular homogenate, however in all cases does not produce single organelle 
fractions as some compartments share similar properties. In reality a distribution of proteins from 
overlapping organelles is produced, with different organelles enriched in different fractions. The Lilley 
group have further developed this technique with the addition of multivariate data analysis to better 
define the overlapping organelle protein distributions. Label based quantification, in the form of iTRAQ 
is employed to measure protein amounts across the density gradient. Quantification of proteins with 
distinct organelle associations can be used to create a phenotypic representation of organelle specific 
protein distribution. These distributions can then be used to assign proteins of unknown association.  
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The use of antibodies to detect known residents of a subcellular compartment is still a widely used 
technique for isolating a specific organelle for subsequent interrogation [21], [22]. A known marker 
allows the normalisation of repeat fractionation protocols, to ensure that the extracted proteome is 
consistent across repeat biological runs. This approach benefits MS-based proteomic approaches, 
which are often limited by instrumental dynamic range. The removal of organelles of disinterest 
facilitates the identification of a larger number of proteins of interest, which may have otherwise been 
unidentified, due to co-eluting tryptic peptides from high abundance proteins originating from removed 
organelles. What must be considered with this approach is however, the possibility of co-fractionating 
proteins from organelles distinct from the compartment of interest. Indeed it is known that 
mitochondrial proteins commonly co-elute with resident endoplasmic reticulum proteins during density 
gradient centrifugation [23]. Functional analysis post MS analysis can be used to clarify the 
localisation of many of the identified proteins, but will not provide complete coverage. 
 
Table 4.1. Characterized ER focused cellular responses to the expression of 1-antitrypsin variants 
 
 
 
We wished to define the subcellular proteomic responses to folding and secretion of the metastable 
wild-type, to misfolding-induced degradation of NHK 1-antitrypsin and Z 1-antitrypsin. To date the 
responses to 1-antitrypsin misfolding have been principally characterised by classical reductionist 
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cell biology methods. An overview of these expected responses is highlighted in Table 4.1, responses 
it was hoped could be further expanded upon by our methodology. In our highly complementary 
approach we therefore undertook label-free (MS
E
), unbiased, ER-focused proteomic studies in a non-
malignant, mammalian cell expression system (CHO-K1, Tet-On) for secreted proteins that fold within 
the ER. This epithelial-like line is also validated as a good phenotypic model for the expression of 1-
antitrypsin variants in hepatocytes [24]. We obtained 6 ER-focused proteomic profiles associated with 
low (non-induced) and high (doxycline-induced) expression of wild-type, NHK 1-antitrypsin and Z 1-
antitrypsin. The approach is enriched for response components of high relevance to the secretory 
pathway and misfolding responses that will localise to the ER itself. 
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4.2 Materials and Methods 
 
4.2.1 Preparation of CHO Cell ER Samples 
Chinese hamster ovary (CHO)-K1 cells stably transfected with Tet-On expression systems for M , 
NullHongKong (NHK) or Z variants of α1-antitrypsin were cultured, and expression induced with 
doxycycline, as described previously.[24] Non-induced cell lines were not treated with doxycycline but 
otherwise cultured identically, Figure 4.2A. Cells were harvested after 5 days seeded (2 days post-
induction), and lysed by 25-30 passages through an EMBL cell homogenizer (Isobiotec, Heidelberg, 
Germany) loaded with an 8.010 mm ball bearing. The procedure was carried out on ice, and cell 
disruption was confirmed by light microscopy.  
 
Homogenized samples were centrifuged (3000 rpm, Eppendorf 5415D centrifuge, rotor F45-24-11, 5-
10 minutes) to pellet out cell nuclei. Density gradient centrifugation was used to purify the ER 
fractions using an OptiPrep (Axis-Shield, Oslo, Norway) iodixanol gradient system. 600 µl of each 
sample made up to 2 ml of 35% (w/v) iodixanol solution was transferred to the bottom of a centrifuge 
tube. An Auto Densi-Flow Density Gradient Fractionator (Labconco, Kansas City) was used to create 
a density gradient of 30% to 10% (w/v) iodixanol on top of the sample layer, and samples were then 
centrifuged for 2 hours at 100,000g (23,500 rpm using an SW40i rotor, Beckman Coulter, CA, USA) at 
4 °C. 0.5 ml fractions were collected sequentially from the top of the tube. Samples from each fraction 
were run on SDS-PAGE and assessed by western blot analysis for the presence of α1-antitrypsin and 
resident ER chaperones (Grp-98, BiP and protein disulphide isomerase (PDI)) containing the KDEL 
motif, Figure 4.2B. ER-associated fractions (defined as all KDEL-positive fractions) were then pooled 
for further analysis and concentrated to <200 μl. All steps involved in CHO ER sample preparation 
were carried out by Dr Peg Nyon, Gooptu Lab, UCL.  
 
4.2.2 GeLC-MS
E
 Analysis 
Pooled samples were resolved by 1D SDS-PAGE and stained with Coomassie Blue. Each lane was 
divided into seven sections, Figure 4.2C, which were then treated to undergo tryptic digestion as 
described previously [25]. Briefly, bands were destained, disulphide bonds were reduced with 
dithiothreitol and free cysteine residues were alkylated with iodoacetamide. Gel bands were washed 
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and dehydrated prior to the addition of a 10 ng/µl tryptic solution (Promega, Southampton, UK) in 50 
mM ammonium bicarbonate. Digestion was carried out overnight at 37 °C. Resultant tryptic peptides 
were extracted in a two-step process. Solutions were then lyophilised to dryness and stored at -20 °C 
prior to analysis. 
 
Before liquid chromatography (LC)-MS
E 
analysis, digested samples were solubilised in 10 µl of 0.1% 
formic acid. For each sample 1 µl was loaded using a split-less nano-Ultra Performance Liquid 
Chromatography (10 kpsi nanoAcquity Waters Corporation, Milford, MA, USA). Buffers used were (A) 
water + 0.1% formic acid (J.T. Baker, PA, USA) and (B) acetonitrile + 0.1% formic acid (J.T. Baker, 
PA, USA). Samples were desalted using a reverse-phase 2G V/M C18 trap column (180 µm internal 
diameter, 20 mm length, 5 µm particle size, Waters Corporation) at a flow rate of 5 µl/min for 3 
minutes. Peptides were separated by a three step gradient (0.4 µl/min, 55 °C; 99-92% Buffer A over 
7.5 mins, 92-66% Buffer A 62.5 mins, 66-60% 5 mins) using a HSS T3 C18 nano-column (75 µm 
internal diameter, 150 mm length, 1.7 µm particle size, Waters Corporation).  
 
The nanoLC was coupled online through a nanoESI emitter (7 cm length, 10 mm tip; New Objective, 
Woburn, MA, USA) to a quadrupole time-of-flight (QToF) hybrid mass spectrometer (HDMS Synapt; 
Waters UK) tuned to a mass resolution of 10 000 (full width half height). The ToF analyzer was 
externally calibrated from m/z 175.11 to 1285.54 using the fragment ions of a 500 fmol/µl solution of 
[Glu
1
]-fibrinopeptide B (GFP, Sigma Aldrich, St.Louis, MO). Data were lockmass-corrected post 
acquisition using the monoisotopic mass of the doubly charged precursor of GFP (785.8426 m/z), 
delivered at 500 fmol/µl to the mass spectrometer via a NanoLockSpray interface.  
 
Mass measurements were acquired in MS
E
 positive mode, whereby the quadrupole mass analyser is 
set to transmit all ions. The collision energy within the transfer region is alternated from low to high 
throughout analysis facilitating the acquisition of both MS and MS/MS for all ions entering the mass 
spectrometer. The radio-frequency applied to the quadrupole was set such that ion transmission from 
m/z 300-2000 was maximized. This ensured that any ions observed below m/z 300 could be 
confidently assigned as fragment ions from dissociations within the collision cell. For low-energy (MS) 
mode a constant 4 eV was applied while an energy ramp from 15 to 35 eV was used for high-energy 
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mode (MS/MS). Scan time was set to 1 s with a 0.05 s interscan delay and the reference sprayer was 
sampled every 60 s.   2 technical replicate datasets were obtained for each of 3 biological replicate 
experiments for each cell line. 
 
4.2.3 MS
E
 Data Processing 
LC-MS
E
 data were processed using ProteinLynx Global Server (PLGS) v2.5.2. The data processing 
prior to database searching included ion detection, alignment and clustering methods detailed 
elsewhere [26]. Briefly, lockmass corrected spectra were centroided, deisotoped and charge state 
reduced. Initial assignment of fragment ions to parent peptides was achieved by retention time-
alignment. Thresholds used for peak selection were as follows, 150 counts for low energy ion 
detection, 40 counts for high energy ion detection and 500 counts for precursor exact mass retention 
time (EMRT) integrated intensity.  
 
4.2.4 Database Searches 
Data were searched using PLGS v2.5.2 against a Chinese Hamster Ovary (CHO) database 
(www.chogenome.org/files/CHO_refseq_protein.fasta) appended with human α1-antitrypsin and 
common contaminant proteins. Carbamidomethyl (C) was set as a fixed modification while oxidation 
(M), acetylation (K & N-term) and deamidation (N & Q) were set as variable modifications. Precursor 
and fragment ion tolerances were determined automatically by PLGS. Protein identification criteria 
were set as the detection of at least 2 fragments ion per peptide, at least 2 fragments per protein and 
at least 1 peptide identification per protein. A maximum of 2 missed cleavages were allowed. The 
protein level false discovery rate was maintained at < 5%, estimated based upon the number of 
proteins identified from a randomized database. Post-processing the false discovery rate was 
minimized further by applying the additional criterion that for a successful identification a protein must 
be identified in a minimum of two biological repeats (see Chapter 2.2.6).The mass spectrometry data 
and associated database search results have been deposited to the ProteomeXchange Consortium 
via the PRIDE partner repository with the dataset identifier PXD002219 and 10.6019/PXD002219.  
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4.2.5 Protein Quantification 
Protein quantification was achieved through the Hi3 technique. Hi3 is based upon the observation that 
the summed intensity of the three most ionizing peptides per protein correlates with high accuracy 
and precision to protein concentration [27]. As label-free quantification directly compares samples 
analysed in concurrent runs quantification errors can be introduced by run-to-run instrument 
variability. To reduce this within-condition normalization was applied prior to quantification. This was 
undertaken at the peptide level using a script written in-house in R to implement locally-weighted 
scatter point smoothing, Figure 4.2D. Post LOESS normalization, further global normalization was 
applied based upon the total detected protein intensity per run, in order to account for sample 
preparation and loading variability across biological replicates and across conditions. Differential 1-
antitrypsin levels resulted in only minimal change to total protein levels and so are unlikely to have 
had an appreciable effect on the normalisation process. The ratio of 1-antitrypsin levels to total 
protein levels were: 0.0%, 0.01%, 0.02%, and 0.12% respectively for CHO transfected cell lines with 
M and NHK 1-antitrypsin expression non-induced and for M and NHK 1-antitrypsin expression 
induced. Based upon total protein intensity it was found that biological replicates from the same 
condition gave good reproducibility, Figure 4.2D, with 22% variability in average total protein levels. 
Comparison of non-induced to induced conditions showed a similar trend with a 25% difference 
between NHK+ and NHK- and only a 2% difference between M- and M+. The largest difference in 
protein amounts was found between the two induced samples, M+ and NHK+, where the analysis of 
M+ samples consistently identified around 70% more protein than the analysis of NHK+ samples. This 
is consistent with ER stress conditions where protein synthesis is globally reduced. The normalisation 
steps undertaken were therefore important in our conservative approach to identify robust changes in 
expression levels that were likely to be of more specific relevance to misfolding and reduced secretion 
of α1-antitrypsin.  
 
4.2.6 Differential Expression 
Pairwise comparisons of relative expression levels were performed for the six conditions (M and NHK 
α1-antitrypsin stable CHO-K1 Tet-On cell lines, without (-) or with (+) α1-antitrypsin expression induced 
by doxycycline treatment). Differential expression was calculated based on fold change and statistical 
analysis. Fold change was calculated for each comparison using the mean of Hi3 protein intensity 
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across replicates. P values were calculated using a two-sided Student’s t-test, with equal variance 
and was performed on log2 transformed intensity data. Proteins that were calculated to have a fold 
change larger than 1.3-fold and a p value < 0.05 were defined as differentially expressed. MS
E
 
quantitative technical variation has been previously demonstrated to be reproducible at 10-15%. A 
1.3-fold threshold therefore represents a value typically 2-3 times larger than estimated technical 
measurement error and has previously been shown to compare well with more established label-
based methods [28]. Statistical results are provides in the appendix file.   
 
An additional category in the comparison of ER-associated proteomes defined proteins as unique 
between cell lines if they were confidently identified in one condition (present in ≥2 biological repeats) 
but was not detected at all in the other (see Chapter 2.2.10). Lastly a subset of proteins were detected 
in ≥2 biological repeats in one cell line, and in 1 biological repeat in the other. Such proteins fell 
between criteria for “unique” or “differentially expressed” proteins in common between cell lines. They 
were therefore not taken forward for further analysis, but are provided in the appendix file.  
 
4.2.7 Data Storage, LOESS Normalisation and Extraction 
Database search results, as Final fragment.csv ion accounts, were exported from PLGS and loaded 
into a custom built MySQL database that stores data in a hierarchical structure, thus maintaining the 
experimental structure.  Peptide intensities derived from the same protein and identified in adjacent 
gel bands were summed prior to normalisation. Within-condition normalisation was conducted on 
summed peptide intensities, using a R-based script employing the loess {stats} function. Briefly, 
between-sample correlation was calculated and the sample with the highest average correlation was 
taken forward as the sample to which all were normalised. MA plots (log peptide intensity ratios vs 
mean peptide intensity) were calculated for all samples and a local regression line fitted. A weighting 
factor was calculated for each residual and applied to the dataset such that post normalisation the 
local regression fit is close to M= 0A. Data were extracted from the database using custom queries for 
post processing in R. Database construction was carried out by David Sutherland, Thalassinos lab, 
UCL.  
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4.2.8 Live Cell Microscopic Visualisation of Mitochondria 
To assess mitochondrial morphology, cultured CHO-K1 cells expressing M, NHK, or the common 
pathogenic Z (Glu342Lys) variants of α1-antitrypsin mutation were incubated with the MitoTracker Red 
stain M7512 Red CMXRos (Life Technologies, ThermoFisher, MA, USA) as per manufacturer’s 
instructions. Live cells were imaged on an incubated LSM710 laser point scanning confocal 
microscope (Carl Zeiss Ltd, Cambridge UK) and acquired with the Zen 2010 software using a 63x 
1.4NA Plan Apochromat objective lens. The experiments were repeated 3 times for each cell line. For 
quantitative analysis of mitochondrial morphology, mitochondria were selected in an automated 
manner and their sphericity scores calculated using Volocity (PerkinElmer, MA, USA) and Imaris 
(Bitplane, Zurich, Switzerland) software. All imaging was carried out by Charis-Patricia Segeritz, 
Cambridge Stem Cell Institute, Cambridge Institute for Medical Research.   
 
4.2.9 Unsupervised Hierarchical Clustering 
Pairwise comparisons between non-induced and induced samples of the same variant and between 
induced samples across variant were carried out to identify regulated proteins across the conditions. 
Proteins were taken forward for clustering if they were identified in all six conditions, by > 1 biological 
repeat per condition and were identified as regulated (p <0.05). Average intensities were calculated 
and log2 transformed prior to clustering. Unsupervised hierarchical clustering was achieved using the 
R function heatmap.2 {gplots}. The clustering method used was complete linkage.  
 
4.2.10 BLAST Alignment and Conversion 
CHO cell protein accessions were converted to human accession for downstream analysis by the 
Basic Local Alignment Search Tool (BLAST). An expect threshold of 10 was used as a threshold for 
acceptance of alignment. The median expect value for all proteins included in the search was 1x10
-
105
. Where more than one human protein was successfully aligned to a CHO protein, the alignment 
with the lower expect value was taken forward for analysis.  
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4.2.11 Enrichment Analysis 
Enrichment analysis was performed using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID, http://david.abcc.ncifcrf.gov/) [29]. Proteins identified in the non-induced M variant 
1-antitrypsin CHO cell line, post BLAST conversion were searched against a human proteome 
background to identify enriched biological process terms.  
 
4.2.12 STRING and Cytoscape Analysis 
Following conversion of accession information to human paralogues by BLAST search, proteins 
identified as regulated by >1.3 fold were submitted into the STRING database search tool 
(http://string-db.org/) to identify interaction networks [30]. Proteins upregulated were searched 
separately to those found to be downregulated.  All protein-protein interaction prediction methods 
were included in the search results. Protein-protein interactions with a confidence value of ≥ 0.7 (high 
confidence) were imported into cytoscape for visualisation [31]. Nodes were arranged by optimisation 
of the organic layout as provided within cytoscape. Clusters were defined using the ClusterViz 
application within which the EAGLE algorithm was applied [32].    
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4.3 Results 
 
4.3.1 Technical Overview 
CHO-K1 Tet-On cells that were stably transfected to synthesise M or NHK or Z α1-antitrypsin when 
induced by doxycycline treatment were assessed in the non-induced (M-, NHK- and Z-) and induced 
(M+, NHK+ and Z+) states, Figure 4.2A. Successful fractionation of the ER was indicated by 
clustering of the KDEL containing chaperones, Figure 4.2B. Moreover, the proteins that were 
identified were enriched for ER-associations relative to the probabilities of identifying them in a whole 
cell lysate Table 4.2. Highlighted are biological processes which present enrichment (p < 0.01 B-H 
corrected). A large majority of the process agree with the principle functions that occur within the ER, 
including protein translation, protein folding and protein transport, all which display high level of 
enrichment.  
The MS
E
 protocol showed good technical and biological reproducibility of quantitation following 
normalisation across data sets with R
2
 correlation values in log-log intensity plots of 0.75-0.85 and 0.7 
respectively, Figure 4.2D. The good biological reproducibility confirmed the validity of our fraction 
selection strategy. Whilst small shifts were apparent in the distributions of KDEL-positive fractions 
between biological replicates, these were very similar between all cell lines when all repeats were 
considered. Overall no systematic effects were therefore expected to influence our findings that are 
based on data incorporating findings from all repeats. On the other hand, strict pooling of identically 
numbered fractions in all repeats would have risked missing a proportion of ER-containing fractions 
on some occasions and varying enrichment of the pool for ER material overall. 878 proteins were 
identified for M-, 828 for M+, 884 for NHK-, 941 for NHK+, 719 for Z- and 684 for Z+, Figure 4.2E. 
After filtering based on replication, the false discovery rate (FDR) at the protein level was reduced to < 
1% and the peptide level FDR was found to be an average of 0.13%. 
 
 
Chapter 4. Subcellular Proteomics of α1-Antitrypsin in a Mammalian Cell Model of ER Stress and 
Disease  
[181] 
 
 
Chapter 4. Subcellular Proteomics of α1-Antitrypsin in a Mammalian Cell Model of ER Stress and 
Disease  
[182] 
 
Figure 4.2 Subcellular quantitative proteomic characterisation of ER response to α1-antitrypsin misfolding. A)  
Expression of M, NHK and Z α1-antitrypsin variants was induced with doxycycline in CHO-K1 cells transfected 
with Tet-On expression systems. Following cell lysis, density gradient centrifugation was used to separate 
organelles B) ER specific fractions were selected on the basis of SDS-PAGE/western blot positivity for ER 
resident chaperones containing KDEL motifs. Fraction numbers are shown at the top, migration of marker ladder 
indicated (left) with masses indicated in kDa, α1-antitrypsin transfection and induction states are labelled (right). 
Bracket below lowest western blot indicates fractions pooled for that fractionation.  C) Pooled fractions were 
separated by SDS-PAGE and digested with trypsin. The tryptic digest peptides were then separated by UPLC 
prior to analysis by the “data-independent” acquisition mass spectrometry method, MS
E
. D) To correct for 
instrumental variability between runs, LOESS normalisation was applied at the peptide level within conditions 
(left). Here M represents the calculated ratio between the same peptide, identified in different samples and 
plotted on a log2 scale (log2{P1/P2}). A denotes half the log2 value of peptide summed intensity 1/2log2(P1P2). 
Post-normalisation R
2
 values for technical repeats were 0.8-0.99 and 0.7 for biological repeats, based on log-log 
plots (right). E)  Left panel, qualitative comparisons between cell lines in terms of their ER-associated proteomes. 
Proteins identified as common between 2 cell lines were used for quantitative comparisons Right panel, α1-
antitrypsin n expression levels were successfully quantified in induced samples (M+, NHK+ and Z+) and agreed 
with expected levels from known cellular processing. Background leakiness was observed in the NHK- and Z- 
samples. Error bars shown are standard error of the mean (SEM).  
Relative quantitation was conducted on an identified protein if it was detected with a minimum of three 
peptides. Quantitative data post-normalisation is provided in the appendix file. Post-filtering, 87.6% of 
the proteins in the data set were quantifiable by these criteria. This high proportion reflects the 
benefits of using the more comprehensive approach afforded by the power of MS
E
 analysis (data-
independent approach) in comparison to a conventional workflow (where selected peptides are 
analysed using a data-dependent approach). Peptides that were unambiguously assignable to 
proteins were preferentially selected for quantification purposes. 
 
 
 
4.3.2 Analysis of Proteomic Profiles 
Qualitatively, differences in the studied ER-associated proteomes were indicated by different profiles 
of KDEL-containing chaperones observed on western blot analysis of the cellular fractions Figure 
4.2B. This suggested that total levels of protein disulphide isomerase (PDI) were increased when 
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NHK α1-antitrypsin was expressed, even at low levels Figure 4.2E, relative to the wild-type M protein. 
The effects were less pronounced when comparing Z variant expression to wild-type demonstrating a 
phenotypic difference between the two samples. Proteomic profiling allowed far more exhaustive and 
quantitative assessment. Subcellular α1-antitrypsin profiles were consistent with the known cellular 
handling of the three variants. Thus in the M+ system, minimal α1-antitrypsin was observed within the 
cell whilst expression of NHK α1-antitrypsin showed a signal of intracellular retention within the ER 
and cytoplasm Figure 4.2E  and Figure 4.3. Although not statistically significant the Z+ system was 
found to have further increased α1-antitrypsin levels which can be attributed to the retention of self-
ordered polymers that are not present in the NHK+ system. These findings are consistent with 
misfolded NHK and Z α1-antitrypsin recognition by the ERAD machinery and retrotranslocation into 
the cytoplasm. Background leakiness of the expression system was indicated by MS detection of 
NHK and Z α1-antitrypsin retention in the ER in the absence of doxycycline induction. It is likely that M 
α1-antitrypsin was produced at similar levels in the non-induced state, but not detected due to its 
highly efficient secretion from the cell. These data illustrate the superior sensitivity of the MS methods 
applied in this study relative to western blot analyses, which were unable to detect background α1-
antitrypsin levels present in NHK- cells, Figure 4.3. 
Comparison of data from the different cell lines allowed assessment of their similarity based upon the 
relative abundance of proteins identified in all 6 lines using hierarchical clustering Figure 4.4A. It was 
found that all non-induced samples clustered together, indicating low levels of cellular response in the 
presence of low α1-antitrypsin expression levels. Samples where the two misfolding variants were 
expressed, NHK & Z, were found to cluster together which is consistent with the variants activating 
common ER specific responses as a result of their misfolding. Interestingly the system expressing 
wild-type, M α1-antitrypsin showed the greatest divergence from all other samples. This is 
unsurprising as these samples represent basal levels of ER homeostatic mechanisms would not be 
expected to be as active in non-induced cells but will be highly regulated upon the expression of 
misfolding variants.     
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Table 4.2 Results from enrichment analysis of proteins identified by the LC-MS
E
 analysis of the CHO ER-associated 
proteome. Proteins queried were those detected in M- cells.  
 
Cluster analysis therefore successfully validated our approach where we focused our further analyses 
upon differences observed between M+, NHK+ and Z+ states to characterise responses to the 
misfolding variant relative to wild-type α1-antitrypsin that is efficiently secreted. Proteins were 
identified as unique to one or the other cell type, or common to both. The relative abundances of the 
latter group of proteins were then compared between the two states in terms of fold-change, and the 
statistical significance of the difference calculated. To determine cellular response that were unique to 
the two misfolding variants Z+ and NHK+ were directly compared using the same approach, Figure 
4.4B . 
Biological Process Term Number of Genes Percentage of Total P-Value FDR
translation 165 4.6 8.20E-33 2.30E-29
translational elongation 74 2.1 4.00E-29 5.60E-26
cellular respiration 59 1.7 2.60E-17 2.40E-14
cellular protein metabolic process 634 17.8 1.60E-16 7.60E-14
small GTPase mediated signal transduction 121 3.4 2.40E-14 1.30E-11
protein transport 240 6.7 2.80E-13 1.30E-10
respiratory electron transport chain 40 1.1 2.10E-12 8.20E-10
negative regulation of protein modification process 58 1.6 2.10E-11 7.10E-09
nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process 81 2.3 2.50E-11 7.70E-09
nucleobase, nucleoside and nucleotide biosynthetic process 81 2.3 2.50E-11 7.70E-09
ribonucleotide biosynthetic process 59 1.7 4.60E-11 1.30E-08
nucleoside phosphate metabolic process 108 3 1.30E-10 3.30E-08
negative regulation of cellular protein metabolic process 75 2.1 2.20E-10 5.10E-08
ATP synthesis coupled electron transport 34 1 3.70E-10 7.80E-08
positive regulation of ligase activity 40 1.1 5.40E-10 1.10E-07
negative regulation of protein metabolic process 76 2.1 6.50E-10 1.20E-07
protein folding 73 2 6.80E-10 1.20E-07
positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle 38 1.1 7.50E-10 1.20E-07
cellular protein complex assembly 68 1.9 1.20E-09 1.80E-07
nucleoside triphosphate biosynthetic process 49 1.4 1.70E-09 2.40E-07
purine ribonucleotide metabolic process 60 1.7 2.50E-09 3.50E-07
negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle 36 1 3.10E-09 4.10E-07
carboxylic acid metabolic process 172 4.8 4.30E-09 5.40E-07
mitochondrial electron transport, NADH to ubiquinone 27 0.8 6.40E-09 7.60E-07
regulation of ubiquitin-protein ligase activity 40 1.1 6.50E-09 7.50E-07
hexose metabolic process 75 2.1 6.70E-09 7.40E-07
purine nucleoside triphosphate metabolic process 54 1.5 8.20E-09 8.70E-07
negative regulation of ligase activity 36 1 8.90E-09 9.10E-07
cellular carbohydrate catabolic process 42 1.2 1.00E-08 1.00E-06
glucose metabolic process 63 1.8 1.20E-08 1.20E-06
acetyl-CoA metabolic process 22 0.6 1.80E-08 1.70E-06
hexose catabolic process 36 1 2.40E-08 2.10E-06
purine nucleotide biosynthetic process 60 1.7 5.50E-08 4.80E-06
monosaccharide catabolic process 36 1 6.10E-08 5.10E-06
mitochondrial transport 35 1 9.60E-08 7.80E-06
proton transport 32 0.9 1.40E-07 1.10E-05
intracellular protein transport 119 3.3 2.60E-07 2.00E-05
coenzyme catabolic process 18 0.5 9.20E-07 6.80E-05
Golgi vesicle transport 52 1.5 1.00E-06 7.40E-05
energy coupled proton transport, down electrochemical gradient 23 0.6 1.70E-06 1.20E-04
ATP synthesis coupled proton transport 23 0.6 1.70E-06 1.20E-04
ion transmembrane transport 26 0.7 2.10E-06 1.40E-04
phosphorylation 215 6 8.40E-06 5.70E-04
cytoskeleton-dependent intracellular transport 25 0.7 3.00E-05 1.90E-03
protein targeting to mitochondrion 19 0.5 3.00E-05 1.90E-03
nucleobase biosynthetic process 11 0.3 5.90E-05 3.70E-03
post-Golgi vesicle-mediated transport 26 0.7 8.30E-05 5.10E-03
protein polymerization 23 0.6 1.10E-04 6.30E-03
RNA processing 149 4.2 1.20E-04 7.00E-03
cell redox homeostasis 27 0.8 1.40E-04 8.30E-03
protein targeting 68 1.9 1.50E-04 8.20E-03
regulation of programmed cell death 209 5.9 1.90E-04 1.00E-02
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Figure 4.3  Western blot analyses of cell lysate fractions, probing for 1-antitrypsin in cells transfected with M or NHK 1-
antitrypsin. Cells were cultured in the absence (M-, NHK-) or presence (M+, NHK+) of doxycycline to compare non-induced 
and induced states with respect to 1-antitrypsin expression 
 
Some of the proteins identified in this way are database-annotated as ER-resident, whilst others have 
clear potential for some physical association with ER proteins, based upon their assigned functions. In 
the remainder, such associations could not be established from current annotation. This last category 
likely contains some proteins that localise to the ER in a manner that remains to be characterised 
and/or annotated in the protein database. The other proteins are likely to have co-fractionated for 
other reasons e.g. general upregulation of that protein within the cell, causing its increased 
representation across a wide range of cellular fractions. Analysis of the datasets using current 
annotation does not allow discrimination between these different options concerning apparently ‘non-
ER’ proteins co-fractionating with the ER at this time. However subcellular proteomics offers the ability 
to provide data on a scale not currently possible by other techniques and so it is an ideal workflow to 
provide enhanced cellular location annotation. Work by the Lilley lab is therefore highly 
complementary in this regard, since it combines fractionation of cell contents with multivariate data 
analysis to group proteins within compartments using the Localisation of Organelle Proteins by 
Isotope Tagging (LOPIT) approach [20]. For this study we were ultimately interested in understanding 
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the cellular response to α1-antitrypsin misfolding, albeit with a focus on upstream ER responses. We 
therefore elected to analyse change in the ‘ER-associated’ proteome as a whole. This approach 
allows ready application of future advances in understanding of protein behaviour to our published 
dataset. Moreover, it provided the potential to identify strong signals of other intracellular responses to 
misfolding for further study.  
Based on binary comparisons, Figure 4.4B, the expression of misfolding variants was observed to 
induce a number of statistically significant expression changes. Annotation of these expression 
changes will improve current knowledge of ER specific regulation of protein folding. When the two 
variants, NHK+ & Z+ are directly compared little difference was observed with few proteins being 
identified as being statistically significant. Our data, appears to identifying similar ER responses upon 
the expression of the two misfolding variants. Our work, therefore, focuses on the differences 
observed between the M+ and NHK+ cell lines. This is based on the results from the binary 
comparisons suggesting that the majority of our findings will be directly applicable to the Z+ cell lines.  
Proteins showing significant differences in abundance were assessed by two independent 
approaches. Network analysis related these proteins on the basis of previously described interactions 
between them, Figure 4.5, Figure 4.7 and Appendix F, while pathway analysis was based upon 
KEGG database annotation of each individual protein within different physiological pathways, Figure 
4.6 and Appendix G. 
STRING network analysis, Figure 4.5 and Appendix F, of the ER-associated proteome in cells 
expressing NHK compared with those expressing M α1-antitrypsin was conducted using stringent 
criteria. Data were then imported to Cytoscape for further analysis. Misfolding of NHK α1-antitrypsin 
induced increased representation of proteins interacting within six principal clusters, defined by the 
ClusterViz algorithm as implemented within Cytoscape, Figure 4.5 [31], [32]. Most of these clusters 
are directly relatable to control of protein load and misfolding within the ER. Cluster I (labelled Gold, 
Appendix F) comprises proteins 
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Figure 4.4 Quantitative pairwise comparisons of M+, NHK+ and Z+ expression levels. A)Unsupervised hierarchical 
clustering of regulated proteins, based on pairwise comparisons between all  conditions. B) Volcano plot of M+ vs 
NHK+, Z+ vs M+ and Z+ vs NHK+. Plot colours are representative of average Hi3 protein intensity for the most 
highly expressed protein from each binary comparison. Plot sizes are representative of the average number of 
unique peptides identified for each protein. Averages are calculated across the conditions and include 
redundancy from peptides identified in more than one gel band. Proteins whose expression data are plotted in 
the two upper outer quadrants indicated by the dotted lines are defined as differentially expressed. C) Log2 fold-
change for all proteins found in both M+ and NHK+ cells. Proteins defined as ER-specific by gene ontology 
annotation are highlighted in red   
capable of interacting with pre-mRNAs, and/or effects upon mRNA splicing, turnover and transport. 
These include serine/arginine-rich splicing factor (SRSF)7, small nuclear ribonucleoproteins (SNRPs) 
D1, D3 and E and heterogeneous nuclear ribonucleoproteins (HNRNPs) C, D, F, R, U & M. It also 
contains three heat shock proteins (HSPs, A8, A5 and A4) which act as repressors of transcriptional 
activity. These findings are consistent with the general principle that the ER stress response involves 
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modification of upstream elements controlling differential splicing and the rate of polypeptide 
synthesis for folding within the ER [23]. 
 
Figure 4.5 Protein-protein interaction network. Protein-protein interaction network (STRING) analysis for proteins 
with detected expression levels >1.3 fold higher in NHK+ (relative to M+). Only interactions with a score of ≥ 0.7 
are included. Interaction network layout is the yFiles organic setting as implemented within cytoscape. Colours 
denote clusters as calculated by the EAGLE clustering algorithm (ClusterViz plugin) [22]. I, Gold: mRNA 
handling. II, Red: Ribosomal subunits and translation initiation factors. III, Blue: Proteostasis and cytoskeleton. 
IV, White: Glutathione processing. V, Green: Bioenergetics. VI, Grey: Ubiquitin, Proteasome and α1-antitrypsin  
 
Similarly, Cluster II (labeled Red, Appendix F) consists of predominantly ribosomal proteins and 
translation initiation (and elongation) factors (eIFs) such as subunits of eIF2, 3, 4 and 5. It also 
includes GNB2L1 that can act as a repressor of translation. The same cluster also includes tumor 
protein, translationally-controlled (TPT)1 that plays a role in phenotypic reprogramming. Cluster III 
(Blue, Appendix F) represents proteins involved in chaperoning and degradation and cytoskeletal 
elements. The directly proteostatic elements include: valosin-containing protein (VCP)/p97, a ubiquitin 
segregase known to regulate both proteasome- and lysosome-mediated degradation of substrates 
from diverse sources [24]; 26S proteasome non-ATPase regulatory subunit 2 (PSMD2); the UPR 
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chaperone heat shock 70 protein 4; and prolyl isomerase FK506 binding protein (FKBP)4, a member 
of the immunophilin family involved in protein chaperoning and trafficking. It also contains actins and 
tubulins, raising the possibility that ER stress is coupled to increased interactions with cytoskeleton 
components. Cluster IV (White, Appendix F) consists of proteins involved in glutathione transferase-
mediated processes of disulphide bond manipulation in protein folding quality control including 
glutathione S-transferase P and microsomal glutathione S-transferase 1. Class V (Green, Appendix 
F) relates to bioenergetic pathway elements. These include proteins involved in glycolytic metabolism 
(phosphoglycerate kinase (PGK), pyruvate kinase M (PKM), gamma enolase (ENO2) and lactate 
dehydrogenase (LDH) A and B). Class VI (Grey, Appendix F) contains α1-antitrypsin and further 
proteostatic components, the proteasomal subunits PSMA 1,7,3,8 and PSMB 1,3,4,5, the ubiquitin-
related protein USP5.  
Pathway analysis confirmed NHK α1-antitrypsin misfolding was associated with generally increased 
levels of ERAD and UPR elements compared with normal folding of M α1-antitrypsin Figure 4.6A. In 
addition this approach reported a complex pattern of changes in ribosomal proteins Figure 4.6B, 
Appendix H) in the ER-associated proteome. Further pathway analyses of these processes are 
shown in Appendix G. However, significant alterations were again observed in proteins involved in 
metabolic processes and bioenergetics, Figure 4.7, and included contrasting changes of expression 
in mitochondrial and cytoplasmic pathways. Major increases were predominantly seen in glycolysis 
pathway components, while reductions were dominant in oxidative phosphorylation pathway 
components. More minor reductions were observed in proteins involved in the tricarboxylic acid cycle.  
Fewer proteins are specifically downregulated in relative terms as a result of switching from 
expression of M to NHK α1-antitrypsin expression and these cluster less distinctly, Figure 4.8.  
Interestingly, Rab proteins 1, 4, 5 and 14 are reduced, consistent with a reduction in ER- 
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Figure 4.6 Pathway analysis (KEGG) of NHK+ expression levels to M+: ER and ribosomal processes. A) Functional 
organisation of differentially-expressed proteins annotated as belonging to ER protein processing pathways. 
Colours of nodes indicate measured fold change. Where more than one protein accession was mapped to the 
same node, more than one colour is included within the plot. B) Bar plot of fold changes in expression of proteins 
annotated as belonging to the ribosomal complex 
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Golgi trafficking as a result of ER stress responses. A number of subunits of mitochondrial respiratory 
chain complexes I, II, III and V are also downregulated in cells expressing NHK α1-antitrypsin further 
pointing to alterations in bioenergetics processes, Mitochondria are key hubs of cellular metabolism 
and bioenergetic processes and play host to the tricarboxylic acid cycle and oxidative 
phosphorylation. Moreover mitochondrial dynamics are linked with alterations in redox homeostasis. 
Changes in bioenergetics are often associated with changes in mitochondrial function and 
morphology [8]. We therefore undertook live cell confocal microscopy of mitochondria in situ within the 
 
Figure 4.7 Pathway analysis (KEGG) of NHK+ expression levels to M+: Bioenergetics processes. Measured fold-change 
bar plot for proteins mapped to three bioenergetic pathways: the tricarboxylic acid cycle, oxidative 
phosphorylation and glycolysis pathways. The different pathways are affected in a non-uniform manner.  
 
CHO-K1 cells, Figure 4.9. These demonstrated dramatic changes in mitochondrial morphology 
between cells secreting well-folded, highly-secreted M α1-antitrypsin and those with high misfolding 
load of the NHK variant.  Mitochondria expressing wild-type M α1-antitrypsin were predominantly small 
and punctate, whilst fusiform, tubular mitochondria were prominent in the cells handling the misfolding 
variant. We next looked at cells expressing the more common Z variant of α1-antitrypsin. Z α1-
antitrypsin also misfolds, but to a less dramatic degree than NHK and additionally forms polymers. 
The mitochondrial network in cells expressing the Z α1-antitrypsin variant adopted a mixed  
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Figure 4.8 Protein-protein interaction network analysis (STRING) of proteins identified to be > 1.3 fold downregulated in 
cells expressing NHK α1-antitrypsin compared with cells expressing M α1-antitrypsin. Clusters have been manually curated 
to highlight networks that contain multiple proteins with similar functional roles. The interaction network is composed of 
interactions with at least a high confidence (Score ≥ 0.7, as defined by STRING) 
 
morphology including both tubular and punctate structures. We were able to quantify the change in 
mitochondrial morphology in terms of the mitochondrial ‘sphericity’ in all mitochondria that could be 
identified in 32 cells from each cell line using unbiased, automated image processing software. In 
agreement with our observations, whilst variability was observed, M+, Z+ and NHK+ cells showed 
highly significant differences between the different cell lines (p<0.0001) assessed pairwise (by t-test) 
or by ANOVA. 
Proteins that were successfully mapped during pathway analysis of the pairwise comparison of M 
induced cells and NHK induced cells were taken forward to include Z induced cell expression data. 
Proteins successfully mapped onto KEGG pathways and identified in all three conditions were 
analysed by unsupervised hierarchical clustering to identify expression patterns, Figure 4.11. 
Expression levels for proteins that were mapped to the ribosome complex or were identified as 
mitochondrion residing were found to be similar for the NHK and Z induced cells, with the two cell 
lines clustering together with M+ cell levels consistently being the most divergent.        
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Figure 4.9 Mitochondrial morphologies associated with switching expression from well-folding to increasingly misfolded 
variants of α1-antitrypsin. A: characteristic mitochondrial appearances associated with expression of each variant. B: left, 
example of automated analysis of mitochondrial morphology (maximal sphericity coloured entirely red and scored 1.0, 
more elongated structures heatmap coloured with increasing blueness and scoring lower for sphericity); right, box and 
whiskers (mean, interquartile range and standard errors) plot of sphericity scores for each variant. *** p<0.0001 
 
Binary comparison did identify a subset of proteins that displayed differential expression between 
NHK and Z variant induction and could therefore represent signatures of unique ER . The tubulin 
protein, Tubulin alpha-3-chain, was identified as being the most statistically significant expression 
change in addition to being largest fold increase in the Z variant induced cells (> 20 upregulated). 
Analysis of its expression levels in the M variant induced cells found 9 times higher than NHK induced 
cells (P=0.0015) but not a significant difference between Z and M cells (x 3.4 up in Z, p=0.14). The 
detected changes are likely to be associated with the detected changes in mitochondrial morphology.  
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Figure 4.10 Protein intensity heatmap for expression levels detected in cell lines expressing M , NHK and Z α1-antitrypsin. 
Proteins have been mapped as ribosomal proteins or mitochondrial proteins by pathway analysis. Hierarchical clustering 
was performed based on detected protein levels.     
 
Proteins that had been identified as having significant difference between NHK induced and Z 
induced cells were analysed by gene ontology to identify biological processes that were well 
represented Figure 4.11A. Six out of seven proteins involved in translation were upregulated in Z 
induced cells, Figure 4.11B, including the elongation factor1-gamma which is responsible for the 
delivery of aminoacyl tRNAs to the ribosome and may be involved in tethering the assembly of 
multisubunit complexes. Similarly upregulated were proteins involved in oxidation reduction Figure 
4.11C, suggesting an increase in oxidative stress upon Z variant misfolding.     
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Figure 4.11 Gene ontology annotation of proteins identified as differentially expressed in pairwise comparison of NHK α1-
antitrypsin and Z α1-antitrypsin induced cells. A) Biological process annotation of differentially expressed proteins, number 
of proteins mapped to each process shown in white. B) Measured fold change of proteins involved in translation. C) 
Measured fold change of proteins related to oxidation reduction.      
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4.4 Discussion 
 
ER stress responses maximally activate protein folding quality control pathways that are of 
fundamental importance to eukaryote biology[33], and are increasingly implicated as common 
pathways activated within diverse disease states. The CHO cell system is one of the most commonly 
used experimental models of mammalian cells. Moreover, the synthesis and appropriate folding of 
high volumes of secreted proteins in CHO cells is also important to biotechnology industries [34]. M 
α1-antitrypsin is one of the most highly secreted proteins in the human body, and the NHK variant is 
widely used as an experimental trigger of ER stress responses. While whole cell studies, including 
proteomic approaches can provide valuable data, ER-focused studies are enriched to assess direct 
responses to protein misfolding within that compartment. Our approach is further complementary to 
classical cell biology studies as it informs upon changes that persist after accounting for expansion of 
the ER compartment as a whole. While it enhances changes in terms of ER-localised proteins this 
approach appears similarly capable of highlighting alterations within the mitochondrial compartment, 
and reporting major changes in cytosolic proteins. 
The changes in ER proteins that we have identified between states associated with folding of these 
variants are plausible based upon existing knowledge, while providing new insights. Thus it is 
consistent that numerous elements of the ER quality control machinery for handling misfolded 
polypeptides are found in higher abundance in the cells expressing NHK than M variants. Within the 
ER these include ERp57, calreticulin, UDP-glucose:glycoprotein glucosyltransferase (UGGT) and 
cytoskeleton-linking membrane protein of 63kDa (CLIMP-63) that regulates Dicer [35]. They also 
include the interacting chaperones BiP (Heat Shock Protein (HSP)70 family member), nuclear 
exchange factor (NEF), and glucose regulated protein (GRP)94 (the ER-resident HSP90 family 
member) that interact together. Levels of the ER-associated HSP40 protein DnaJ-like subfamily B 
member (DnaJB)11 that co-chaperones with BiP and GRP94 is also detected and is stable between 
cells expressing both M and NHK α1-antitrypsin. As detailed above, BiP biology is critical in both 
chaperoning protein folding in the ER and mediating the UPR in the face of misfolding and 
proteostatic challenge. The coupling of BiP to the nuclear exchange factor SEL1 facilitates substrate 
release. However the proteins that are increased within the ER-associated proteome in the context of 
NHK α1-antitrypsin expression that are mapped as NEFs (accession numbers G3I973 and G3GWF4) 
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appear closest to members of the HSP105/110 class of chaperones. Whilst they contain nucleotide 
binding domains and associate with HSP70 and HSP40 chaperones, it is not clear whether they are 
mainly functioning as nucleotide exchange factors. Indeed they have been recently shown to 
represent the mammalian functional counterpart, [36], of the HSP104/ClpB disaggregase family in 
yeast and bacteria. When associated with HSP70 and HSP40 family members such proteins have the 
ability to disassemble protein aggregates including amyloid [37], [38]. Reference to pathway analysis 
identified hypoxia upregulated protein 1 (3.4 fold high in NHK+, p value < 0.05) and HSP105 fragment 
(uniquely identified in NHK+ system) as being directly mapped to NEF within the ‘Protein processing 
in the ER’ KEGG pathway. Sequence alignment of hypoxia upregulated protein 1 against human 
HSP105 validated the mapping results with a sequence identity of 27%, Figure 4.12. Taken together, 
these changes in the ER-associated proteome therefore suggest that expression of NHK α1-
antitrypsin may predispose to the formation of non-polymeric aggregates that are then degraded by 
the BiP(HSP70):DnaJB11(HSP40):NEF(HSP110) system. Interestingly a similar response was 
observed upon Z α1-antitrypsin misfolding (2.8 fold increases, p value < 0.005). Z variant is known to 
form well order polymer aggregates and the regulation of disaggregase associated proteins in 
response is not unexpected.     
This pathway classification also includes proteins that act at the cytoplasmic side of the ER 
membrane and beyond this into the cytosol. The translation initiation factor eIF2α and some 
cytoplasmic ERAD response factors are observed, suggesting that proteins that interact transiently 
with ER membrane bound proteins may be detected by this approach. The β-subunit of cytosolic 
HSP90 is particularly highly upregulated in the latter category. While the detailed significance of this 
requires elucidation, cytosolic HSP90 is implicated in stabilisation of the UPR factor IRE1 [39]. 
A complex ribosomal protein response to α1-antitrypsin misfolding is reported. This likely reflects 
changes in the composition of rough ER-associated ribosomes. In general translation of polypeptides 
into the ER is reduced in ER stress as a compensatory mechanism. The increase in many ribosomal 
proteins in the ER-associated proteome of cells expressing NHK α1-antitrypsin relative to the wild-type 
protein was therefore unexpected. The observed changes might conceivably contribute to reduce 
translation rates of mRNAs encoding secreted proteins. Such selective upregulation of ER stress-
modifying proteins is evident in our data reporting increases in chaperone elements. Additionally, the 
synthesis of some UPR targets is preserved in ER stress or, as in the case of ATF4, enhanced. The  
Chapter 4. Subcellular Proteomics of α1-Antitrypsin in a Mammalian Cell Model of ER Stress and 
Disease  
[198] 
 
 
Figure 4.12 Sequence alignment of hypoxia upregulated protein 1, as identified from the Chinese hamster protein database 
(Uniprot) with human heat shock protein 105.   
role of altered ribosomal protein abundance has yet to be examined in these responses, but our data 
indicate it deserves further analysis. Another consideration is that the co-elution of mitochondrial-
residing proteins, which could potentially include ribosomal proteins, may be producing the complex 
response observed. Mitochondrial ribosomal elements may differ from those that make up the rough 
ER. In order to confirm this whole cell analysis would be required. In addition to proteins that are 
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clearly defined as ‘ER resident’ these studies also indicate changes in other proteins that are 
associated with the ER-containing fractions but seem unlikely themselves to be physically included 
within or attached to the ER. These include proteins involved with mRNA processing. The observed 
mitochondrial changes could relate to changes in the direct interactions between mitochondria and 
the ER as well as changes within mitochondria. Intimate physical and functional links exist between 
the ER and mitochondria, including machinery related to mitochondrial dynamics such as mitofusin 
(Mfn)2, dynamin-related protein (Drp)1 and mammalian mitochondrial Rho (Miro)1.[40] Acute ER 
stress has been demonstrated to stimulate an adaptive increase in mitochondrial respiration, 
promoting cell survival [41]. Moreover, prolonged activation of the ER stress pathway may induce 
mitochondrial dysfunction and apoptosis [42]. The morphological changes we observed in 
mitochondria indicate that the balance of fusion and fission events in the mitochondrial network is also 
affected by the expression of the NHK-variant relative to wild-type M α1-antitrypsin. We therefore 
hypothesise three different and potentially co-existing mechanisms may underlie this element of 
cross-talk between ER protein folding pathways and the dynamics of mitochondrial turnover, Figure 
4.14. Firstly, the ER plays a physical role in at least some mitochondrial fission events [43]. The ER 
stress response is known to streamline its functions to relieve the proteostatic challenge, reducing 
polypeptide synthesis in general and increasing chaperone levels [33]. Changes in the ER proteome 
may therefore also reflect an altered contribution to mitochondrial fission. 
Secondly the difference in mitochondrial morphology between high secretion and misfolding contexts 
may reflect different bioenergetic requirements within the cell. Indeed, overall the data support a shift 
of cellular metabolism from oxidative phosphorylation towards increased glycolysis. In addition the 
UPR/ER stress response alters energetic demands within the ER to focus energy utilisation upon 
alleviation of proteostatic load. Alterations in redox state, that may relate to the changes in levels of 
enzymes involved in disulphide-bond formation and glutathione processing, can also modify 
mitochondrial morphology [44].  
Additionally, mitochondrial stress responses may play a role. Unresolved ER stress may lead to 
apoptosis, and typically involves autophagy, including mitochondrial autophagy (mitophagy). During 
mitophagy, damaged mitochondria are incorporated into autophagosomes and targeted for 
degradation. However under conditions of cellular stress, healthy mitochondria may undergo an 
adaptive fusion response, sparing them from autophagic degradation and promoting cell survival.  
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Figure 4.13 Potential mechanisms for alterations in mitochondrial morphology with α1-antitrypsin misfolding vs secretion 
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Such alterations in mitochondrial morphology are consistent with our observations of a shift towards 
elongated mitochondria accompanying chronic ER-stress in NHK-variant expressing cells. It is 
possible that the changes in mitochondrial morphology also relate to the associated increases in 
cytoskeletal elements that we observe.  
To explore the wider disease relevance of this process we also imaged mitochondria in the CHO cell 
model of Z (Glu342Lys) α1-antitrypsin expression. This is a far more common deficiency variant than 
NHK α1-antitrypsin, its clinicopathological consequences have been studied more extensively. The Z 
variant misfolds to a lesser degree than NHK α1-antitrypsin with ~70% of synthesised Z α1-antitrypsin 
undergoing degradation by ERAD in cell models [45]. However around 15% of the synthesised Z α1-
antitrypsin polypeptides fold sufficiently to self-associate into ordered chains of α1-antitrypsin 
polymers. In hepatocytes, and in CHO cells these are retained within the ER. The remaining material 
is secreted. Polymer accumulation within inclusion bodies is believed to mediate hepatic toxicity. It is 
associated with a lowered threshold to ER stress in the context of a second stimulus, but does not 
directly activate the UPR in CHO cells or hepatocytes.  The CHO cell model recapitulates the ER 
accumulation of Z α1-antitrypsin (~15%) that avoids ERAD, but has aberrant conformational behaviour 
resulting in self-association to form polymer chains rather than secretion. The mitochondrial 
phenotype has not been characterised in these cells to date. However, ex vivo samples of hepatic 
tissue from PiZ mice and human patients demonstrate evidence of an increased mitochondrial 
autophagy response.[46] Moreover, studies using a hepatoma cell line expressing Z α1-antitrypsin 
demonstrated a mitochondrial damage response that could be abrogated by boosting ERAD. These 
data suggested that proteostatic load and/or polymerisation contributed to mitochondrial damage and 
mitophagy in Z α1-antitrypsin deficiency. ER accumulation of serpin polymers is known to trigger 
specific ER responses rather than the classical UPR, suggesting that the presence of polymers 
directs subcellular responses independently of protein misfolding per se. Nevertheless our data 
demonstrate a correlation of genotype to mitochondrial phenotype from PiM to PiZ to PiNullHongKong 
that matches the degree of proteostatic challenge rather than the potential to form polymers. 
Specifically mitochondria in cells expressing Z α1-antitrypsin showed more mixed fusiform and 
punctate morphologies, giving sphericity scores intermediate between the M and NHK expression 
models, but significantly different from either.   
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These phenotypic changes may have potential as live cell readouts of α1-antitrypsin misfolding versus 
folding and secretion, amenable to automated quantification in high throughput compound screens for 
drug discovery. This would first require specific validation for this application. In particular, studies 
would need to ascertain whether shifts of mitrochondrial morphology in response to treatment did in 
fact correlate well with reduced proteostatic challenge and/or dysfunctional consequences. In cell 
models of Z α1-antitrypsin deficiency, it would also be important to assess how such changes 
correlated with alterations in ER polymer load since these appear to have toxic properties relevant to 
the development of liver disease. 
Reductionist studies have been used to good effect to characterise the cellular responses to NHK and 
Z α1-antitrypsin misfolding including those unique to each variant. Proteomic analysis allows the 
identification of cellular responses in a more unbiased and high-throughput manner. In this study we 
hoped to use the approach to better define the differences in ER specific responses. Surprisingly our 
data only identified a small subset of proteins that were significantly changed between the two 
variants. Stress responses induced upon NHK misfolding and detected by our workflow were on the 
whole recapitulated in cells expressing the Z variant. Our data therefore suggests that NHK and Z α1-
antitrypsin misfolding promotes ER stress responses to a more similar extent than reductionist studies 
have found. Mass spectrometry-based proteomic studies, despite continued improvements in 
instrument speed and sensitivity are still limited in the depth proteins that can be quantified from a 
biological sample and this study is no exception. As the ERAD response is the primary response 
element to unfolding in the ER and is known to be common between NHK and Z variants, expression 
changes induced by the ERAD may be preferentially detected. Being the primary unfolding response, 
it would be expected that many of the proteins directly involved in the ERAD response would be 
highly expressed. Indeed based upon Hi3 intensity BIP is the second most highly expressed protein 
detected in the NHK variant induced cells. Our results therefore may be a result of inadequate 
dynamic range to probe other ER specific cellular responses that may involve lower abundance 
proteins. The use of new instrumentation with higher sensitivity and dynamic range, increased protein 
level fractionation or a combination of both would help improve the depth of coverage and help better 
identify cellular responses unique to the misfolding of the two variants. 
Although limited, a small set of proteins were identified as differentially regulated between the two 
conditions. Tubulin alpha-3-chain, the most significant of the changes detected could be related to 
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mitochondrial morphology changes however expression levels better correlate to the expressed 
variants ability to form ER residing polymers (8-fold higher NHK+, 26-fold higher Z+). This raises the 
possibility that Tubulin alpha-3-chain, which is known to be involved in protein polymerization directly 
associates with the polymer form of α1-antitrypsin. Another notable upregulated protein was 
calumenin, an ER residiing calcium-binding protein. It is known to play a role in protein folding and 
protein sorting and importantly has been shown in mice to alleviate ER stress as monitored by 
reduced levels of ER stress markers GRP78, PERK and CHOP. Calumenin is upregulated in 
response to NHK α1-antitrypsin misfolding(3-fold increase) but is upregulated further still in response 
to Z variant expression (4-fold increase). Our data therefore suggests that calumenin could be a 
marker for the ER overload response which is known to be activated to a far higher degree by Z 
variant misfolding. 
Proteins involved in translation, including both ribosomal proteins and translation initiation factors 
were in general found to be more abundant in cells expressing Z α1-antitrypsin. Interestingly one 
these proteins EIF1γ is involved in protein assembly and folding as it possess a glutathione-S-
transferase domain. Why the formation of Z polymer would induced this change is unclear.  
Oxidative reduction-related proteins showed a similar trend for upregulation in Z variant inducing cells. 
Data available for other misfolding diseases, such as Alzheimer’s disease, provides evidence towards 
one of the toxic mechanisms of protein aggregation being the generation of reactive oxygen species 
(ROS). Upregulation of proteins involved in oxidative reduction could represent a protective 
mechanism induced upon Z polymer formation. The upregulation of superoxide dismutase in 
particular could be a major protective element. It has been shown previously in a mouse Alzheimer’s 
disease model that the overexpression of SOD-2, reduces AD pathology.       
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4.5 Conclusion 
An ER focused label-free quantitative proteomic workflow has been developed to obtain expression 
data on ER stress responses to the misfolding of two α1-antitrypsin variants relative to basal levels 
upon wild-type α1-antitrypsin expression in CHO cells. Overall, our findings validate a focused, 
systematic approach that provides a general context for understanding proteomic correlates of 
misfolding responses as defined by classical reductionist cell biological studies in this widely used 
model of ER stress. Expected responses, including the upregulation of the well characterised 
molecular chaperones upon NHK α1-antitrypsin induction were quantified. Further to this, previously 
uncharacterised ER responses were quantified, including a complex ribosomal expression pattern 
that represents a new resource for identifying ER stress related targets in reductionist studies. 
Interestingly NEF, a member of the HSP 105/110 family which has been implicated as a functional 
counterpart of the bacterial HSP104 disaggregase was found upregulated in both NHK and Z α1-
antitrypsin induced cells.  15% of expressed Z α1-antitrypsin is known to form ordered polymers in 
hepatocyte ER, however polymers are not observed for NHK α1-antitrypsin. Our findings present the 
possibility that NEF as part of the HSP70-HSP40-HSP110 system are able to dissemble early non-
polymeric aggregates. Such findings demonstrate that this approach can provide novel mechanistic 
insights relevant to misfolding diseases. 
A known limitation of the use of a gradient density for ER residing proteins is the co-elution of 
organelles with similar densities, namely the mitochondria. Despite being a known contaminant, the 
large observed fold change measurements in the data lead us to conduct live cell confocal imaging of 
mitochondrial was conducted on CHO cells expressing the three α1-antitrypsinvariants. Mitochondrial 
morphological changes, which have not been previous reported in the context of ER stress, were 
observed when the two misfolding variants were expressed. Interestingly a statistically significant 
difference was observed between all three cell lines, indicating the degree/type of misfolding effects 
mitochondrial response. We propose three possible mechanisms that could change the balance of 
mitochondrial fission/fusion. Firstly streamlining of ER functions upon increasing proteostasis 
challenge may reduce the role it plays in mitochondrial fission events. Secondly changes in the 
balance of secretion and misfolding may present different bioenergetic cellular requirements, which 
are subsequently represented by changes in mitochondrial fission/fusion events. Lastly, chronic ER 
stress is known to trigger apoptosis including autophagy. It has been previously demonstrated that 
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mitochondrial elongation is able to prevent mitophagy and promote cell survival [47] Mitochondrial 
morphological changes could be a result of an adaptive fusion response to increased apoptosis. 
Interestingly we observed the degree of mitochondrial elongation was directly relatable to the degree 
of protein misfolding but does not appear to be affected by protein polymerisation. These findings are 
amenable to further interrogation and hypothesis refinement in future studies. A major element of 
such work will be to define the proteins involved in processes of molecular cross-talk between protein 
misfolding within the ER and mitochondrial behavior. These may relate to the disease mechanism 
and/or ameliorative responses in α1-antitrypsin deficiency. If indeed these morphological changes are 
validated, most likely in a further range of α1-antitrypsin variants, an interesting prospect would the 
use of our findings as a relatively fast functional read out for drug binding studies.  
Recently it was demonstrated that an approach integrating ion mobility mass spectrometry and 
nuclear magnetic resonance (NMR) can be used to screen small-molecule ligands that confer 
thermodynamic stability to α1-antitrypsin misfolding variants [48]. By monitoring conformational 
flexibility upon ligand binding in the presence of increasing collisional energy the efficacy of small 
molecules can potentially be screened in a high throughput manner. By the further incorporation of a 
measure of mitochondrial morphology into the screen approach, the in vivo effects of ligand binding 
on the extent of protein misfolding could be reported. It would be expected that the introduction of this 
extra information should increase the confidence of small molecule drug efficacy.    
Limited differences in ER responses were detected between the two misfolding variants, Z and NHK 
α1-antitrypsin. This is most likely to be a combination of the ERAD response being the predominant 
protein signature being activated by the induction of misfolding α1-antitrypsin variants and the limited 
coverage achieved by our instrumentation. Future studies with current generation technology and, if 
necessary extensive fractionation, will increase proteome coverage to an extent that close to 
complete coverage of the ER proteome can be characterised. Using such an approach lower 
abundance stress response such as the ER overload response could be successfully characterised to 
an extent not previously achieved. More extensive coverage would provide better information for 
correlating observed mitochondrial morphological alterations with ER stress signatures and should aid 
our understanding of its biological significance.     
Proteins involved in translation and oxidative reduction were well represented in the subset of proteins 
that were differentially regulated. Increases in proteins involved in oxidative reduction are seen in 
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other misfolding diseases where polymer aggregates are formed and could suggest the aggregation 
of Z α1-antitrypsin is associated with an increase in reactive oxidative species. Oxidative species are 
known to cause cellular damage in a wide variety of disease contexts and increased levels can even 
result in cell death. Our findings may present a pathological pathway from α1-antitrypsin polymer 
formation to in vivo hepatocyte damage in A1ATD.   
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5.0 Conclusions 
 
5.1 Project Summary 
 
Correct protein folding is essential for proper cellular function. Numerous protective mechanisms exist 
for maintaining protein fold homeostasis [1], [2]. Despite this the misfolding, oligomerisation and 
subsequent accumulation of proteins within tissue is common to a wide range of chronic diseases. 
Misfolding diseases account for the majority of neurodegenerative disorders and many of these are 
associated with ageing. The link between protein misfolding and ageing is, however, not fully 
understood. With an ever increasingly aged population the socioeconomic burden of increased 
neurodegenerative disease prevalence is poised to escalate [3], [4]. Better understanding of the 
association between ageing and neurodegeneration is key to developing treatments for late-onset 
Alzheimer’s disease. Ageing, however, is not the only factor that can contribute to the development of 
misfolding diseases. Indeed polymorphisms have been identified that lead to a number of 
neurodegenerative diseases [5], [6]. The serpinopathies, which includes α1-antitrypsin deficiency 
(AATD), is a class of disease caused by the misfolding of a serpin protein [7]. The serpinopathies are 
of interest because genetic variants that induce gross misfolding represent the aetiology of the 
disease.  
Label-free quantification is emerging as a powerful mass spectrometry-based proteomic tool for 
studying complex disease states. Improvements in mass spectrometry sensitivity and resolving 
power, alongside improved liquid chromatography peak capacity and robustness now means that 
label-free quantification precision is now closely comparable to label-based methods [8], [9]. Benefits 
of label-free quantification include ease of implementation, low relative cost and importantly the ability 
to compare an unlimited number of samples. 
Initially quantitative proteomics, GeLC-MS
E
 analysis, was undertaken as a follow-up, unbiased, 
approach to investigate previously published data demonstrating an age-related vulnerability to Aβ42 
toxicity (Chapter 2). The experimental design allowed the identification of differentially expressed 
proteins in the context of ageing and Aβ toxicity. The approach successfully identified proteins 
previously implicated in AD but provided previously unknown information on protein specific 
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responses to ageing in the presence of Aβ42 toxicity. Data identified chaperoning proteins and small 
GTPase-related proteins as interesting biological targets for follow-up functional studies. Based on 
results from this project, D. melanogaster genetic lines have been obtained to identify the functional 
consequence of differentially expressed proteins, initially in terms of lifespan and climbing 
phenotypes.        
Since its development, and subsequent integration into a commercial instrument, ion mobility mass 
spectrometry (IMMS), has become an effective tool for studying protein and protein complex 
geometries [10]–[12]. Recently the separating capacity of IM was extended to proteomic analysis and 
has been shown to increase protein identification rates > 50% without an increase in analysis run 
time. Using this new technology, HDMS
E
, a second orthogonal project was undertaken to better 
understand the link between ageing and AD. The increased identification rates afforded by HDMS
E
 in 
comparison to MS
E
 allowed a more comprehensive comparison of wild-type ageing and chronic Aβ 
induction (Chapter 3). Quantitative time-course analysis of D. melanogaster ageing with and without 
the induction of an aggregating variant of Aβ42 successfully identified differentially expressed proteins 
that were attributed to either ageing, Aβ42 toxicity or resulted from a combination of both conditions. 
Cluster analysis, gene ontology enrichment and protein-protein interaction analysis were all used to 
consider the biological significance of the quantitative data. Alterations in mitochondria, metabolic 
function, translation control and detoxification pathways were all well represented in our data. 
Pleasingly parts of our data were successfully validated by comparison with the previous proteomic 
approach (Chapter 1), recently published proteomic data [13] and recently published transcriptomic 
data [14]. 
Protein misfolding is known to activate a variety of cellular stress responses. AATD’s activation of 
different endoplasmic reticulum (ER) stress responses has been previously characterised, in-part, by 
reductionist studies. Using the increased coverage provided by label-free quantification we used 
GeLC-MS
E
 analysis, combined with subcellular enrichment of the ER, to characterise the ER enriched 
response to the misfolding of two α1-antitrypsin variants in Chinese hamster ovary (CHO) cells. Data 
were directly compared to the ER response of the expression of the well-folded wild-type variant 
(Chapter 4). Stress responses quantified included those known to participate in the ER associated 
degradation (ERAD) and unfolded protein response (UPR) pathways. Interestingly, co-fractionating 
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proteins associated with bioenergetics were found to display large fold changes. In vivo confocal 
imaging of mitochondria in the presence of misfolded α1-antitrypsin successfully correlated the 
observed fold changes with mitochondrial morphological alterations. The results from this project 
represent novel findings and implicate mitochondrial dysregulation upon chronic ER stress. 
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5.2  Future Directions          
Mass Spectrometry-based proteomics has, in recent years, seen dramatic improvements in 
acquisition speed and sensitivity. The identification and quantification of whole proteomes is no longer 
the impossible task it once seemed [15], [16]. This, alongside the continued developments in label-
free quantification, which can be applied to any sample type, means that mass spectrometry has 
cemented its position as the most effective analytical technique for dissecting complex cellular 
processes and systems. 
One particular area that has seen recent development is data independent acquisition (DIA), which 
aims to reduce the intensity bias that is inherent in traditional data dependent acquisition (DDA) 
methods [17]–[19]. Due to the high levels of precision and its ability to quantify large numbers of 
proteins in relatively short run times, SWATH in particular, is being heavily adopted by biomarker 
discovery labs as a replacement for immunoassay techniques during the validation stages of the 
discovery workflow. This is a good example of the increasingly large push towards replacing 
traditional immunoassay-based validation techniques such as Western blotting with mass 
spectrometry-based assays [20]. Indeed acquisition modes including SRM, pseudo SRM, PRM and 
now DIA offer higher sensitivity, precision and specificity than Western blotting assays. The ease of 
DIA implementation and the increasing number of software tools being developed to aid quantification 
means we could soon begin to see the routine adoption of mass spectrometry as the method of 
choice for protein quantification validation.  
Despite improvements in mass spectrometry technologies, the challenges facing discovery 
proteomics are still large. Label-free quantification has helped increase the amount of information that 
can be obtained from analytical runs but the data is only capture a subset of the proteome present in 
a sample [21]. The development of label-free methods for absolute quantification is a perfect example 
of where mass spectrometry can now, with relative ease, provide accurate quantitative data where 
previously the assay would have been complex and expensive [22], [23]. A recent paper, however, 
demonstrated how much information is still discarded from most discovery proteomic experiments. 
Work by J.M. Chick and co-workers demonstrated, with the use of a mass-tolerant database search 
approach, that the vast amount of unmatched MS/MS spectra originate from unidentified post 
translational modifications (PTMs) [24]. This novel approach to data analysis was able to identify large 
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numbers of PTMs and amino acid variants but was still unable to assign all spectra with confident 
identifications. As mass spectrometry-based proteomics moves towards a meta-analysis approach of 
cataloguing proteomes and mass spectrometry data becomes ever more comprehensive, novel 
computational methods such as those by J.M Chick and colleagues will be an increasingly important 
tool towards the routine identification and quantification of all PTMs, single nucleotide polymorphisms 
(SNPs) and other chemical variants present. 
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APPENDIX A  
R script for LOESS peptide level normalisation 
 
MSdata <- read.csv('test data for MA3.csv')  # read in peptide intensity matrix 
MSdata[MSdata == 0] <- NA   # replace 0 values with NA 
cor <- cor(MSdata, use= 'complete') 
coravg <- colMeans(cor, na.rm=T)   # calculate average correlation 
coravg1 <- as.matrix(coravg) 
ref <- which.max(coravg1[,1])   # record which  column to which all other are 
normalised 
 
M <- matrix(nrow=nrow(MSdata), ncol=(ncol(MSdata))) { 
 for (i in 1:ncol(M)) {M[,i] = log2(MSdata[,ref]/MSdata[,i])  # calculate M values 
} 
A <- matrix(nrow=nrow(MSdata),ncol=ncol(MSdata)) { 
 for (i in 1:ncol(A)) {A[,i] = log2(0.5*(MSdata[,ref]*MSdata[,i])) # calculate A values 
} 
 
Mcor <- matrix(nrow=nrow(M),ncol=ncol(M))    # loess regression 
for(i in 1:ncol(M)){ 
 l <- loess(M[,i]~A[,i]) 
 pred <- predict(l,A[,i]) 
 Mcor[,i] <- pred 
} 
 
Mnew <- matrix(nrow=nrow(M),ncol=ncol(M))   # calculate normalised M values 
for (i in 1:ncol(M)) { 
 Mnew[,i] <- M[,i]-Mcor[,i] 
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}       # back calculates normalised intensities 
MSnormintensity <- matrix(nrow=nrow(M),ncol=ncol(M))      
        
for(i in 1:ncol(M)) { 
 MSnormintensity[,i] <- PeptideIntensity[,1]/2^(Mnew[,i]) 
} 
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Appendix B 
 
Quantification of total Aβ42 in four different conditions and five different batches of an inducible D. 
melanogaster AD model (Chapter 2) 
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Appendix C 
 
Tabulated results from binary comparison (Chapter 2) 
Old + / Old - 
Accession Protein Function 
Fold 
(34P/34M) 
Effect Size 
(Cohen's d) 
P value 
Q9W3L4 CG2233 Unknown 0.49 1.98 0.00039 
P29844 
Heat shock 70Kda protein cognate 
3 
Assembly of multimeric protein 
complexs inside ER 
1.47 1.13 0.00069 
Q7JWQ7 CG3074 
Immune response and 
proteolysis.Belongs to peptidase 
C1 family 
2.24 2.16 0.00287 
P25228 Ras-related protein Rab-3 
Exocytosis. Neurotransmitter 
release 
0.6 1.49 0.0043 
Q961R8 Glycyl-tRNA synthase Aminoacyl-tRNA synthase 1.56 1.3 0.00559 
P22700-2 
Calcium-transporting ATPase 
sarcoplasmic/endoplasmic 
reticulum type 
Catalysis of ATO hydrolysis 1.84 1.72 0.00768 
   
 Old - / Young – 
Accession Protein Function 
Fold (34d-
/19d-) 
Effect Size 
(Cohen's d) 
P value 
P33438 Glutactin Calcium Binding 1.49 1.18 
0.00147577
4 
Q9W3L4 CG2233 Unknown 2.30 2.22 0.00247914 
B7Z061 
Photoreceptor 
dehydrogenase 
Oxidoreductase 0.59 1.51 
0.00368765
4 
P40417-3 
Mitogen-activated protein 
kinase ERK-A 
Signal transduction pathways 0.55 1.68 
0.00374100
4 
Q9U915 Adenylate kinase 
Cellular energy homeostasis 
and metabolism 
0.70 1.06 
0.00380722
7 
Q0E9G4 CG1600 Oxidoreductase 0.55 1.67 
0.00655227
5 
 
Old + / Young + 
Accession Protein Function 
Fold 
(34d+/19d+) 
Effect Size 
(Cohen's d) 
P value 
Q961R8 
Glycyl-tRNA 
synthetase 
Aminoacyl-tRNA synthetase 1.53 1.25 0.0002925 
Q95028 
L-lactate 
dehydrogenase 
Glycolysis 0.47 2.07 
0.00747528
1 
O62530 
Clathrin-associated 
protein AP2 (AP50) 
Protein transport. 
Neurotransmitter secretion 
0.61 1.42 
0.00929865
1 
Q7K084 RH04549p 
Sensory perception of chemical 
stimulus 
0.68 1.11 
0.01020011
6 
Q960M4 Peroxiredoxin 5 Oxidoreductase 1.64 1.43 
0.01078998
7 
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Young + / Young – 
Accession Protein Function 
Fold 
(19P/19M) 
Effect Size 
(Cohen's d) 
P value 
P29844 Heat shock 70 kDa protein cognate 3 Chaperone 2.06 1.99 2.15091E-07 
Q960M4 Peroxiredoxin 5 Oxidoreductase 0.62 1.40 0.001742624 
Q9W5W8 CG9577 Isomerase 0.65 1.27 0.004163219 
Q24583 V-type proton ATPase subunit F 1 Ion transport 1.40 1.00 0.006504416 
P25455-2 
1-phosphatidylinositol 4,5-bisphosphate 
phosphodiesterase classes I and II 
Lipid 
degradation 
1.98 1.90 0.009649766 
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Appendix D 
 
Proteins defined as unique to a condition from pairwise comparisons 
Old- unique (vs old+)  
Accession Protein Number of Bios 
old + 
Number of Technical 
old + 
Number of Bios 
old - 
P92177-4 14-3-3 protein epsilon 4 6 0 
Q24086 Soluble guanylyl cyclase beta subunit 3 4 0 
Q7JVK6 Translin 3 4 0 
A4V4A5 Ran 3 3 0 
E1JHJ4 Myosin heavy chain 3 3 0 
Q08012 Protein enhancer of sevenless 2B 3 3 0 
Q4QQA3 ProteinC kinase 98E 3 3 0 
Q9VVU2 Ribosomal protein L26 3 3 0 
O15971 Rab 10 3 3 0 
Q9VM50 Rab 30 3 3 0 
Q9W3K6 CG2258 3 3 0 
A1ZB71 Glutathione S transferase E6 2 3 0 
P11146 Heat shock 70 protein cognate 2 2 3 0 
Q7K2D2 Probbale dynactin subunit 2 (Dynamitin) 2 3 0 
Q7KN62-2 Transitional endoplasmic reticulum ATPase TER94 2 3 0 
Q8INN5 Unc-115-Isoform B 2 3 0 
Q8MT29 Tom 70 2 3 0 
Q9VY05 GH11762p 2 3 0 
O97471 Microsomal glutathione S-transferase-like protein 2 3 0 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
   
[225] 
 
Young - unique (vs old +)  
Protein Number of Bios 
19day- 
Number of Technicals 
19day- 
Number of Bios 
34dayM 
14-3-3 protein epsilon 4 5 0 
CG33303 3 5 0 
Cytoplasmic phosphatidylinositol transfer protein 1 2 4 0 
CG10077 3 4 0 
Eukaryotic translation initiation factor 3 subunit 5-1 2 4 0 
Putative peptidyl-prolyl cis-trans isomerase dodo 2 4 0 
Cellular retinaldehyde binding protein 3 3 0 
CG6613 2 3 0 
ATPase ASNA1 homolog 2 3 0 
Actin, larval muscle 2 3 0 
26S protease regulatory subunit 4 2 3 0 
Bitesize isoform 3 (granuphiliin homolog) and 
synaptotagmin-like protein 
2 3 0 
Mustard 2 3 0 
CG6463 2 3 0 
Acyl carrier protein, mitochondrial 2 3 0 
60S ribosomal protein L31 2 3 0 
Vitellogenin-2 2 3 0 
Heat shock protein 27 2 3 0 
CG31281 2 3 0 
Cytochrome b-c1 complex subunit 9 2 3 0 
F-actin-capping protein subunit beta 2 3 0 
Eukaryotic translation initiation factor 5A 2 3 0 
CG30378 2 3 0 
CG8888 2 3 0 
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Young + unique (vs old +)  
Protein 
Number of Bios 
34day- 
Number of 
Technicals 34day- 
Number of Bios 
34day+ 
NAP1 4 6 0 
14-3-3 protein epsilon 4 5 0 
HSP27 4 5 0 
Heterogeneous nuclear 
ribonucleoprotein A1 
3 5 0 
Microtubule-assocaited protein Jupiter 4 5 0 
cAMP-dependent protein kinase type I 4 5 0 
Eukaryotic translation initiation factor 3 
subunit F-1 
3 4 0 
Heat shock protein 26 4 4 0 
Heat shock 70 kDa protein cognate 2 2 4 0 
Myosin regulatory light chain 2 3 4 0 
CG9090 2 4 0 
Proteasome subunit beta type 3 4 0 
Eb1, isoform F 2 3 0 
Sec22 2 3 0 
Myofilin 2 3 0 
Myosin heavy chain, muscle 2 3 0 
Dihydroorotate dehydrogenase (quinone, 
mitochonrial 
3 3 0 
Flightin 2 3 0 
Troponin1 2 3 0 
Tetraspanin 42Ef 2 3 0 
CG11474 2 3 0 
Sarcoplasmic calcium-binding protein 1 2 3 0 
IA-2 2 3 0 
cg991 2 3 0 
40s ribosomal protein s5a 2 3 0 
cg9512 2 3 0 
Glycogen Synthase 3 3 0 
 
 
 
 
 
 
 
 
 
Appendix 
   
[227] 
 
Young + unique (vs young -) 
Protein 
Number of Bios 
19dayP 
Number of 
Technicals 19dayP 
Number of Bios 
19dayM 
Proteasome subunit alpha type-7-1 4 7 0 
Heat shock protein 26 4 4 0 
tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit 
wuho 
3 5 0 
Proteasome subunit beta type 3 4 0 
Myosin regulatory light chain 2 3 4 0 
Dihydroorotate dehydrogenase (quinone), mitochondrial 3 3 0 
60S ribosomal protein L7a 2 4 0 
Myosin heavy chain, muscle 2 3 0 
Protein kinase shaggy (differences in isoforms) 2 3 0 
Flightin 2 3 0 
Putative hydroxypyruvate isomerase 2 3 0 
Sarcoplasmic calcium-binding protein 1 2 3 0 
CG9911 2 3 0 
40S ribosomal protein S28 2 3 0 
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Appendix E 
 
Ageing protein-protein interaction network  
 
 
 
Appendix 
   
[229] 
 
APPENDIX F 
Protein-protein interaction networks for protein >1.3 fold upregulated, NHK+/M+ (Chapter 4)  
Cluster I 
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Cluster II 
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Cluster III 
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Cluster IV 
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Cluster V 
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Cluster VI 
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APPENDIX G 
KEGG pathway analysis, NHK+ vs M+ (Chapter 4) 
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Appendix H 
 
